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INTRODUCTION
Adhesion formation and adhesion-related complications
Peritoneal adhesions form in more than 90 percent of patients following open abdominal 
or pelvic surgery, which is predominantly performed by surgeons, gynaecologists 
and urologists.(1-3) Adhesion formation carries a huge clinical and socio-economical 
burden due to the lifelong risk for various clinical complications. Traditionally, intestinal 
obstruction, female infertility and chronic abdominal pain were regarded as the most 
important complications caused by adhesions.(4) In a recent systematic review and 
meta-analysis the incidence of reoperations for adhesive small bowel obstruction 
(ASBO) after abdominal surgery is estimated at 2.4 percent. The overall incidence of 
ASBO might actually be higher because presence of adhesions cannot always be 
confirmed in patients who had conservative management of their small bowel 
obstruction. The mean length of hospital stay after admission for an adhesive bowel 
obstruction is 7.8 days and in-hospital mortality is estimated at 2.5 percent.(4) 
Pregnancy rate in female fertile-aged patients is 65 percent after colorectal surgery 
for inflammatory bowel disease surgery, which is significantly lower in comparison to 
medically treated patients who have a pregnancy rate of 82 percent. As many as 
23 percent of these female patients seek fertility treatment after surgery.(4) 
The incidence of chronic postoperative abdominal pain (CPAP) is estimated at 11 percent 
and is associated with a decrease in overall quality of life and an increase of gastro-
intestinal symptoms.(5, 6) Adhesions and chronic abdominal pain often coincide after 
surgery, albeit their causative relationship has been debated due to the discrepancy 
between the incidence of adhesion formation and CPAP. Diagnosing adhesions as 
the cause of CPAP and gastrointestinal complaints is usually done per exclusionem. 
Nevertheless, in 57% of patients adhesions are deemed to be the cause of CPAP.(4) 
While performing “pain mapping experiments” Demco et al found that touching and 
moving certain, but not all, adhesions caused a pain sensation in patients.(7) Additionally, 
a small follow-up study of a randomized controlled trial comparing the effectiveness 
of an adhesion barrier versus no treatment found that patients who received an adhesion 
barrier had less abdominal pain 10 years after surgery.(8) In contrast, a randomized 
controlled trial showed no additional benefit from laparoscopic adhesiolysis versus 
a diagnostic laparoscopy for patients with CPAP.(9) Establishing a more causative 
role between postoperative adhesions and CPAP can lead to renewed interest in this 
topic and improved treatment.
During repeat abdominal surgery, the need for adhesiolysis results in a 5.8% incidence 
of iatrogenic bowel injury, increased operative time of 15 minutes and a longer and 
more complicated convalescence.(4) The sequelae of iatrogenic bowel injury include 
unplanned bowel resection and the mortality rate is estimated at between 8 and 
50 percent, depending on whether the injury was recognized during surgery.(10-12) 
Due to a higher life expectancy and advances in surgical technology an increasing 
number of patients require abdominal surgery multiple times during their lifetime. The 
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Risk factors for adhesion-related complications
The most frequent investigated adhesion-related complication is ASBO. The highest 
incidence is found after pediatric surgery and surgery of the lower gastrointestinal 
tract, however, it has not been elucidated why pediatric and colorectal surgery 
particularly harbour this risk.(4) One explanation is the longer life time risk, which is 
especially true for pediatric surgery. Another explanation, more applicable for 
colorectal surgery, is the extensive dissection which is needed causing adhesion 
formation between the remaining colon, small bowel, abdominal wall and, retroperi-
toneum. Such adhesion formation may compromise intra-abdominal bowel movement 
and increase the chance of the occurrence of an obstruction. This explanation is 
supported by the finding that a panproctocolectomy and total colectomy carry the 
highest risk for adhesion-related readmissions, with rates up to 30 percent.(26) 
A completely non evidence-based explanation often given by surgeons is that a 
single adhesive band harbours a higher risk for bowel obstruction than multiple 
tenacious adhesions. In line with this opinion, some argue that usage of adhesion 
barriers might be dangerous due to incomplete prevention of postoperative adhesions 
thereby creating the possibility of patients ending up with single bands of abdominal 
adhesions. 
In order to prevent adhesiolysis-related morbidity and guide adhesion barrier use, 
more knowledge of epidemiological patterns for repeat abdominal surgery is needed. 
Repeat abdominal surgery has only been investigated in a number of disease specific 
cohorts which assessed risk factors for undergoing reoperations for disease 
recurrence.(27, 28) However, repeat abdominal surgery might not be related to the 
index surgery, e.g. a sigmoid resection following previous hysterectomy. In this 
example the close proximity of these organs in the lesser pelvis can induce dense 
adhesions in the operative area causing significant risk during the second procedure. 
Two population based studies showed that the incidence of repeat abdominal 
surgery is 14 percent at two years after predominantly colorectal procedures and 
36.7 percent at ten years after any type of abdominal surgery.(3, 29) Both studies lack 
patient-specific details and do not provide information regarding the indication or 
anatomical location of the repeat operation. Both are important to select patients at 
risk for repeat surgery and to optimize placement of a barrier at the right anatomical 
location after surgery. 
Little is known about patient specific risk factors for the formation of peritoneal 
adhesions or adhesiolysis-related complications. Reported studies are small or of 
limited current relevance.(30, 31) The influence of the time interval between surgeries 
on the extent and severity of postsurgical adhesions is a topic of debate. Other risk 
factors that seem to impact the severity of adhesions are a history of peritonitis and 
presence of intra-peritoneal mesh.(2, 32-34) 
rising life expectancy following abdominal surgery for benign and malign conditions, 
makes quality of life and socioeconomic costs an increasingly important outcome of 
elective abdominal surgery.(13-18) However, little is known of the impact of adhesiolysis- 
related complications on quality of life and socioeconomic costs. This information is 
important for patients undergoing elective surgery in giving informed consent, shared- 
decision making and to guide usage of adhesion barriers.
Prevention of adhesion formation
Part of the morbidity from postoperative adhesion formation might be preventable by 
using a surgical technique that minimizes peritoneal trauma and adhesion barriers. 
Good surgical technique remains difficult to substantiate. An important limitation of 
surgical technique, when used as the only means to prevent adhesions, is that the 
dissection areas and resection planes (in oncologic surgery) or the inserted materials 
(e.g. mesh and sutures in surgery for a ventral hernia) remain similar. However, there 
is some evidence that the incidence of adhesions and ASBO is lower after laparo- 
scopic surgery in comparison to open surgery.(19) 
Usage of an adhesion barrier is the next step in preventing peritoneal adhesion 
formation. Adhesion barriers work through separating injured peritoneal tissues and 
they are produced in various forms such as a solution, gel, spray or membrane. More 
than 20 different adhesion barriers have been investigated in clinical studies, many 
were either unsuccessful in reducing the formation of adhesions or were only 
assessed using outcomes of minor clinical importance.(20-22) A recent systematic 
review of 4 commercially available adhesion barriers demonstrated that these barriers 
were safe to use and two adhesion barriers showed modest benefits in reducing 
clinically relevant consequences of adhesions.(23) There is paucity in evidence 
regarding outcomes of clinical efficacy of adhesion barriers despite the extensive 
number of studies assessing adhesion barriers in the pre-clinical and clinical setting. 
Although the burden of adhesions is high and the benefit of some barriers has been 
proven, these are seldom applied. In a nationwide survey in 2009 in The Netherlands 
only 13.4% of surgeons indicated to have used any adhesion barrier in the previous 
year.(24) Doubts about clear indications for appropriate usage and cost-effectiveness 
may explain the reluctance for using adhesion barriers. It is deemed unlikely that 
adhesion barriers will be cost-effective for patients undergoing all types of abdominal 
surgery.(25) Identification of sub-groups of patients more at risk for adhesion-related 
complications and patient-specific risk factors for adhesion-related complications 
might aid in establishing a tailored approach for usage of adhesion barriers in 
individual patients. 
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In chapter 6 risk factors are identified for prolonged and difficult adhesiolysis under- 
neath the incision by analysing a prospective cohort of patients undergoing a repeat 
median laparotomy.
In chapter 7 a nomogram is determined to assess the risk of the occurrence of an 
iatrogenic enterotomy during elective general abdominal surgery for individual patients.
A follow-up study of the prospective cohort in chapter 3 is presented in chapters 8 
and 9. Patterns and risk factors for repeat abdominal surgery are described in chapter 8. 
The incidence and risk factors of adhesive bowel obstruction was assessed in chapter 9 
with emphasis on the severity of adhesions and adhesiolysis data at initial surgery. 
Available pre-clinical evidence regarding the prevention of adhesion reformation with 
anti-adhesive barriers is assessed by using systematic review and meta-analysis in 
chapter 10.
A general discussion and a summary of this thesis are presented in chapter 11 and 
chapter 12.
Limited evidence suggests that the local expression of growth factors and proteins 
regulating fibrinolysis are increased in the peritoneum of patients with adhesions, 
potentially leading to aggravated adhesion reformation when lysed.(35, 36) Therefore, 
efficacy of adhesion barriers might be reduced if adhesions are already present 
during repeat abdominal surgery. This is supported by an animal study assessing the 
efficacy of repeated usage of adhesion barriers.(37) Improved knowledge of the 
effectiveness of adhesion barriers after repeat abdominal surgery could lead to more 
effective anti-adhesion strategies. 
Combining patient-specific risk factors for adhesion-related complications and more 
effective usage of adhesion barriers could help to select patients that benefit most 
from adhesion prevention and thereby aid in effective anti-adhesion strategies. 
Aim
The aim of this thesis is to determine the clinical impact of adhesiolysis. Secondary 
aims are the impact of adhesiolysis on the quality of life in abdominal surgery and to 
elucidate risk factors for short- and long-term complications of adhesiolysis and 
adhesions. The third aim is to assess the pre-clinical evidence regarding the 
prevention of adhesion reformation.
Outline
In chapter 2 the current literature is reviewed regarding the pathophysiology of peritoneal 
inflammation, adhesion formation, sepsis and tumor growth. Injury to peritoneal meso- 
thelial cells leads to an inflammatory response involving immunological, humoral, 
coagulation and neurological pathways interacting together in order to heal the 
injured surface. 
In chapter 3, the results of a prospective cohort study of patients undergoing elective 
general abdominal surgery to assess the impact of adhesiolysis on postoperative 
morbidity, mortality and costs are presented. In 715 patients detailed data on 
adhesiolysis were gathered by direct observation during surgery. A comparison was 
made between surgical procedures with and without adhesiolysis. 
In chapter 4 the relationship between adhesiolysis and adhesiolysis-related complications 
and quality of life is assessed. 518 patients completed pre- and postoperative the 
Short Form-36 and Duke’s Activity Status Index questionnaires and by using a multi- 
variable regression analysis the impact of adhesiolysis on quality of life was assessed.
In chapter 5 risk factors were assessed for the prevalence of postoperative chronic 
abdominal pain. 518 patients completed pre- and postoperative questions regarding 
pain and gastro-intestinal complaints. A multivariable regression analysis was performed 
to assess the relationship between the presence of adhesions, the need for adhesiolysis 
and postoperative pain and gastro-intestinal complaints.
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CHAPTER 2 PATHOLOGICAL PROCESSES IN THE PERITONEUM
Introduction
The peritoneal cavity is a confined space between the parietal peritoneum lining the 
abdominal wall, the retroperitoneum, and the visceral peritoneum covering the abdominal 
organs. Its total surface area is almost equal to the body surface area of the skin.(1) 
The peritoneum is a serous membrane of mesodermal origin, consisting of a monolayer 
of flat mesothelial cells anchored to the basement membrane. The subjacent connective 
tissue consists mainly of loose collagen fibers, including fibroblasts, blood and lymphatic 
vessels, as well as nerve fibers. The mesothelial cells play an active role in the physio- 
logical function as well as in pathological processes of the peritoneum. The peritoneal 
cavity contains less than 100 ml of serous fluid, an ultra-filtrate of plasma, which together 
with hyaluronan and a surfactant, produced by mesothelial cells, facilitates frictionless 
movement of the abdominal organs.(2) The peritoneum acts as a bidirectional semi- 
permeable membrane. The peritoneal mesothelial cells are interrupted by intermeso-
thelial gaps (stomata of von Recklinghausen), which adapt to pathological conditions 
by retraction of the cell margins in response to pathological stimuli and in relation with 
diaphragmatic movements. At these stomata the peritoneal cavity is directly exposed 
to the extracellular matrix.(3) The action of the diaphragm generates a cephalad flow 
of peritoneal fluid through the stomata.(4) Under normal circumstances, approximately 
one-third of the peritoneal fluid drains through the diaphragmatic stomata into the 
main thoracic lymphatic ducts, the remainder exits through the parietal peritoneum.
The peritoneal defense mechanism can be triggered by various types of pathological 
processes “injuring” the peritoneum. Apart from (surgical) trauma, injury can be 
caused by invasive pathogens and tumor. The peritoneum responds to injury with an 
inflammatory reaction. This inflammatory reaction comprises four interacting pathways: 
immunological, humoral, coagulation, and neurological. In this article, we aim to give a 
comprehensive overview of the response to pathological processes in the peritoneal 
cavity.
General peritoneal response to injury
Injury of the peritoneum, whether surgical, inflammatory, or ischemic, causes a complex 
inflammatory reaction. This response has an integral role in wound healing and tissue 
repair to heal any sustained damage. The disruption of the cellular membrane, through 
apoptosis or necrosis, causes a release of intracellular molecules such as DNA, ATP, 
and IL-1α in the extracellular space.(5–7) These have been named as Damage- 
Associated Molecular Pattern molecules (DAMPs), but the mechanisms by which 
they generate an inflammatory response are not fully understood. The DAMPs induce 
a local cascade through activating receptors on mesothelial and local inflammatory 
cells. The mesothelial and local inflammatory cells produce chemoattractants (IL-8 
and MCP-1), cytokines (TNF α, IL-1β, and IL-6), and growth factors (TGF β, IGF-1, and 
PDGF), which result in neutrophil extravasation which infiltrate the damaged area.(8) 
Abstract
The peritoneum is one of the most common sites for pathological processes in pediatric 
surgery. Its response to pathological processes is characterized by an inflammatory 
reaction with specific pathways depending on the type of injury or peritoneal process 
involved. This review discusses the current understanding of peritoneal inflammation, 
adhesion formation, intra-abdominal sepsis, peritoneal metastasis, and ascites and 
briefly reviews new therapeutic strategies to treat or prevent these pathological 
entities. Recent studies have improved the understanding of the peritoneal responses 
to pathological processes, resulting in possible new targets for prevention and therapy.
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adhesion between two formerly unconnected structures. Under normal circumstances, 
these fibrin deposits are degraded by fibrinolysis. This process of fibrinolysis is driven 
by the enzyme plasmin produced by macrophages and mesothelial cells. Plasmin is 
derived from its inactive substrate plasminogen by tissue-type plasminogen activator 
(t-PA) and urokinase-like plasminogen activator (u-PA). In its turn, t-PA is inhibited in 
its reaction by plasminogen activator inhibitor 1 (PAI-1) to keep the balance. However, 
peritoneal trauma leads to the absence of adequate fibrinolytic activity of the 
mesothelium and a mismatch in the fibrinolytic balance in favor of the persistence of 
fibrin clots.(13) Neighboring organs or the abdominal wall may adhere, generating a 
fibrin bridge between the attached tissues.(14) Under the actions of various cytokines, 
these fibrin bands are transformed into granulation tissue by the ingrowth of capillaries 
and fibroblasts and subsequently converted into permanent, collagenous, and highly 
organized tissue containing nerve fibers and vessels.
Adhesions frequently cause long-term complications after abdominal and pelvic surgery. 
After pediatric abdominal surgery, the incidence of adhesive small bowel obstruction 
can be as high as 15.6%, for example, after treatment of gastroschisis and omphalocele 
in neonates.(15,16) Other important clinical consequences of adhesions include infertility, 
chronic abdominal pain, malabsorption, and technical difficulties at reoperation. 
Many pharmacological methods and barriers have been used for adhesion prevention 
but only few have been proven to be successful. Prevention of adherence of adjacent 
structures by keeping them apart seems most efficacious. In a recent systematic 
review, the efficacy and safety of the four adhesion barriers approved for use in 
Europe and the USA were evaluated, showing evidence that membranes of oxidized 
regenerated cellulose and hyaluronate carboxymethylcellulose reduce adhesion 
formation.(17) Moreover, there is evidence that hyaluronate carboxymethylcellulose 
reduces the number of reoperations for adhesive small bowel obstruction. Evidence 
for efficacy on other clinically critical outcomes is lacking. Of the liquid adhesion 
barriers that are available in the market, icodextrin 4% solution is the most widely 
used. There is, however, limited evidence for the beneficial effect of icodextrin on the 
incidence of small bowel obstruction or other adhesion-related complications.(17,18) 
An understanding of the pathological processes enables the modulation of the 
peritoneal environment and fibrinolytic capacity, which seems to harbor a therapeutic 
opportunity to prevent postsurgical adhesion formation. Intraperitoneal treatment 
with recombinant human plasminogen activator (rPA) was effective in preventing 
postoperative adhesion formation in experimental studies.(13) A pilot study in humans, 
however, showed no reduction of adhesions.(19) Since there was no measurable 
elevation of plasma t-PA level in the treatment group, this negative result was ascribed 
to too small a dosage. An interesting option to potentially combine anti-inflammatory, 
anti-coagulatory, and profibrinolytic properties is the use of statins. Beside their cho-
lesterol-lowering capacity, there is accumulating evidence that statins effectively 
Mast cells are abundantly present around bowel mucosa and are believed to play an 
important role in the inflammatory response of the peritoneum by inducing vasodilation 
through release of histamine. They can also be activated by DAMPs and activate 
several local immunological and endothelial cells and nerve fibers.(9) Neutrophils 
persist at the injured site for 1–2 days and are followed by monocytes recruited in the 
same manner; these differentiate into macrophages which contribute to the 
inflammatory reaction. The primary injury of the peritoneum not only leaves a denuded 
area with damaged mesothelial cells but also causes bleeding and extravasation of 
plasma proteins. Coagulation is up-regulated through the expression of tissue factor 
(TF) by macrophages and mesothelial cells. Interaction of TF with plasma proteins 
and thrombocytes forms a transient fibrinous matrix. The formation of an extensive 
fibrinous matrix is possible because the balance between coagulation and fibrinolysis 
is disturbed. The fibrinogen split products are known to promote pleural mesothelial 
proliferation, this might also be the case with peritoneal mesothelial cells.(10) Fibrinolysis, 
however, is decreased because there is an up-regulation of plasminogen activator 
inhibitor 1 (PAI-1) and a down-regulation of tissue-type plasminogen activator (t-PA). 
There is increasing evidence that inflammation and coagulation significantly affect 
each other. Coagulation is induced by inflammatory cytokines, while the coagulation- 
induced modulation of inflammatory activity is driven by specific cell receptors on 
inflammatory cells and endothelial cells.(7) Moreover, thrombocytes play their part in 
inflammation through storage and release of the pro- and anti-inflammatory factors 
TGF β and IL-1.(5) The neurological pathway of the inflammatory response of the 
peritoneum is activated by IL-1 binding to paraganglia cells. The “inflammatory reflex” 
is formed by signalling through afferent fibers of the vagus nerve to parasympathetic 
regions in the brainstem, leading to the release of neuropeptides from efferent nerve 
fibers and a resultant feedback on inflammation.(11) Different neuropeptides can lead 
to either anti-inflammatory (e.g., acetylcholine) or proinflammatory (e.g., substance P) 
effects on inflammation. While in the past resolution of inflammation has always been 
seen as a passive process, the discovery of locally acting mediators (pro-resolving 
mediators) has changed this view.(12) These proresolving mediators are produced via 
transcellular biosynthesis (i.e., between neutrophils and thrombocytes) and down- 
regulate the inflammatory reaction.
Adhesion formation
Healing of the injured peritoneum can result in the formation of peritoneal adhesions. 
As mentioned, injury of the peritoneum leads to a denuded surface with submesothelial 
damage evoking an inflammatory response. Simultaneously the coagulation cascade 
is activated and fibrin deposited at the site. A serosanguinous exudate rich in 
inflammatory cells, fibronectin, glycosaminoglycans, and proteoglycans is secreted 
through increased vascular permeability. This results in fibrin deposits that form an 
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contamination, the omentum acts to absorb microbes and contaminants through its 
stomata and secretes phagocytes through the milky spots. The omentum promotes 
healing via the local expression of growth factors and the stimulation of angiogenic 
activity.(31) An abscess forms when this localizing defense mechanism fails to 
completely clear the bacterial contamination. Such abscesses consist of bacteria, 
neutrophils, and necrotic debris walled off by a fibrinous or fibrous capsule termed 
pyogenic membrane. When viable bacteria are entrapped in the abscess wall or in 
the center, they cannot be reached by phagocytes and antibiotic therapy. This can 
result in bacterial proliferation(32) and, if overwhelmed, can lead to a systemic inflammatory 
response syndrome through the release of pro-inflammatory mediators (e.g., TNF α 
and IL-1) into the systemic circulation.(33)
The cornerstones of successful therapy in intra-abdominal infection are—source 
control, drainage of abscesses, and appropriate antibiotics. Very early antibiotic 
intervention is effective in reducing mortality in sepsis. Empirical use of antibiotics is 
often necessary when confronted by a sick patient and should be re-evaluated by 
local resistance surveillance.(34) The choice of the empirical antibiotic regimen should 
cover the intestinal flora, aerobes, and anaerobes. Examples of broad-spectrum 
antimicrobial regimens for pediatric patients with complicated intra-abdominal infection 
are an aminoglycoside-based regimen, a carbapenem (imipenem, meropenem, or 
ertapenem), a β-lactam/β-lactamase inhibitor combination (piperacillin–tazobactam 
or ticarcillin–clavulanate), or an advanced-generation cephalosporin (cefotaxime, 
ceftriaxone, ceftazidime, or cefepime) with metronidazole.(35) After surgically eliminating 
the source of abdominal infection in patients with severe abdominal sepsis, open 
abdomen should be avoided, since it leads to higher mortality.(36) An open abdomen 
is defined as a situation where the skin and fascia cannot be closed after laparotomy 
and the viscera are exposed, needing temporary closure or coverage techniques.(37) 
The only indication for open abdominal management is abdominal compartment 
syndrome, although even in this circumstance, temporary closure without tension is 
recommended. Planned re-laparotomy is not recommended and results in a higher 
mortality, a longer ICU and hospital stay, and higher costs when compared with an 
“on-demand” strategy of surgical re-exploration.(34,36)
Ascites
Ascites is a pathological state where an excess of fluid is accumulated within the 
peritoneal cavity. In approximately 80% of cases in adults, ascites is caused by hepatic 
cirrhosis. Other common causes include malignancy in 10% and heart failure in 3%.(38) 
Hepatic disorders are the most common cause of ascites in infants and children.(39)
Three pathophysiologic processes contribute to the development of ascites in patients 
with cirrhotic liver disease: portal hypertension, vasodilation, and hyperaldosteronism. 
During the development of hepatic cirrhosis, the sinusoidal endothelial cells of the 
lower plasma levels of CRP, have potent anti-inflammatory properties, and are 
effective stimulators of fibrinolytic activity by increasing t-PA and lowering PAI-1.(20,21) 
Also, the use of an angiotensin-II receptor blocker has potential efficacy in adhesion 
prevention through decreasing TGF β. The intraperitoneal administration of these 
agents alone and combined effectively reduced postsurgical adhesions in mice.(22) 
However, no data on efficacy in humans are available yet. Another potentially viable 
therapeutic target is substance P (a specific proinflammatory neuropeptide).(23) The 
effects associated with substance P are increasing inflammatory cytokine mRNA 
expression, stimulating angiogenesis, and proliferation of fibroblasts. This is mainly 
mediated through binding to neurokinin-1 receptor. Binding to the neurokinin-1 
receptor can be inhibited through intraperitoneal administration of a neurokinin-1 
receptor antagonist. In rats, interference with the actions of substance P with this 
antagonist showed early effects on the mRNA expression of several key mediators of 
adhesiogenesis.(24)
Intra-abdominal infection, abscess formation, and peritonitis
Intra-abdominal infection encompasses all forms of bacterial peritonitis, intra- abdominal 
abscesses, and infections of intra-abdominal organs. Perforation of a hollow organ is 
the leading cause of intra-abdominal infection, followed by postoperative peritonitis, 
ischemic damage of the bowel wall, infection of intra-abdominal organs, and translocation 
in nonbacterial peritonitis.(25)
Within minutes of bacterial invasion, a substantial proportion of the bacteria are 
absorbed from the peritoneal cavity through the stomata of von Recklinghausen in 
the diaphragmatic peritoneum and into the thoracic lymphatics.(26) At the same time, 
the bacteria activate the local response triggered by reaction of mesothelial cells and 
peritoneal macrophages, very similar to the response induced by sterile stimuli.(27) 
Chemoattractants, produced by mesothelial cells and local inflammatory cells, induce 
the recruitment of phagocytes (neutrophils and later macrophages), transmigrating 
from peritoneal capillaries to the mesothelial surface. Dilation of peritoneal blood 
vessels results in enhanced permeability, peritoneal edema, and the formation of 
protein-rich peritoneal exudates.(28) The local defense mechanism is able to localize 
and control the bacterial invasion through the formation of fibrinous adhesions 
trapping microbes and promoting local effector mechanisms to phagocytose them.
(29) The omentum contributes to the overall localization process. The mesothelial cell 
layer of the omentum encloses two distinct types of tissue: an adipose-rich area and 
a thin translucent membranous area.(30) The adipose-rich area contains omental 
milky spots, consisting mainly of inflammatory cells. The translucent area has a 
net-like structure with multiple fenestrations, and its function is associated with 
regulating fluid transport. The fenestrations also facilitate adhesion of the omentum to 
damaged or inflamed organs, giving it motile properties. Once localized to the site of 
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double-blinded, randomized, placebo-controlled study also showed longer para-
centesis-free survival, although this did not lead to an improved overall survival.(57) 
Complete resection of peritoneal metastasis is often not possible in patients with 
malignant ascites. Furthermore, the duration of postoperative recovery is comparable 
to the median overall survival time, making this patient category often considered 
ineligible for cytoreductive surgery combined with hyperthermic intra peritoneal chemo- 
therapy (HIPEC).(58) Therefore, a laparoscopic approach with limited adhesiolysis and no 
cytoreductive surgery combined with HIPEC has been advocated. Due to its minimally 
invasive nature, this procedure has shown to be safe, and promising results with regard 
to palliation and overall survival have been reported.(59,60)
Peritoneal metastasis
Peritoneal metastasis is a common route for gastrointestinal malignancies, including 
appendiceal, colorectal, gastric, and pancreatic cancers. It is the primary metastatic 
route for ovarian malignancies. Peritoneal carcinomatosis is associated with a poor 
prognosis, irrespective of the primary origin of the tumor.(8,27) The process of intra-
peritoneal tumor dissemination differs from hematologic metastasis where tumor cells 
need to enter and exit the circulation and penetrate tissues. Peritoneal dissemination 
occurs in gastrointestinal malignancies when tumor cells exfoliate from the primary 
tumor after it has invaded the visceral peritoneum or in the case of a perforation of the 
gastrointestinal tract.(11) After dissemination into the peritoneum, tumor cells must 
prevent apoptosis and evade peritoneal clearance through the lymphatic system. 
This requires tumor cells to attach to the disrupted mesothelial surface or the exposed 
extracellular matrix (ECM) or at the stomata of von Recklinghausen for further disease 
progression. Tumor cells may adhere to the surface of mesothelial cells through 
various receptors(61–63) but show a predilection of adhering to type 1 collagen of the 
ECM.(64,65) The ECM is, therefore, the initial site of metastasis.(66) Surgical injury of the 
peritoneum exposes the ECM and damages the mesothelial cell layer.(67) Additionally, 
interactions between immune, mesothelial, and tumor cells create an inflammatory 
environment that causes the mesothelium to retract, exposing more of the ECM. 
Furthermore, inflammatory cytokines up-regulate mesothelial cell surface receptors 
enabling the attachment of tumor cells (68,69) and therefore increase metastatic spread. 
Tumor cells have the ability to assemble into multicellular aggregates, named spheroids, 
through direct cell–cell attachments.(70) When formed into spheroids, tumor cells 
have increased resistance against anoikis and chemotherapeutics.(71) Additionally, 
spheroid formation is associated with more invasive tumors.(72) Targeting spheroid 
formation by attenuating the contractile abilities of tumor cells might be an important 
treatment modality and is an area of extensive research.(73) The presence of ascites 
in patients with advanced ovarian cancer decreases their life expectancy when 
compared with patients who present without ascites in similar advanced ovarian 
intra-hepatic microcirculation fail to function, resulting in aberrant paracrine signalling. 
This process causes inflammation, fibrosis, and impaired vasomotor control, leading 
to increased intra-hepatic vascular resistance and portal hypertension.(40) Additionally, 
sinusoidal cells are highly permeable to albumin, making lymph formation dependent 
on hydrostatic forces alone, which are increased due to portal hypertension. A systemic 
effect of portal hypertension is vasodilation through increased nitric oxide production 
and hydrostatic pressure of the splanchnic circulation, leading to more fluid extra- 
vasation into the peritoneum. Furthermore, systemic vasodilatation results in relative 
hypovolemia and stimulates the renin–angiotensin–aldosterone system.(41) Increased 
antidiuretic hormone secretion induces water retention. While angiotensin normally 
promotes vasoconstriction, in the presence of hepatic cirrhosis, this effect is dampened.(42) 
If a patient develops hypoalbuminemia, a lower intra-vascular osmotic pressure exacerbates 
this process. An extensive summary of the different treatments for ascites due to cirrhotic 
liver disease goes beyond the scope of this review. In short, the intake of sodium should 
be restricted, and in most patients, addition of a diuretic is necessary. The most effective 
diuretic is spironolactone but a combination with furosemide might be required.(43,44) 
Paracentesis is a safe and effective treatment in the management of diuretic-resistant 
ascites.(45) If more than 5 l of fluid will be removed through paracentesis, intravenous 
albumin has been shown to improve survival.(46) A transjugular intra-hepatic porto- 
systemic shunt has shown to improve transplant-free survival in comparison to large- 
volume paracentesis.(47) Liver transplantation is a viable treatment in patients who 
develop diuretic-resistant ascites and early referral to a transplant center should be 
standard care.
In the presence of peritoneal malignancy, ascites has a completely different etiology. 
Malignant ascites develops because of a mismatch between filtration and drainage 
in the peritoneal cavity. In patients with peritoneal carcinomatosis, the cross-sectional 
area of microvessels that line the peritoneal cavity is increased.(48) Furthermore, 
due to the secretion of Vascular Endothelial Growth Factor (VEGF) by tumor cells, 
the permeability of microvessels is increased,(49) leading to an increased accumulation 
of protein-rich fluid in the peritoneal cavity. This shifts the oncotic pressure gradient 
further in the direction of the peritoneum. Impaired drainage from the peritoneum can 
also be caused by tumor cells blocking the peritoneal stomata, but this is a less 
important mechanism.(50) Due to the differences in etiology between malignant and 
cirrhotic ascites, diuretics are less effective in the treatment of malignant ascites. 
However, patients with extensive liver metastases might benefit from a diuretic.(51) 
Intraperitoneal chemotherapeutics, corticosteroids, cytokines, and a VEGF inhibitor 
have been reported to improve the control of ascites.(52–55) A randomized clinical trial 
using intraperitoneal administration of a monoclonal antibody, Catumaxomab, showed 
longer paracentesis-free survival and improved palliation in comparison to paracentesis 
alone.(56) Aflibercept, a VEGF inhibitor given intravenously, was evaluated in a phase 2, 
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cancer.(74) Malignant ascites contains multiple growth factors and cytokines, (75–77) which 
enhance resistance against chemotherapeutic agents(78) and promote spheroid formation 
of tumor cells.(79) Increased amounts of fibrinogen and fibrin found in ascites may lead 
to the assemblage of tumor deposits that can become vascularized because of the 
presence of angiogenic growth factors.(80) Notably, heparin-binding epidermal growth 
factor (HB-EGF) has been shown to contribute to disease progression in ovarian cancer 
patients.(81) A small study reported promising results with an inhibitor of HB-EGF.(82)
The cornerstone in the treatment of peritoneal carcinomatosis, in the absence of 
other systemic metastasis, is complete cytoreductive surgery and HIPEC. Although 
associated with considerable morbidity and mortality, it has shown to improve overall 
survival. An important prognostic factor for survival is complete macroscopic tumor 
resection.(83,84)
Conclusion
The inflammatory reaction of the peritoneum forms an essential part of the physio-
pathology of abscess formation, adhesion formation, malignant ascites, and peritoneal 
metastasis. Specific pathways and interactions depend on the type of injury to the 
peritoneum. An increased understanding of these pathological processes has yielded 
potential targets for new therapies.
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Introduction
Peritoneal adhesions develop after more than 90% of operations in the abdominal 
cavity, procedures frequently performed by general, vascular, and gynaecological 
surgeons and urologists.(1–3)
Intestinal obstruction, female infertility, and abdominal pain are well-known adhesion- 
related complications that negatively impact millions of lives worldwide.(1;2;4–7) Surprisingly, 
adhesion-related complications receive little attention in clinical practice.(8–11)
Complications that occur after adhesiolysis during repeat surgery might even form a 
larger burden of morbidity.(8) In a retrospective cohort, the risk of inadvertent bowel 
defects was as high as 19%.(12) The risk of needing repeat abdominal surgery is 
relatively high and is expected to increase in the western world with the increase of life 
expectancy and developments in surgical technology.(13–17)
Little is known of the impact of adhesiolysis and related organ injury on morbidity and 
socioeconomic costs in comparison with other adhesion-related complications. 
Knowledge of the morbidity related to adhesiolysis is needed to properly inform 
patients before surgery to take adhesiolysis risks into account in the operative deci-
sion-making, and to improve diagnosis of postoperative complications. In addition, 
proper data on adhesiolysis time and the socioeconomic burden of adhesions are 
helpful for operative room management and health care insurance.
In this prospective study, we did a detailed assessment and analysis of adhesiolysis, 
(post)operative complications, and socioeconomic factors in a large cohort of 
elective abdominal operations (clinicaltrials.gov registration number: NCT01236625).
Methods
Study Design and Patients
This was a prospective observational study as part of the LAPAD (LAParotomy or 
LAParoscopy and ADhesiolysis) study. The LAPAD study was designed to assess 
the incidence and impact of adhesiolysis on preoperative and postoperative 
complications, quality of life, and socioeconomic costs. All adult patients planned for 
elective abdominal surgery at the Department of Surgery of the Radboud University 
Nijmegen Medical Center between June 2008 and June 2010 were screened for 
inclusion. Patients planned for admission to the surgical day-care unit were excluded 
because the short hospital stay did not allow for adequate follow-up.
Inclusion criterion was an elective laparotomy or laparoscopy. Exclusion criteria were 
age under 18 years and mental disorder. Patients were included after giving oral and 
written informed consent.
Relevant patient, surgical, and medical data were prospectively assessed before, 
during, and after hospital stay and at the outpatient clinic until 6 months after discharge. 
At surgery, detailed information of adhesions, adhesiolysis, and inadvertent organ 
damage was collected through direct observation by a trained researcher (R.B., C.S., 
Abstract
Objective: To determine the incidence of bowel injury in operations requiring adhesiolysis 
and to assess the impact of adhesiolysis on the incidence of surgical complications, 
postoperative morbidity, and costs.
Background: Morbidity of adhesiolysis during abdominal surgery seems an important 
health care problem, but the direct impact of adhesiolysis on inadvertent organ 
damage, morbidity, and costs is unknown.
Methods: In a prospective cohort study, detailed data on adhesiolysis were gathered 
by direct observation during elective abdominal surgery. Comparison was made 
between surgical procedures with and without adhesiolysis on the incidence of 
inadvertent bowel defects. Secondary outcomes were the effect of adhesiolysis and 
bowel injury on surgical complications, other morbidity, and costs.
Results: A total of 755 (out of 844) surgeries in 715 patients were included. Adhesiolysis 
was required in 475 (62.9%) of operations. Median adhesiolysis time was 20 minutes 
(range: 1–177). Fifty patients (10.5%) undergoing adhesiolysis inadvertently incurred 
bowel defect, compared with 0 (0%) without adhesiolysis (P < 0.001). In univariate 
and multivariate analyses, adhesiolysis was associated with an increase of sepsis 
incidence [odds ratio (OR): 5.12; 95% confidence interval (CI): 1.06–24.71], intra-ab-
dominal complications (OR: 3.46; 95% CI: 1.49–8.05) and wound infection (OR: 2.45; 
95% CI: 1.01–5.94), longer hospital stay (2.06 ± 1.06 days), and higher hospital costs 
[$18,579 (15,204–21,954) vs $14,063 (12,471–15,655)]. Mortality after adhesiolysis 
complicated by a bowel defect was 4 out of 50 (8%), compared with 7 out of 425 
(1.6%) after uncomplicated adhesiolysis (OR: 5.19; 95% CI: 1.47–18.41).
Conclusions: Adhesiolysis and inadvertent bowel injury have a large negative effect 
on the convalescence after abdominal surgery. The awareness of adhesion-related 
morbidity during reoperation and the prevention of postsurgical adhesion deserve 
priority in research and clinical practice.
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intensive care unit admission, intensive care unit stay, parental feeding, tube feeding, 
incidence of emergency reoperations, and incidence of readmission to the hospital 
within 30 days after discharge.
Cost analysis was performed in United States dollars (unit of analysis) and included 
only the direct hospital costs: operation costs, ward stay, intensive care unit stay, 
extra charges for parental and tube feeding, postoperative diagnostics, reoperation 
costs, and blood products. Cost calculations were performed using the guidelines 
for cost analysis of the Dutch College of Health Insurance Companies using a 
top-down approach.(19) Operation costs were calculated based on total anaesthesia 
time using operating room costs of $1390 per hour, including personnel, material, 
and overhead costs. Total costs for the surgical ward and intensive care unit were 
$661 and $2289 per day, respectively, and included basic nutritional costs. More 
than basic parental and tube feedings were considered as extra nutritional costs. 
Diagnostic and reoperation costs were calculated using the 2004 price lists for 
medical procedures by the Dutch College of Health Insurance Companies. Medication 
costs and blood products costs were calculated according to the standardized price 
list of the Dutch College of Health Insurance Companies updated for June 2008.(20)
Baseline demographics included sex, age, body mass index, Alcohol Use Disorders 
Identification Test alcohol abuse index,(21) history of abdominal operations, number 
of laparotomies in history, number of laparoscopies in history, history of generalized 
peritonitis, American Society of Anaesthesiologists classification, P-Possum score, 
Revised Cardiac Risk Index, diabetes mellitus, extent of surgery, surgical approach 
(open or laparoscopic), anatomical site of operation [upper gastro-intestinal, lower 
gastro-intestinal, hepatobiliary–pancreatic, abdominal wall, or other], and level of 
surgical experience (surgeon or resident).
Statistical Methods
Univariate comparisons were performed using linear regression for continuous and 
logistic regression for dichotomous data. Effect size was expressed as mean 
difference with standard deviation for continuous data and odds ratios (ORs) for 
dichotomous data. Despite the large number of patients, differences in baseline 
factors between the groups were expected because adhesions are mostly due to 
prior surgery. To avoid potential bias by an unequal distribution of risk factors, we 
calculated an adjusted effect size using multivariate linear and logistic regression for 
continuous and dichotomous data, respectively. All factors with unequal distribution 
at baseline with P < 0.010 were included in the multivariate model, except a history of 
peritoneal surgery and generalized peritonitis, and peritoneal surgery and previous 
peritonitis were considered pathogenic for adhesion formation and were not expected 
to have further independent adverse effects on treatment outcomes. In composite 
outcomes, statistical results were presented for both the composite outcome and the 
or Y.I.) who did not take part in the operation. Evaluation of adhesions was comprised 
of a description of the location, for example, ventral abdominal wall, operative area, 
and other parts of the abdomen, grading of adhesions at these 3 locations according 
to the Zühlke classification, and timing the duration of adhesiolysis by stopwatch.(18) 
Findings were recorded into the real-time database by the researcher present in 
the operating theatre. Operative and treatment decisions were made according to 
department guidelines or at the discretion of the surgical staff. As a rule in our institution, 
adhesiolysis was done by sharp dissection and not by electrocautery or ultrasonic 
dissection. The study was approved by the local medical ethical committee and 
conducted according to the revised version of the Declaration of Helsinki (October 
2008, Seoul).
Variables
Primary outcomes were the incidence of adhesions, adhesiolysis time, the incidence 
of bowel defects, seromuscular injury, injuries to other organs and structures, and the 
incidence of major surgery-related complications.
A detailed description of any adhesion present was obtained by direct observation. 
Adhesiolysis time was measured in minutes from the start of adhesiolysis until the 
operative area was cleared of adhesions.
Bowel defects were classified as inadvertent enterotomy or delayed diagnosed 
perforation. Inadvertent enterotomy was defined as any iatrogenic, unintended full 
thickness bowel defect detected during operation. Preexisting fistulas or defects 
created while dissecting the bowel loop that harboured the fistula were not scored as 
inadvertent enterotomy. Delayed diagnosed perforation was defined as a bowel defect 
with spill of gastrointestinal content that was diagnosed postoperatively by imaging, 
at reoperation, or at autopsy, and that could not be explained by anastomotic leakage, 
bowel ischemia, or any other obvious causes of leakage unrelated to adhesiolysis.
Seromuscular injury was defined as injury to the serosal and muscular layers of the 
bowel, without visualization of the bowel lumen or spillage of bowel content. Other 
intraoperative injuries were comprised of any injury to the spleen, liver, pancreas, 
urogenital structures, lung, vascular structures, or nerves.
Postoperative complications noted as major surgery-related complications were death, 
wound infection (categorized as superficial or deep), anastomotic leak, fistula and 
abscess, pneumonia, sepsis, haemorrhage, and urinary tract infection. Major surgery- 
related complications were defined according to the criteria of the International 
Classification of Diseases, Tenth Revision, the National Nosocomial Infections 
Surveillance System, the Centre for Disease Control and Prevention, or according to 
the decision of the senior medical staff of the department.
Secondary outcomes were other morbidity and socioeconomic costs including total 
operative time, blood loss, recovery unit stay, hospital stay, unplanned or prolonged 
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Impact of Adhesiolysis on Peroperative Complications
The incidence of full thickness bowel defects was 10.5% in the adhesiolysis group 
and 0% in the nonadhesiolysis group (P < 0.001). During 43 operations, there was a 
median of 1 (range: 1–9) inadvertent enterotomy. Bowel resection and anastomosis 
were required in 24 operations (55.8%) with 1 or more enterotomies, and in the 
remaining operations, enterotomies were repaired by primary suturing. Injury to the 
seromuscular layer occurred in 131 procedures (27.6%) with adhesiolysis compared 
with 11 (3.9%) without adhesiolysis (P < 0.001). As a rule, seromuscular injuries were 
repaired by suturing.
individual components of the composite. Costs are presented as mean cost with a 
95% confidence interval (CI). Statistical comparison of costs was performed by 
multivariate regression on the logistically transformed values of the costs to reduce 
the impact of outliers. All outcomes were assessed per operation and analysed 
according to an intention-to-treat, unless otherwise stated.
In the subgroup of operations with adhesiolysis, we compared major surgery-related 
complications, other morbidities, and costs between adhesiolysis complicated by 
bowel defects and uncomplicated adhesiolysis.
In an additional analysis, we calculated the risk for enterotomy, seromuscular injury, 
and other organ injury by categorizing adhesiolysis time (none, 1–15, 16–30, 31–60, 
and >60 min).
There was only minimal missing data; thus, we excluded per analysis those cases 
with missing data. We used SPSS for Windows version 16.0 software (SPSS, Chicago, 
IL) for statistical analysis. Values of P < 0.05 were considered significant.
Results
Cohort and Baseline Comparison
A total of 844 consecutive elective surgeries were screened for eligibility; 89 operations 
were excluded. Main reasons for exclusion were cancellation of the operation (N = 38), 
refusal to participate (n = 11), and mental incompetence of the patient (N = 8). A total of 
755 operations carried out in 715 patients were included in the study (Figure 1). Adhesiolysis 
time was missing in 4 operations (0.5%). There were no further missing data.
The incidences of adhesions and adhesiolysis were 497 out of 755 (65.8%) and 475 
out of 755 (62.9%), respectively. Most common etiologies for the presence of 
adhesions were previous intra-abdominal surgery and peritonitis (Table 1); mean 
adhesiolysis time was 20 minutes (range: 1–177). Adhesions to the incision scar of a 
previous operation were found in 399 (80.3%) of operations with adhesions, whereas 
in 416 operations (83.7%), adhesions were present in the operative area and in 329 
operations (63.6%), adhesions were found in other parts of the abdomen. Median 
Zühlke score was 2 (range: 1–5) at all 3 locations. Severe adhesions (Zühlke score: 3 
or 4) were found under a previous scar in 233 operations (46.9%) with adhesions, at 
the operative area in 235 operations (47.3%), and in other parts of the abdomen in 160 
operations (32.2%). Patients who had adhesions and no prior surgery or general 
peritonitis in their history usually only had a few low-grade adhesions with a median 
adhesiolysis time of 5 minutes (range: 1–93). Those adhesions were mostly located 
adjacent to a local inflammatory process or tumour.
Table 1 shows the baseline data for the 2 groups. There were significant differences 
in the anatomical location of the operation (P < 0.001), operative severity (P < 0.001), 
surgical approach (P = 0.01), and body mass index (P = 0.003).
Figure 1  Flow diagram of the included operations.
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Delayed diagnosed perforation occurred after 10 surgeries. A delayed diagnosed 
perforation occurred after 8 out of 142 seromuscular injuries (5.6%) and 3 out of 
43 enterotomies (7.0%). The 3 patients with a delayed diagnosed perforation after an 
enterotomy also had seromuscular injuries. In 2 patients with delayed diagnosed perforation 
(20.0%), no seromuscular injury or enterotomy occurred during initial operation. 
Injury to other organs was 8.6% in the adhesiolysis group compared with 2.5% in the 
nonadhesiolysis group (P = 0.001). Most common injuries in the adhesiolysis group 
were to the liver (n = 14), vascular structures (n = 11), urogenital structures (n = 8), 
spleen (n = 4), and bile ducts (n = 3). Injuries in the nonadhesiolysis group were 
comprised of vascular structures (n = 4), spleen (n = 2), and bile duct (n = 1).
After adjustment for anatomical location, operative severity, surgical approach, and 
body mass index, the difference in incidence of seromuscular injury and other organ 
injuries remained significant (Fig. 2A). Multivariate analysis could not be conducted 
for bowel defects as none occurred in the nonadhesiolysis group.
The 43 inadvertent enterotomies occurred exclusively in patients who underwent open 
surgery. One patient (2.9%) who underwent laparoscopy had a delayed diagnosed 
perforation compared with 9 (2.0%) who underwent open surgery (P = 0.75).
Table 1  Baseline comparison between operations with and without adhesiolysis.
Adhesiolysis 
group (n=475)
No adhesiolysis 
group (n=280) 
P- value
Demographics
Sex
 Male 264 (55.6%) 116 (59.3%)
 Female 211 (44.4%) 114 (40.7%) .32
Age* 58.1 ± 13.8 59.4 ± 14.1 .23
BMI* 26.0 ± 4.8 25.1 ± 3.8 .003
Smoking status
 Non Smoker 163 (34.3%) 104 (37.3%)
 Ex- Smoker 210 (44.2%) 130 (46.6%) .20
 Smoker 102 (21.5%) 45 (16.1%)
Alcohol abuse
 Low Risk 450 (94.9%) 261 (93.5%)
 Moderate Risk 18 (3.8%) 12 (4.3%) .60
 High Risk 6 (1.3%) 6 (2.2%)
Peritoneal Surgery in History
 Yes 412 (86.7%) 90 (32.1%)
 No 63 (13.3%) 190 (67.9%) <.001
Laparotomies in History† 2 (0-56) 0 (0-3) <.001
Laparoscopies in History† 0 (0-2) 0 (0-1) <.001
Generalized Peritonitis in History
 Yes 66 (13.9%) 1 (0.4%)
 No 409 (86.1%) 279 (99.6%) <.001
Preoperative risk assessement
ASA Slassification
 I 77 (16.2%) 46 (16.4%)
 II 284 (59.8%) 172 (61.4%)
 III 113 (23.8%) 62 (22.1%) .83
 IV 1 (0.2%) 0 (0.0%)
P- Possum Score* 6.2 ± 9.8 6.0 ± 8.7 .79
Revised Cardiac Risk Index
 2 396 (83.4%) 222 (79.3%)
 3 66 (13.9%) 45 (16.1%) .25
 4 13 (2.7%) 13 (4.6%)
Diabetes Mellitus in History
 Yes 43 (9.1%) 29 (10.4%)
 No 432 (90.9%) 251 (89.6%) .56
Operative Severity
 Minor 0 (0.0%) 2 (0.7%)
 Moderate 22 (4.6%) 14 (5.0%)
 Large 311 (65.5%) 134 (47.9%) <.001
 Major 142 (29.9%) 130 (46.4%)
Table 1  Continued.
Adhesiolysis 
group (n=475)
No adhesiolysis 
group (n=280) 
P- value
Characteristics of planned operation
Open surgery/Laparoscopy
 Open surgery 440 (92.6%) 244 (87.1%)
 Laparoscopy 35 (7.4%) 36 (12.9%) .01
Anatomical site of primary intervention
 Upper GI- tract 25 (5.3%) 58 (20.7%)
 Lower GI- tract 219 (46.1%) 122 (43.6%)
 HPB 82 (17.3%) 61 (21.8%)
 Abdominal wall 115 (24.2%) 9 (3.2%) <.001
 Other 34 (7.2%) 30 (10.7%)
Surgical Experience
 Surgeon 330 (69.5%) 194 (69.3%)
 Resident 145 (30.5%) 86 (30.7%) .96
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The incidence of enterotomy was 0.0% in virgin abdomens, 2.5% after 1, 8.7% after 2, 
and 15.5% after 3 or more prior abdominal operations. A high Zühlke score correlated 
with an increased incidence of enterotomy. Incidence of enterotomy was 0% in grade 1, 
0.7% in grade 2, 8.9% in grade 3, and 36.4% in operations with grade 4 adhesions in 
the operative area. Enterotomies were found in 2 operations (0.6%) without adhesions 
to a previous scar, 0% with grade 1, 2.2% with grade 2, 12.0% with grade 3, and 26.9% 
with grade 4 adhesions to a previous scar. The correlation between adhesion grade 
and enterotomies was less strong for adhesions in other parts of the abdomen with 
an incidence of 0.5% without adhesions, 2.9% with grade 1, 7.4% with grade 2, 19.5% 
with grade 3, and 18.9% with grade 4 adhesions. The incidence of enterotomy, sero- 
muscular injury, and other organ injury significantly increased with longer adhesiolysis 
time (Figs. 3A–C).
Impact of Adhesiolysis on Surgical Complications 
In the adhesiolysis group, 111 (23.4%) of surgeries had 1 or more major surgery-related 
complications compared with 50 (17.6%) in the nonadhesiolysis group [adjusted 
P = 0.05; (Fig. 2A)]. There was a significantly higher risk for sepsis, incisional wound 
infection, and abdominal complications in the adhesiolysis group (univariate analysis 
and after correction), although there were no significant differences in the incidence 
of death, urinary tract infection, pneumonia, or hemorrhage (Fig. 2A). The adjusted OR 
for sepsis was 5.12 (95% CI: 1.06–24.7), for wound infection 2.45 (95% CI: 1.01–5.94), 
and for abdominal complications 3.46 (95% CI: 1.49–8.05). Other variables included 
in multivariate analysis were not significant. Wound infections were found in 6 out of 
67 operations (9.0%) performed with a history of peritonitis, compared with 32 out of 
688 operations (4.7%) without peritonitis in their history—this difference was not 
significant (P = 0.137). 
Impact of Adhesiolysis on Other Morbidity and Costs 
Adhesiolysis was associated with a statistically significantly longer operative time, 
recovery time, and hospital stay. There was 29% more operative blood loss in the 
adhesiolysis group and more need of postoperative parental feeding. There tended 
to be more additional surgeries in the adhesiolysis group, although the difference 
was not significant (P = 0.060). Unplanned admissions to the intensive care unit and 
intensive care unit stays were comparable between the groups (Table 2). 
Figure 2  A, Crude and adjusted ORs with 95% CI for (post)operative complications 
compared between surgery with and without adhesiolysis. B, ORs with 95% CI of post- 
operative complications after surgery with adhesiolysis compared between surgery 
with or without in advertent bowel defect.
A
B
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The inpatient costs were higher in the adhesiolysis group for all domains, resulting in 
a total of $18,579 (15,204–21,954) per operation for direct hospital costs compared 
with a total of $14,063 (12,471–15,655) in the nonadhesiolysis group (P < 0.001; Table 3). 
Readmission rate within 30 days after discharge was also significantly higher in the 
adhesiolysis group (P = 0.002). In the adhesiolysis group, 48 out of 69 readmissions 
(70.0%) were for a complication possibly related to previous surgery (abscess in 15, 
wound infection in 9, small bowel obstruction in 8, sepsis in 6, pneumonia in 5, and 
urinary tract infection in 5). In the nonadhesiolysis group, 12 out of 20 readmissions 
(60.0%) possibly were for a surgery-related complication (5 times for abscess, 2 times 
each for pneumonia, wound dehiscence, and leakage of the cervical anastomosis 
after esophageal resection, and once for urinary tract infection). 
Impact of a Bowel Defect on Surgical Complications, Morbidity, and Costs 
A major surgery-related complication occurred more than twice as often after 
adhesiolysis complicated by a bowel defect (Fig. 2B). The in-hospital mortality rate 
increased fivefold from 1.6% to 8.0% in the case of a bowel defect (Fig. 2B). The bowel 
defect group had significantly more additional surgical interventions (P < 0.001; 
Table 2). Hospital stay was a mean of 10.2 ± 2.4 days longer in the bowel defect 
group (P = 0.036). Total costs were almost threefold higher in patients with a bowel 
defect [$43,784 (16,629–70,938)] compared with those without a defect [$15,614 
(13,642–17,586); Table 3].
Figure 3  Risk of inadvertent organ injury with 95% CI stratified by adhesiolysis time: 
A, Enterotomy. B, Seromuscular injury. C, Other organ injury.
 
A
B
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Table 2  Morbidity Outcomes Compared Between Operations With and Without 
Adhesiolysis and Compared Between Surgery With or Without Inadvertent Bowel  
Defect in the Subgroup of Operations With Adhesiolysis; *= mean ± SD ;  
†= Unadjusted coefficient ± SD.
Adhesiolysis 
group (n=475)
No adhesiolysis 
group (n=280) 
Crude OR 
(95% CI) 
P-value Adjusted OR 
(95% CI)
P-Value Enterotomy/ 
DDP (n=50)
No enterotomy/ 
DDP (N=425)
OR 
(95% CI)
P-value
Operation time (min.) 195 ± 98* 179 ± 89* 16.2 ± 7.1† .020 22.5 ± 6.0† <.001 221 ± 101* 192 ± 97* 29.5 ± 14.56† .05
Blood loss (ml) 934 ± 1 630* 725 ± 905* 209 ± 106† .024 305 ± 101† .003 1 119 ± 1 438* 912 ± 1 652* 207 ± 244† .35
Recovery unit stay (hours) 7.9 ± 10.9* 6.4 ± 9.0* 1.49 ± 0.77† .043 2.21 ± 0.74† .003 7.2 ± 8.8* 8.0 ± 11.2* -0.8 ± 1.6† .54
Hospital stay (days) 11.5 ± 16.5* 9.4 ± 8.5* 2.06 ± 1.06† .024 3.14 ± 1.08† .004 20.6 ± 33.1* 10.4 ± 12.8* 10.2 ± 2.4† .04
Unplanned/ prolonged ICU admission 77 (16.2%) 51 (18.2%) 0.87 (0.59- 1.28) .478 1.09 (0.70- 1.70) .70 14 (28.0%) 63 (14.8%) 2.24 (1.14- 4.38) .02
ICU stay (days) 1.9 ± 11.6* 1.0 ± 3.4* 0.94 ± 0.71† .101 1.22 ± 0.73† .10 9.3 ± 31.8* 1.08 ± 5.2* 8.25 ± 1.70† .07
Parenteral feeding 77 (16.2%) 25 (8.9%) 1.97 (1.22- 3.18) .005 2.00 (1.19- 3.34) <.001 20 (40.0%) 57 (13.4%) 4.30 (2.29- 8.09) <.001
Parental feeding (days) 3.0 ± 11.2* 1.4 ± 5.9* 1.58 ± 0.72† .012 1.95 ± 0.74† .009 11.7 ± 26.2* 2.0 ± 7.2* 9.73 ± 1.62† .01
Tube feeding 95 (20.0%) 92 (32.9%) 0.511 (0.37 – 0.72) <.001 0.99 (0.65- 1.49) >.999 10 (20.0%) 85 (20.0%) 1.00 (0.48- 2.08) >.999
Unplanned tube feeding 67 (14.5%) 44 (15.7%) 0.88 (0.58 – 1.33) .546 1.09 (0.70- 1.70) .21 10 (20.0%) 57 (13.4%) 1.61 (0.77- 3.41) .21
Tube feeding (days) 3.3 ± 11.8* 3.55 ± 6.3* -0.24 ± 0.76† .718 0.47 ± 0.76† .54 6.14 ± 23.7* 3.0 ± 9.5* 3.17 ± 1.76† .35
Reoperations
Any 74 (15.6%) 28 (10.0%) 1.66 (1.05 .030 1.62 (0.98 .06 16 (32.0%) 58 (13.6%) 2.98 (1.55 .001
Relaparotomy 57 (12.0%) 19 (6.8%) 1.87 (1.09 .021 1.68 (0.94 .08 13 (26.0%) 44 (10.4%) 3.04 (1.50 .001
Central Venous Line 11 (2.3%) 7 (2.5%) 0.93 (0.35 .873 1.13 (0.41 .81 1 (2.0%) 10 (2.4%) 0.85 (0.11 .88
Other 16 (3.4%) 6 (2.1%) 1.59 (0.62 .333 2.03 (0.67- 6.15) .21 5 (10.0%) 11 (2.6%) 4.18 (1.39 – 12.58) .006
Readmissions within  
30 days of discharge
69 (14.5%) 20 (7.1%) 2.21 (1.31- 3.72) .002 2.37 (1.36- 4.13) .002 13 (26.0%) 56 (13.2%) 2.32 (1.16- 4.62) .02
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Discussion
In this study, adhesiolysis-induced morbidity was high: a median of 20 minutes increase 
of operative time, a 1 in 10 risk of inadvertent bowel defects, a sevenfold increase in sero- 
muscular injury, and a threefold to fourfold increase in other organ injury. Adhesiolysis, 
particularly with the resulting bowel defects, led to more postoperative sepsis, intra- 
abdominal complications including surgical site infections, a longer hospital stay, 
more readmissions, and increased costs.
Adhesiolysis at repeat surgery has received less attention than bowel obstruction and 
infertility in reports assessing the clinical and socioeconomical burden of postoperative 
adhesions. Underestimation of the related morbidity and the passiveness of many 
physicians, who consider adhesiolysis an annoying but unavoidable part of redo surgery, 
account for the paucity of reports on the consequences of adhesiolysis. The available 
literature is limited to small series in specific surgical areas or retrospective series in 
which previous surgeries or rehospitalisation are taken as the measure of adhesiolysis.
(2;12;22;23) We designed a large prospective study to provide accurate incidences of 
adhesiolysis-related morbidity and socioeconomical costs. This study provided for 
continuous observation of the surgical procedures in the operating theatre by a 
trained researcher who did not take part in the surgery. This enabled the collection of 
reliable data that most probably could not have been retrieved from other sources 
such as operative reports.(24–26)
The long total adhesiolysis time reflected the high complexity of these operations: 
when the adhesiolysis was longer than 1 hour, 40% of the operations resulted in 
bowel defects. Previous studies have used adhesion scores and entry times as the 
parameter for complexity.(18;23) However, an adhesion score is subjective and loses 
merit when adhesions are present in different parts of the abdominal cavity. Entry 
time is only a useful parameter when opening a previous abdominal incision and 
reflects a minor part of total adhesiolysis time and adhesiolysis-related complications.
(12;23) We also had difficulty in distinguishing between adhesiolysis required just to 
enter the abdomen and adhesiolysis required to free the operative area in cases with 
massive adhesion formation to the ventral and lateral abdominal walls.
The incidence of inadvertent enterotomy in this study was lower than the 19% previously 
reported by our group.(12) The increased awareness of the impact of adhesiolysis and 
the modification in our department’s protocol for cutting adhesions may have 
contributed to the decrease in bowel defects. Another explanation could be the strict 
definition of iatrogenic bowel defects, which no longer included enterotomies in the 
proximity of a pre-existing bowel fistula. The presence of an observer might also have 
raised the surgeon’s vigilance to avoid injury. We noted, however, that the operating 
teams rapidly became accustomed to having an observer in the operating theatre.
The need for adhesiolysis in 60% of the surgical procedures and the low number of 
laparoscopies could limit the generalizability of the study results. However, these Ta
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This study has demonstrated the substantial clinical and socioeconomical burden of 
adhesiolysis, particularly when a bowel defect occurs. All physicians treating patients 
with disorders of the abdominal cavity that might require surgery should be aware 
of the adverse effects of adhesiolysis. Our data can be of help when counselling 
patients before surgery, when physicians and health care providers make decisions 
on implementing anti-adhesive strategies, and for the reimbursement policy of 
insurance companies.
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percentages have been consistent in our academic department during the past decade, 
and they compare with those in a large multicentre series of patients who underwent 
elective colorectal surgery for a benign disease.(27;28) The percentage also results 
from the exclusion of short-stay surgery, which is predominantly minimally invasive 
surgery in virgin abdomens and emergency abdominal surgeries.
Our article is the first showing adhesiolysis as a risk factor for postoperative surgical 
complications, longer hospital stays, more readmissions, and increased costs. Inadvertent 
bowel defects increased even more morbidity and costs and they also caused significant 
mortality, which agrees with the results from our retrospectively collected data.(12;22) 
Incisional wound infection was the most prominent complication reflecting the longer 
adhesiolysis-related operating times and increased blood loss, events that are used 
to estimate the risk of surgical site infection.(29) The high morbidity, long hospital stay, 
and high costs of a surgical site infection are well known from other reports.(30;31) 
The portion of patients with surgical site infection after previous surgery could not be 
identified from the patients’ medical charts. A history of peritonitis could be reliably 
obtained and was not a significant risk factor for surgical site infection.
The economical burden of adhesive bowel obstruction in the United States is at least 
2 billion dollars annually.(32) The cost of adhesive small bowel obstruction per patient 
is estimated at $9700 for operatively treated patients and at $4000 for conservatively 
treated patients.(33;34) The cost data from this prospective study permitted an accurate 
calculation of the in-hospital costs related to adhesiolysis. These costs were $4500. 
Taking into account that adhesiolysis was required in 60% of the patients and that 
only about 2% to 4% of the patients acquire an adhesive small bowel obstruction after 
abdominal surgery, the economical burden of adhesiolysis is likely to exceed that of 
adhesive small bowel obstruction.(2;35) These cost calculations can be used for 
reimbursement purposes and to re-evaluate decisions concerning the use of barriers 
to prevent adhesion formation in elective abdominal surgery. Current cost-effectiveness 
analyses have focused on prevention of adhesive small bowel obstruction and, in 
many countries, have not lead to the routine use of anti-adhesive barriers.(33) With the 
projected increase in more repeat abdominal surgeries because of a longer life 
expectancy and newer technologies, prevention of adhesiolysis-related morbidity 
might be even more cost-effective.
The huge burden of adhesiolysis-related morbidity in elective abdominal surgery has 
consequences for the daily practice of physicians with regard to counselling patients. 
Less than 10% of surgeons inform their patients about the risk of adhesions.(9) The 
high risk of adhesiolysis complicating the immediate postoperative course warrants 
routine informed consent.(11) In an analysis of medicolegal claims for complications 
after adhesiolysis, inadvertent bowel injury accounted for a considerable portion of 
both submitted and granted complaints.(36;37)
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CHAPTER 4 ADHESIOLYSIS, QUALITY OF LIFE AND FUNCTIONAL STATUS
Introduction
Quality of care in abdominal surgery is commonly measured by mortality and 
morbidity and seldom by quality of life or functional status.(1, 2) Due to the rising life 
expectancy following abdominal surgery, quality of life and functional status are 
becoming an increasingly important outcome of elective abdominal surgery.(3-7) Important 
mechanisms through which abdominal surgery affects quality of life and functional 
status are postoperative complications, a protracted convalescence and chronic 
postsurgical pain.(7-12) Most studies assessing quality of life after surgery focus on 
specific disorders, types of resection or anatomical reconstruction methods. These 
studies often lack a preoperative assessment of health status masking the impact of 
the operation on postoperative quality of life. Information on quality of life is important, 
especially for patients undergoing surgery for chronic diseases, in informed consent and 
shared decision making, and to evaluate patient reported treatment outcome.(2, 13-15)
Most patients who undergo repeat abdominal surgery have adhesions from previous 
operations and require adhesiolysis.(16) Adhesiolysis results in increased operative 
time and a longer and more complicated convalescence.(17) A 6-10% incidence of 
iatrogenic bowel injury during adhesiolysis is reported, increasing postoperative morbidity 
and mortality.(17, 18) Given the increased incidence of postoperative complications, it may 
be expected that adhesiolysis impairs quality of life and functional status, data to 
support this assumption are lacking. In the prospective LAPAD study adhesiolysis 
and related operative injuries have been assessed in detail for a variety of abdominal 
operations. Additionally, quality of life and functional status have been measured 
before and after surgery. Combined with a comprehensive assessment of baseline 
and postoperative data, the LAPAD database provides a unique opportunity to study 
the impact of both adhesiolysis and other factors on quality of life and functional 
status by an abdominal operation. In this prospective study the quality of life and 
functional status in patients requiring adhesiolysis was compared with patients who 
do not require adhesiolysis, while undergoing general abdominal surgery. 
Methods
Study design and patients
This study was part of the LAPAD (LAParotomy or LAParoscopy and ADhesiolysis) 
study (clinicaltrials.gov registration number: NCT01236625). In the LAPAD study 
adult patients undergoing an elective laparotomy or laparoscopy at the department 
of surgery of the Radboud University Medical Center between June 2008 and June 
2010 were included. Patients younger than 18 years or patients with a mental disorder 
were excluded. Detailed methods of the LAPAD study are published.(17) Relevant 
patient, surgical, and medical data were prospectively assessed before, during and 
after hospital stay and at the outpatient clinic until 6 months after discharge.
Abstract 
Background: Adhesiolysis during abdominal surgery can cause iatrogenic organ injury, 
increased operative time and a more complicated convalescence. We assessed the 
impact of adhesiolysis and adhesiolysis-related complications on quality of life and 
functional status following elective abdominal surgery
Methods: Prospective cohort study, comparing patients requiring and not requiring 
adhesiolysis during an elective laparotomy or laparoscopy using the SF-36 and DASI 
questionnaire scores.
Results: 518 patients were included. Pre- and postoperative quality of life did not 
significantly differ between both groups. Patients with adhesiolysis had a significantly 
lower pre- and postoperative functional status (p<0.01). Higher age, concomitant 
pulmonary disease, postoperative complications, readmissions and chronic abdominal 
pain 6 months after surgery were all associated with a significant and independent 
decline in quality of life and functional status six months after surgery.
Conclusion and relevance: Adhesiolysis in itself does not affect functional status and 
quality of life six months after surgery. Postoperative complications, readmissions 
and chronic abdominal pain are associated with a lower health status. 
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structures. All operative details were real-time collected by an independent observer 
present in the operating theater.
Postoperative complications during admission were classified using the Clavien-Dindo 
classification, combining complications with and without disability after discharge 
and combining complications grade 3a and 3b, and 4a and 4b due to the low 
incidence.(22) Chemotherapy received by patients was defined as any form of chemo - 
therapy or no chemotherapy. Chronic abdominal pain was defined as occasional 
abdominal pain interfering with social activities 6 months after surgery or no abdominal 
pain.(23) Readmissions were categorized as any readmission within 30 days after 
discharge or between 30 days after discharge and 6 months after discharge. 
The two endpoints are the quality of life and functional status based on total score of 
the SF-36 and DASI questionnaires 6 months postoperatively. The secondary endpoints 
are the subdomains of the SF-36. 
Statistical methods
Baseline characteristics were compared between patients requiring or not requiring 
adhesiolysis using a Chi-square, Fisher’s exact test, independent t-test or Mann-Whitney 
U test where appropriate. Continuous variables are presented as means with standard 
deviaton, or medians with interquartile range (25 – 75) if non-normal distribution. 
Dichotomous or categorical variables are presented as absolute numbers and 
percentages. A paired-samples t-test was used to compare the pre and postoperative 
quality of life scores. Variables having impact on quality of life and functional status 
scores 6 months postoperatively were determined using an univariable ANCOVA 
analysis with correction for baseline quality of life score.
All predictors p = ≤0.10 in univariable analysis were considered for multivariable 
linear regression analysis. For the multivariable linear regression analysis, a stepwise 
backwards selection procedure was used with a probability of F ≤0.05 and ≤0.10. 
The adjusted OR was calculated with 95 per cent confidence interval. A value of 
p ≤0.05 was considered significant. 
Additionally, all baseline variables with a significant impact on quality of life or functional 
status were compared between patients who completed both pre- and postoperative 
questionnaires and patients who only completed the pre-operative questionnaires 
but did not return the postoperative questionnaires.
Cases with missing data were excluded per analysis. Statistical analysis was performed 
using SPSS statistical software package version 20.0 (SPSS Inc., Chicago, IL).
Results
715 patients, undergoing 755 operations were included in the LAPAD study. In 53 
patients, pre-operative quality of life assessment was not available leaving 662 
patients for inclusion. Six months postoperative data could not be captured in 144 
Patients who participated in the LAPAD study completed the Short Form 36 Health 
Survey (SF-36) and the Duke Activity State Index (DASI) the day before the operation.
(19, 20) Six months after discharge the SF-36 and DASI questionnaire and a questionnaire 
regarding any readmissions was sent by regular mail. The SF-36 questionnaire 
measures overall quality of life and the DASI questionnaire functional status. Additional 
data was collected from medical records of hospitals, general practitioners and nursing 
homes when applicable. Patients who underwent a second elective abdominal 
operation that was included in the LAPAD study did not fill in a questionnaire before 
the second operation. Patients who did not complete the pre- or postoperative SF-36 
and DASI questionnaires were excluded from analysis. 
Variables
All baseline variables were defined according to the latest relevant guidelines and 
classifications. Medical history and complications were defined according to International 
Classification of Diseases, Tenth Revision, the National Nosocomial Infections Surveillance 
System, the Centre for Disease Control and Prevention. Baseline patient characteristics 
included sex, age, body mass index, smoking status, presence of pulmonary disease 
(comprising chronic obstructive pulmonary disease, asthma and emphysema), 
diabetes, renal failure, history of myocardial infarction, P-POSSUM score (Portsmouth 
Physiological and Operative Severity Score for the enumeration of Mortality and 
morbidity), presence of preoperative pain, presence of an ostomy (either colostomy 
or ileostomy) before surgery, the number of previous abdominal operations (none, 1 or 2, 
≥3) and malignant disease, ventral hernia or other diseases as indication for surgery. 
Characteristics of the operation included surgical approach (open or laparoscopic) 
and anatomical site of the operation categorized as upper gastrointestinal tract, lower 
gastrointestinal tract, hepatobiliary-pancreatic, abdominal wall, or other. Other comprised 
retroperitoneal sarcoma resection, lymphatic and kidney resections as well as 
splenectomies and open abdominal aortic repair. Adhesiolysis time was measured in 
minutes from the start of adhesiolysis until the operative area was cleared of adhesions 
and was categorized as no adhesiolysis, 1-30 and >30 minutes adhesiolysis. The 
severity of adhesions underneath the previous incision and at the operative area were 
assessed using the Zühlke classification, comprising grade 0, 1 and 2 as no or 
mild adhesions and grade 3 and 4 as severe adhesions.(21) Adhesiolysis related 
complications were defined as either an enterotomy, serosal injury or other organ 
injury. Inadvertent enterotomy was defined as any iatrogenic, unintended full thickness 
bowel defect detected during operation. Preexisting fistulas or defects created while 
dissecting the bowel loop that harbored the fistula were not scored as inadvertent 
enterotomy. Serosal injury was defined as injury to the serosal and muscular layers of 
the bowel, without visualization of the bowel lumen or spillage of bowel content. Other 
organ injury was iatrogenic injury to other intra-abdominal organs including vascular 
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did not require adhesiolysis and underwent significantly more often an operation 
for a malignant cause (p = <0.01), and of the upper gastrointestinal and hepatic- 
pancreatic-billiary tract (p = <0.01). Baseline characteristics are shown in table 1.
patients, 29 patients died within 6 months and 115 patients did not return the post- 
operative questionnaires. Data of 518 (78%) patients were available for analysis of 
postoperative quality of life and functional status. A flow-chart is shown in figure 1.
Baseline characteristics 
319 (62%) patients required adhesiolysis during surgery of which 110 patients required 
more than 30 minutes of adhesiolysis. A total of 158 (50%) patients had severe 
adhesions underneath the incision and 154 (49%) patients had severe adhesions at 
the operative area. In 29 (9%) patients requiring adhesiolysis an iatrogenic enterotomy 
occurred. A serosal injury occurred in 89 (28%) patients requiring adhesiolysis and in 
8 (4%) patients who did not require adhesiolysis (p = < 0.01). At baseline, patients 
requiring adhesiolysis had significantly more often pre-operative abdominal pain 
(p = <0.01), more previous abdominal operations (p = <0.01), and had more often 
an abdominal wall repair for ventral hernia (p = <0.01). Patients requiring adhesiolysis 
had more Clavien-Dindo grade 1 (p = 0.04) and 4 (p = 0.01) complications and were 
more often readmitted within 30 days after discharge (p = 0.01). 199 (38%) patients 
Figure 1  Flow-chart. Table 1  Baseline characteristics of patients requiring adhesiolysis and not requiring 
adhesiolysis during elective abdominal surgery.
Baseline characteristics (N = 518)
Patient factors No adhesiolysis 
(n= 199)
Adhesiolysis 
(n=319)
p
Sex 0.22
Male 120 (60%) 175 (55%)
Female 79 (40%) 144 (45%)
Age 60 ± 13 58 ± 13 0.06
BMI 25.4 ± 3.6 26.1 ± 4.8 0.12
Smoking status 0.14
Non-smoker 68 (34%) 117 (37%)
Ex-smoker 103 (52%) 141 (44%)
Smoker 27 (14%) 61 (19%)
P-Possum score 3.0 (1.1 – 6.3) 1.80 (0.8 – 5.5) 0.36
Comorbidity
Pulmonary disease 18 (9%) 32 (10%) 0.71
Diabetes 27 (14%) 36 (11%) 0.44
History of myocardial infarction 17 (9%) 19 (6%) 0.26
Renal failure 6 (3%) 10 (3%) 0.94
Pre-operative abdominal pain 50 (26%) 126 (39%) <0.01
Number of previous abdominal operations <0.01
0 138 (69%) 41 (13%)
1 or 2 60 (30%) 154 (48%)
≥3 1 (1%) 124 (39%)
Presence of an ostomy before surgery 1 (1%) 51 (16%) <0.01
Indication for surgery
Malignancy 137 (69%) 106 (33%) <0.01
Hernia 1 (1%) 95 (30%) <0.01 
Other 61 (30%) 122 (38%) 0.08
Surgical approach 0.02
Open 175 (88%) 299 (94%)
Laparoscopic 24 (12%) 20 (6%)
Anatomical site of operation
Lower gastrointestinal tract 81 (41%) 138 (43%) 0.57
Abdominal wall 4 (2%) 86 (27%) <0.01
Upper gastrointestinal tract 40 (20%) 14 (4%) <0.01
Hepatic-pancreatic-billiary 47 (24%) 48 (15%) 0.01
Other 27 (14%) 33 (10%) 0.27
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The 115 patients who did not return the questionnaire six months after surgery were 
significantly younger (p = 0.02) and smoked more often (p = <0.01). The baseline 
characteristics of the non-responders are shown in table 2. 
Table 1  Continued.
Baseline characteristics (N = 518)
Patient factors No adhesiolysis 
(n= 199)
Adhesiolysis 
(n=319)
p
Adhesiolysis time <0.01
None 199 (100%) 0
0 – 30 minutes 0 208 (65%)
>30 minutes 0 110 (35%)
Severity of adhesions underneath incision <0.01
No, or mild adhesions 192 (99%) 161 (50%)
Severe adhesions 0 158 (50%)
Severity of adhesions operative area <0.01
No, or mild adhesions 193 (100%) 161 (51%)
Severe adhesions 0 154 (49%)
Adhesiolysis related complications
Enterotomy 0 29 (9%) <0.01
Serosal injury 8 (4%) 89 (28%) <0.01
Other organ injury 4 (2%) 32 (10%) <0.01
Creation of an ostomy
Colostomy 16 (8%) 20 (6%) 0.21
Ileostomy 19 (10%) 43 (14%) 0.45
Number of patients with complications
Clavien-Dindo grade 1 24 (12%) 60 (19%) 0.04
Clavien-Dindo grade 2 37 (19%) 80 (25%) 0.09
Clavien-Dindo grade 3 27 (14%) 48 (15%) 0.64
Clavien-Dindo grade 4 1 (1%) 13 (4%) 0.01
Readmissions during follow-up
Readmission within 30 days 18 (9%) 54 (17%) 0.01
Readmission after 30 days 31 (16%) 45 (14%) 0.70
Chemotherapy during follow-up 45 (25%) 34 (13%) <0.01
Postoperative abdominal pain  
6 months after surgery
66 (33%) 118 (37%) 0.36
Table 2  Characteristics of patients having returned and not having returned  
the questionnaire 6 months after abdominal surgery.
Characteristics non-responders
Patient factors Responders
(n= 518)
Non-responders 
(n= 115)
p
Sex 0.67
Male 295 (57%) 63 (55%)
Female 223 (43%) 52 (45%)
Age 58 ± 13 55 ± 17 0.02
Smoking status <0.01
Non-smoker 185 (36%) 34 (30%)
Ex-smoker 244 (47%) 46 (40%)
Smoker 88 (17%) 35 (30%)
P-Possum score 2.3 (0.9 – 5.8) 2.40 (0.9 – 6.7) 0.66
Comorbidity
Pulmonary disease 50 (10%) 16 (14%) 0.18
History of myocardial infarction 36 (7%) 7 (6%) 0.74
Indication for surgery 0.40
Malignancy 243 (47%) 49 (43%)
Surgical approach 0.07
Open 474 (91%) 99 (86%)
Laparoscopic 44 (9%) 16 (14%)
Anatomical site of operation 0.20 
Lower gastrointestinal tract 219 (42%) 62 (54%)
Abdominal wall 90 (17%) 17 (15%)
Upper gastrointestinal tract 54 (10%) 9 (8%)
Hepatic-pancreatic-billiary 95 (18%) 19 (17%)
Other 60 (12%) 8 (7%)
Requirement adhesiolysis 0.58
Yes 319 (62%) 74 (64%)
No 199 (38%) 41 (36%)
Adhesiolysis related complications
Serosal injury 97 (19%) 22 (19%) 0.92
Number of patients with complications
Clavien-dindo grade 2 117 (23%) 35 (30%) 0.08
Clavien-dindo grade 3 75 (15%) 15 (13%) 0.69
Clavien-dindo grade 4 14 (3%) 2 (2%) 0.75
Readmissions during follow-up
Readmission within 30 days 72 (14%) 16 (14%) 1.00
Readmission after 30 days 76 (15%) 22 (19%) 0.25
Preoperative SF36 score 0.64 (0.46 – 0.84) 0.57 (0.42 – 0.80) 0.06
Preoperative DASI score 32.20 (20.70 – 50.70) 31.45 (15.45 – 50.70) 0.30
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Impact of patient factors on quality of life
Higher P-Possum score, concomitant pulmonary disease, presence of an ostomy, 
serosal injury during the operation, postoperative complications Clavien-Dindo grade 
2, 3 and 4, readmissions within and after 30 days and chronic abdominal pain all 
negatively impacted quality of life six months after surgery. A laparoscopic procedure, 
lower gastrointestinal tract as the anatomical location of surgery and a higher 
preoperative SF-36 score had a positive impact on quality of life. The results of the 
univariable analysis are shown in supplement 1. 
In the multivariable analysis (table 3), higher age (95% CI -0.00 – -0.00; p 0.04), 
concomitant pulmonary disease (95% CI -0.11 – -0.00; p 0.04), postoperative Clavien- 
Dindo grade 4 complications (95% CI -0.25 – -0.05; p <0.01), readmission within 
30 days (95% CI -0.11 – -0.02; p 0.01), readmissions after 30 days (95% CI -0.12 
-0.03; p <0.01) and chronic abdominal pain 6 months after surgery (95% CI -0.18 – 
-0.11; p <0.01) were all associated with a significant and independent decline in 
quality of life six months after surgery. Patients that underwent surgery on another 
anatomical site than the lower or upper gastrointestinal tract, hepatic-pancreatic- 
biliary tract or the abdominal wall were associated with a reduced quality of life (95% 
CI -0.13 - -0.03; p <0.01). A trend was seen towards impaired quality of life six months 
after surgery where a serosal injury occurred during surgery (95% CI -0.08 – 0.01; 
p 0.10). Laparoscopic approach (95% CI 0.00 – 0.12; p 0.04) and a higher preoperative 
SF-36 score (95% CI 0.36 – 0.51; p <0.01) were associated with improved quality of 
life after surgery. 
Pre- and postoperative quality of life and functional status 
The results of the SF-36 score are shown in figure 2. A trend was seen towards a 
lower preoperative quality of life for patients requiring adhesiolysis in comparison to 
patients not requiring adhesiolysis (p = 0.05). Postoperative quality of life did not 
significantly differ between both groups (p = 0.12). Quality of life 6 months after 
surgery was comparable to preoperative quality of life in both patient groups (p = 
0.43 and p = 0.82, respectively). The preoperative physical functioning, physical role 
and bodily pain subdomains of the SF-36 were significantly lower for patients 
requiring adhesiolysis during surgery, whereas the mental health subscale was 
significantly higher for patients requiring adhesiolysis. Postoperatively, only physical 
functioning was lower for these patients. Both groups showed significantly improved 
mental health and reduced general health after operation (results not shown). 
Patients requiring adhesiolysis had a significantly lower pre- 28.70 (18.95 – 50.20) 
and postoperative 28.70 (18.95 – 44.7) DASI score in comparison to the pre- 37.45 
(23.45 – 52.95) and postoperative 36.70 (23.45 – 50.70) DASI score of patients not 
requiring adhesiolysis (p = <0.01 and p = <0.01) (figure 3). Change of functional 
status in both groups of patients was not significant (p = 0.36 and p = 0.22, 
respectively). 
Figure 2  Total pre- and postoperative SF-36 scores for patients requiring 
adhesiolysis and patient without requiring adhesiolysis. The box-plot represents  
the median, IQR 25 – 75 and the range. The SF-36 scores for the adhesiolysis 
group were 0.62 (0.45 – 0.81) preoperatively and 0.64 (0.44 – 0.85) postoperatively. 
The no adhesiolysis group had a preoperative SF-36 score of 0.70 (0.49 – 0.86)  
and a postoperative score of 0.70 (0.49 – 0.86).
Figure 3  Total pre- and postoperative DASI scores for patients requiring 
adhesiolysis and patients not requiring adhesiolysis. The box-plot represents the 
median, IQR 25 – 75 and the range. The DASI scores for the adhesiolysis group 
were 28.70 (18.95 – 50.20) preoperatively and 28.70 (18.95 – 44.7) postoperatively. 
The no adhesiolysis group had a preoperative DASI score of 37.45 (23.45 – 52.95) 
and a postoperative score of 36.70 (23.45 – 50.70).
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were all associated with a significant and independent decline in functional status 6 
months after surgery. A higher preoperative DASI score (95% CI 0.47 – 0.59; p <0.01) 
was significantly associated with a higher postoperative functional status (table 4). 
Discussion
In this large cohort study of surgical patients, data are provided regarding the impact 
of adhesions on patient reported outcomes. Almost two-third of patients needed 
adhesiolysis as part of the surgical procedure. They reported a lower functional 
status both before and after operation but adhesiolysis independently did not affect 
quality of life or functional status. Irrespective of adhesiolysis, major complications, 
readmissions and chronic abdominal pain have a large negative impact on quality of 
life and functional status. Six months after surgery, patient reported outcomes were 
comparable to preoperative values. High preoperative functional status and quality of 
life were associated with better postoperative outcomes. 
Patients needing adhesiolysis at repeat abdominal surgery represent a surgical 
population with a lower level of physical functional performance compared to patients 
having their first abdominal operation or having insignificant adhesions. The lower 
performance pre-operatively in the adhesiolysis group may relate to the higher 
percentage of patients with preoperative abdominal pain, other consequences of 
their previous conditions and surgeries and the indication for their current operation. 
Impact of patient factors on functional status
Higher age, smoking, higher P-Possum score, concomitant pulmonary disease, 
history of myocardial infarction, malignancy as indication for surgery, postoperative 
complications Clavien-Dindo grade 2, 3 and 4, readmissions within and after 30 days 
and chronic abdominal pain were all associated with a decline in functional status of 
patients six months after surgery in the univariable analysis. A laparoscopic procedure 
and a higher pre-operative DASI score was associated with an increased functional 
status six months after surgery. The results of the univariable analysis are shown in 
supplement 2.
In multivariable analysis (table 4) higher age (95% CI -0.34 - -0.17; p <0.01), concomitant 
pulmonary disease (95% CI -9.53 - -2.30; p <0.01), postoperative Clavien-Dindo 
grade 4 complication (95% CI -13.07 - -0.16; p 0.05), readmission within 30 days (95% 
CI -7.44 - -1.39; p <0.01), readmissions after 30 days (95% CI -9.08 - -3.23; p <0.01) 
and chronic abdominal pain 6 months after surgery (95% CI -8.72 - -4.15; p <0.01) 
Table 3  Multivariable analysis for patient factors impacting the postoperative SF-36 score.
Patient factor B Standard 
error
95% confidence 
interval
P
Lower Upper
Age - 0.00 0.00 - 0.00 0.00 0.04
Comorbidity
Pulmonary disease - 0.06 0.03 - 0.11 - 0.00 0.04
Laparoscopic approach 0.06 0.03 0.00 0.12 0.04
Anatomical site of operation
Lower gastrointestinal tract Not included
Abdominal wall Not included
Upper gastrointestinal tract Not included
Hepatic-pancreatic-billiary Not included
Other - 0.08 0.03 - 0.13 - 0.03 <0.01
Adhesiolysis-related complication
Serosal injury - 0.04 0.02 - 0.08 0.01 0.10
Postoperative complications
Clavien-Dindo grade 4 - 0.15 0.05 - 0.25 - 0.05 <0.01
Readmission
Within 30 days after discharge - 0.06 0.02 - 0.11 - 0.02 0.01
After 30 days after discharge - 0.07 0.02 - 0.12 - 0.03 <0.01
Postoperative abdominal pain  
6 months after surgery
- 0.14 0.02 - 0.18 - 0.11 <0.01
Preoperative SF-36 score 0.44 0.04 0.36 0.51 <0.01
Table 4  Multivariable linear regression analysis of patient factors impact on 
postoperative functional capacity of patients.
Patient factor B Standard 
error
95% confidence 
interval
P
Lower Upper
Age -0.25 0.04 - 0.34 - 0.17 <0.01
Comorbidity
Pulmonary disease - 5.92 1.84 - 9.53 - 2.30 <0.01
Postoperative complications
Clavien-Dindo grade 4 - 6.61 3.29 -13.07 - 0.16 0.05
Readmission
Within 30 days after discharge - 4.41 1.54 - 7.44 - 1.39 <0.01
After 30 days after discharge - 6.16 1.49 - 9.08 - 3.23 <0.01
Postoperative abdominal pain 6 
months after surgery
- 6.44 1.16 - 8.72 - 4.15 <0.01
Preoperative DASI score 0.53 0.03 0.47 0.59 <0.01
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readmitted within 30 days more often.(29-31) Therefore it is not surprising that our study 
found a decreased quality of life and functional status for elderly patients. The indication 
for surgery did not seem to impact quality of life or functional status 6 months after 
surgery.
This is a large study assessing quality of life in a prospective cohort of patients 
undergoing elective abdominal surgery with pre- and postoperative quality of life and 
functional performance measurements, and detailed data of patients and procedures. 
Strengths are the large sample size and a completed follow-up of 78% which make 
the results generalizable for patients undergoing open elective abdominal surgery in 
a general surgery department of an academic hospital. Although heterogeneous, 
this reflects the mixed population in departments of general surgery and increases 
the generalizability of our results. Patients who did not respond to the questionnaire 
showed a trend towards a lower preoperative quality of life, which finding corresponds 
with earlier reports.(32) Thus, quality of life might have been overestimated in this 
study. Results should be extrapolated with caution regarding patients undergoing 
laparoscopic surgery because they are underrepresented in this study. A higher 
quality of life after laparoscopic surgery has been reported compared to open 
procedures.(33) The LAPAD cohort was studied between 2008 and 2010. Arguably, 
selection and perioperative management of patients might have changed after these 
years, although these are likely to be minimal because our hospital adopted ‘enhanced 
recovery after surgery’ programs as early as 2006.(34, 35) A range of different quality 
of life measurement instruments are available, we chose the DASI and SF-36 
questionnaires because they measure both general functional status and quality of 
life. This corresponds with the aim of our study, to assess the impact of adhesiolysis 
on midterm general quality of life after general abdominal surgery.
Awareness of the impact of age, concomitant pulmonary disease and the possible 
occurrence of postoperative complications, readmissions and chronic abdominal 
pain on quality of life and functional status should lead to improved pre-operative 
counseling of patients. Especially, in case of benign and relative indications for 
surgery these factors are important to incorporate in shared-decision making 
because functional status and quality of life does not seem to improve postoperative-
ly. Clinicians should meticulously query the presence of abdominal pain during pre- 
and postoperative consultations and take appropriate treatment measures. 
Additionally, programs to enhance pre-operative functional status might lead to 
improved postoperative functional status. Collecting quality of life and functional 
status after every medical and surgical treatment at multiple time points could lead to 
a more complete and transparent evaluation of quality of care and thus ultimately, 
lead to improved care. 
Chronic pain is a known denominator of quality of life and physical functioning in 
particular. One third of all patients reported abdominal pain six months after surgery, 
this percentage is comparable to the literature.(11, 17, 24) Abdominal (and pelvic) pain 
is an increasingly recognized long term surgical complication, is more common in 
patients with preexisting pain and after open lower gastrointestinal surgery and 
ventral hernia repair, which constitute the most frequent operations in our series.(11, 25) 
In comparison with baseline measurements of quality of life and presence of pain we 
have shown a clear negative impact of chronic abdominal pain six months after 
surgery on quality of life and functional status. 
Our group previously reported a higher prevalence of, predominantly, infectious 
complications when adhesions were present in the abdominal cavity and had to be 
lysed to perform the intended procedure. The complication rate of postoperative 
pneumonia and wound infections more than doubled when an inadvertent enterotomy 
occurred.(17) In this large subgroup of the LAPAD cohort we have found comparable 
relationships between adhesiolysis and morbidity and readmissions, and now 
demonstrate that major complications and readmissions negatively impact quality of 
life and functional status at 6 months after surgery, albeit that adhesiolysis is not 
independently associated with reduced quality of life or functional status in our 
multi-variable regression analysis. A relationship between major complications and 
low postoperative quality of life has previously reported in a systematic review, 
however, results of this review should be interpreted with caution due to heterogeneity 
in quality of life questionnaires and in definitions of postoperative complications, 
missing baseline measurements and unclear duration of follow-up in some studies.(7) 
A short-term impact of complications and readmission on quality of life and physical 
functioning after surgery is plausible and a six months follow-up might be relatively 
short for complete physical and mental recovery. Shortly after a negative treatment 
experience patients value their quality of life lower, and assessment of quality of life 
and functional status may change following complications and readmission.(26, 27) 
A previous quality of life study with 2 years of follow-up, however, showed only marginal 
improvements after 6 months.(12) Interpreting this finding, higher quality of life results 
are not to be expected for our patients with a longer follow up. Notably, in both patients 
groups overall quality of life was not improved six months after surgery compared to 
before surgery and general health was even significantly lower. Lack of improvement 
in quality of life and functional performance after abdominal operations has important 
consequences for shared decision making, particularly in elderly patients who mostly 
focus on keeping or restoring their functional independence after surgery.(28)
Higher age and pulmonary morbidity were independent risk factor for reduced 
postoperative quality of life and functional performance. Due to small numbers we 
could not perform a separate analyses of elderly patients but they likely have a lower 
preoperative functional status, suffer from more postoperative complications and are 
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Conclusion
Adhesiolysis in itself does not affect functional status and quality of life of patients six 
months after surgery. Major postoperative complications, readmissions, chronic 
abdominal pain, higher age and concomitant pulmonary disease have a negative 
impact on postoperative quality of life and the functional status. Higher preoperative 
quality of life and functional status is predictive for higher postoperative functional 
status and quality of life. 
Supplement 1  Univariable ANCOVA analysis of postoperative SF-36 score corrected 
for baseline SF-36 score.
Patient factors B Standard 
error
95% Confidence 
interval
p
Sex
Male Ref.
Female - 0.16 0.18 - 0.05 0.02 0.38
Age - 0.00 0.00 - 0.00 0.00 0.21
BMI 0.00 0.00 - 0.00 0.00 0.75
Smoking status
Non-smoker Ref.
Ex-smoker - 0.03 0.02 - 0.07 0.01 0.17
Smoker - 0.03 0.03 - 0.08 0.02 0.26
P-Possum score - 0.00 0.00 - 0.00 - 0.00 0.01
Comorbidity
Pulmonary disease - 0.09 0.03 - 0.15 - 0.03 <0.01
Diabetes - 0.02 0.03 - 0.07 0.04 0.58
History of myocardial infarction - 0.06 0.03 - 0.13 0.00 0.06
Renal failure - 0.07 0.05 - 0.17 0.03 0.16
Pre-operative abdominal pain - 0.01 0.02 - 0.05 0.03 0.68
Number of previous abdominal 
operations
0 Ref.
1 or 2 - 0.01 0.02 - 0.05 0.03 0.73
≥3 - 0.04 0.02 - 0.09 0.00 0.07
Presence of an ostomy before 
surgey
- 0.05 0.03 - 0.11 0.01 0.04
Indication for surgery
Malignancy - 0.02 0.02 - 0.05 0.02 0.41
Hernia - 0.01 0.02 - 0.05 0.04 0.82
Other 0.02 0.02 - 0.02 0.06 0.33
Surgical approach
Open Ref.
Laparoscopic 0.09 0.03 0.03 0.15 <0.01
Anatomical site of operation
Lower gastrointestinal tract 0.03 0.02 - 0.00 0.07 0.06
Abdominal wall 0.01 0.02 - 0.04 0.05 0.73
Upper gastrointestinal tract - 0.03 0.03 - 0.09 0.03 0.32
Hepatic-pancreatic-billiary - 0.01 0.02 - 0.05 0.04 0.77
Other - 0.05 0.03 - 0.11 0.00 0.05
Adhesiolysis time
None Ref.
0 – 30 minutes - 0.00 0.20 - 0.04 0.04 0.91
>30 minutes - 0.04 0.02 - 0.08 0.01 0.14
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Supplement 1  Continued.
Patient factors B Standard 
error
95% Confidence 
interval
p
Severity of adhesions underneath 
incision
No, or mild adhesions Ref.
Severe adhesions - 0.04 0.02 - 0.07 0.00 0.07
Severity of adhesions operative area
No, or mild adhesions Ref.
Severe adhesions - 0.02 0.02 - 0.06 0.02 0.26
Adhesiolysis related complications
Enterotomy - 0.00 0.04 - 0.08 0.07 0.95
Serosal injury - 0.06 0.02 - 0.10 - 0.01 0.01
Other organ injury -0.06 0.03 -0.01 0.13 0.09
Creation of an ostomy
Colostomy 0.02 0.03 - 0.05 0.09 0.60
Ileostomy - 0.00 0.03 - 0.06 0.05 0.93
Number of patients with 
complications
Clavien-dindo grade 1 - 0.03 0.02 - 0.08 0.01 0.15
Clavien-dindo grade 2 - 0.05 0.02 - 0.09 - 0.01 0.02
Clavien-dindo grade 3 - 0.05 0.03 - 0.10 - 0.01 0.03
Clavien-dindo grade 4 - 0.18 0.05 - 0.29 - 0.08 <0.01
Readmissions during follow-up
Readmission within 30 days -0.09 0.03 -0.14 -0.04 <0.01
Readmission after 30 days -0.07 0.03 -0.12 -0.02 <0.01
Chemotherapy during follow-up - 0.01 0.03 - 0.06 0.04 0.77
Postoperative abdominal pain 6 
months after surgery
- 0.13 0.02 - 0.17 - 0.10 <0.01
Preoperative SF-36 score 0.54 0.04 0.46 0.62 <0.01
Supplement 2  Univariable ANCOVA analysis for the postoperative DASI score, 
corrected for baseline DASI score.
Patient factors B Standard 
error
95% Confidence 
interval
p
Sex
Male Ref.
Female - 1.71 1.19 - 4.04 0.62 0.15
Age - 0.22 0.04 - 0.30 - 0.13 <0.01
BMI - 0.11 0.13 - 0.37 0.15 0.42
Smoking status
Non-smoker Ref.
Ex-smoker - 2.13 1.28 - 4.63 0.37 0.1
Smoker - 3.93 1.69 - 7.26 - 0.61 0.02
P-Possum score - 0.17 0.07 - 0.29 - 0.04 0.01
Comorbidity
Pulmonary disease - 7.58 1.95 - 11.42 - 3.74 <0.01
Diabetes - 0.53 1.79 - 4.05 2.99 0.77
History of myocardial infarction - 4.64 2.29 - 9.15 - 0.14 0.04
Renal failure - 6.01 3.36 - 12.61 0.59 0.07
Pre-operative abdominal pain - 0.15 1.27 - 2.64 2.34 0.90
Number of previous abdominal 
operations
0 Ref.
1 or 2 - 0.02 1.36 -2.65 2.65 0.99
≥3 - 1.17 1.58 - 4.26 1.93 0.46
Presence of an ostomy before 
surgey
- 2.39 1.95 - 6.21 1.44 0.22
Indication for surgery
Malignancy - 3.05 1.17 - 5.35 - 0.75 0.01
Hernia 1.76 1.52 - 1.22 4.74 0.25
Other 2.07 1.21 - 0.31 4.45 0.09
Surgical approach
Open Ref.
Laparoscopic 5.42 2.08 1.34 9.50 0.01
Anatomical site of operation
Lower gastrointestinal tract 1.31 1.18 - 1.00 3.62 0.26
Abdominal wall 1.31 1.54 - 1.71 4.33 0.40
Upper gastrointestinal tract - 0.05 1.91 - 3.80 3.70 0.98
Hepatic-pancreatic-billiary - 1.69 1.51 - 4.65 1.27 0.26
Other - 2.45 1.81 - 6.01 1.11 0.18
Adhesiolysis time
None Ref.
0 – 30 minutes - 1.51 1.32 - 4.10 1.08 0.25
>30 minutes - 1.51 1.59 - 4.63 1.60 0.34
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CHAPTER 5 ADHESIONS, CHRONIC PAIN AND GASTROINTESTINAL COMPLAINTS
Introduction
The incidence of chronic postoperative abdominal pain (CPAP) is estimated at 11% 
after abdominal surgery. CPAP is associated with an increase of gastrointestinal 
symptoms and decreases overall quality of life.(1, 2) Around 30% patients after gastro-
intestinal surgery report to have pain-related interference with mood, sleep and 
enjoyment of life and 12% visit the emergency department for pain related symptoms.(3) 
Intra-abdominal adhesions are deemed as the cause of CPAP in 60% of the patients. 
In these patients no anatomic or functional abnormalities are found apart from 
adhesions. (4) Adhesions are linked to several gastrointestinal complaints such as 
bloating and irregular bowel habits.(5) Causality between adhesions, chronic pain 
and abdominal symptoms is disputed, mainly due to doubt regarding the long term 
efficacy of surgical adhesiolysis as treatment of pain.(6, 7) 
Most studies regarding chronic post-surgical pain are performed in patients under- 
going other types than abdominal surgery and report various risk factors including 
demographic, perioperative and psychological factors.(8, 9) The few studies that have 
been performed in abdominal surgery show an increased risk for female gender, 
lower age, preoperative anxiety and depression in developing CPAP. However, 
studies lack data on preoperative health and pain status, or are limited by small 
patient samples.(1, 3) Generalizability of these results is also limited due to a lack of 
standardization of outcome measures.(10)
In a large prospective database pain-related measurements and a questionnaire regarding 
gastro-intestinal complaints have been collected before and after abdominal surgery.
(11) Combined with a comprehensive assessment of baseline and peri-operative 
data, this database provides a unique opportunity to study pre- and postoperative 
pain and gastrointestinal symptoms and to relate these with baseline adhesions and 
adhesiolysis data. 
The aim of this study is to assess risk factors for CPAP and gastrointestinal complaints 
in a large prospective cohort of patients who undergo primary and repeat elective 
abdominal surgery.
Methods
Study design and patients
This study is part of the LAPAD (LAParotomy or LAParoscopy and ADhesiolysis) study 
(clinicaltrials.gov registration number: NCT01236625). In the LAPAD study adult patients 
undergoing an elective laparotomy or laparoscopy at the department of surgery of 
the Radboud university medical center between June 2008 and June 2010 were 
included. Patients younger than 18 years or patients with a mental disorder were 
excluded. The LAPAD study was approved by the local medical ethical committee 
and detailed methods were published.(11) Relevant patient, surgical, and medical 
data were prospectively assessed before, during and after hospital stay and at the 
Abstract
Objectives: The incidence of chronic postoperative abdominal pain (CPAP) after 
abdominal surgery is substantial and decreases overall quality of life. One in three 
patients report to have pain-related interference with mood, sleep and enjoyment of 
life and 12% visit the emergency department for pain related symptoms. Previous 
studies lack data on preoperative health and pain status, or are limited by small 
patient samples. The aim of this study is to assess risk factors for CPAP and gastro-
intestinal complaints.
Methods: Prospective cohort study including patients undergoing an elective lapa- 
rotomy or laparoscopy at a tertiary referral centre. Relevant patient, pain, surgical, and 
medical data as well as the Gastrointestinal Symptom Rating Scale (GSRS) were 
assessed before, during and after hospital stay and at the outpatient clinic until 6 months 
after discharge. Linear and logistic regression analysis were used to assess risk factors.
Results: Out of 518 included patients, 184 (36%) had CPAP. The median GSRS score 
was 5 (IQR 3 – 10). The presence of pre-operative pain shorter (OR 2.69; p 0.016) or 
longer than three months (OR 3.99; p 0.000), usage of opioid analgesia preoperatively 
(OR 3.54; p 0.001), severe adhesions underneath the incision (OR 1.63; p 0.040) and 
the NRS pain score on postoperative day 2 (OR 1.23; p 0.004) showed to independently 
increase the risk for chronic abdominal pain. Chronic pancreatitis as indication for 
surgery (B 4.20; p 0.03), 3 or more previous abdominal operations (B 1.03; p 0.03), 
presence of pain more than 3 months before surgery (B 1.61; p <0.01), upper gastro-
intestinal tract as the anatomical location of surgery (B 1.43; p 0.03) and a higher 
preoperative GSRS score (B 0.36; p <0.01) independently increased the GSRS score 
six months after surgery.
Discussion: The duration and severity of preoperative pain, more severe acute post- 
operative pain and the presence of anxious and depressive symptoms were the most 
relevant risk factors for CPAP. The number of operations and the anatomical location 
of the operation showed to be important risk factors for increasing the number of 
gastrointestinal complaints. 
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the operation. Epidural analgesia was noted. Acute postoperative pain was registered 
using the NRS, with a minimal and a maximal value for each postoperative day until 
day 5.
The endpoints of this study were the presence of abdominal pain six months post-
operatively (chronic abdominal pain) and the total postoperative GSRS score. The 
presence of abdominal pain was extracted from the GSRS questionnaire and was 
defined as no abdominal pain or abdominal pain interfering with social activities.
Statistical methods
Continuous variables are presented as means with standard deviation, or medians with 
interquartile range if non-normal distribution. Dichotomous or categorical variables 
are presented as absolute numbers and percentages. 
Due to missing data of the acute postoperative NRS score, we performed a multiple 
imputation with predictive mean matching analysis for the minimal and maximal NRS 
values of postoperative day 0, 1, 2, 3, 4 and 5 using all baseline characteristics and 
the presence of postoperative abdominal pain for prediction. All values were imputed 
20 times and the pooled OR, 95 per cent confidence interval and p-values were used 
for the univariable and multivariable logistic regression. The minimal and maximal 
NRS values of postoperative day 2 were used in the analysis because this was the 
last postoperative day on which more than 95% of the patients were still admitted to 
the surgical ward.
A univariable logistic regression analysis was used to assess risk factors for chronic 
abdominal pain and a univariable linear regression was performed for risk factors for 
the total postoperative GSRS score. All variables in the univariable analysis with a 
p < 0.10 were considered for their respective multivariable analysis. For both the 
multivariable logistic and linear regression analyses, a stepwise, backwards selection 
procedure was used with a P entry ≤0.10 and P stay ≤0.10. For the linear regression 
analysis the regression coefficient (B) is presented with a 95% CI, for the logistic 
regression analysis the Odds Ratio (OR) and 95% CI were calculated. If significant 
co-linearity was detected, the multivariable analysis was repeated with and without 
the variables causing co-linearity.
A value of p ≤ 0.05 was considered significant. Statistical analysis was performed 
using SPSS for Windows version 20.0 software (SPSS, Chicago, IL). We excluded per 
analysis the cases with missing data.
outpatient clinic until 6 months after discharge. One predefined objective of the 
LAPAD study was to establish the relation between adhesions and adhesiolysis and 
pre- and postoperative pain and gastrointestinal complaints. 
Patients who participated in the LAPAD study completed the Gastrointestinal 
Symptom Rating Scale (GSRS) and the Short Form (SF-36) the day before undergoing 
surgery. Six months after discharge the GSRS and a questionnaire regarding any 
readmissions was sent to patients. Additionally, data regarding new admissions was 
collected from medical records of hospitals, general practitioners and nursing homes 
when applicable. Patients who underwent a second elective abdominal operation 
that was included in the LAPAD study were not asked to fill in a questionnaire before 
their second operation. Patients who did not complete the pre- and postoperative 
GSRS questionnaires were excluded. 
Variables
The severity of pain was determined with a numeric rating scale (NRS) and was 
categorized as no pain, a NRS of less than 4 or a NRS of 4 or greater. The duration of 
preoperative pain was classified as no pain, pain existing for 3 months or less, pain 
existing longer than 3 months. Usage of analgesia was categorized as no usage of 
analgesia, NSAID or acetaminophen only or usage of opioid analgesia.
The GSRS is a questionnaire that measures the impact of gastrointestinal complaints 
on overall functioning. A higher score correlates to more impaired functioning.(12) 
The SF-36 measures overall quality of life and was used to measure the preoperative 
mental and emotional health of patients.(13)
Baseline demographics included sex, age, body mass index, smoking status, 
preoperative mental health, role emotional, social functioning and vitality subscales 
of the SF-36 and the number of previous abdominal operations (none, 1 or 2 or ≥3). 
The indication for the operation was categorized as malignancy, ventral hernia, ulcerative 
colitis, Crohn’s disease, chronic pancreatitis, diverticulitis or other reasons. 
Characteristics of the planned operation included surgical approach (median, sub- 
costal or other incision, and laparoscopic procedures), anatomical site of the operation 
(upper gastrointestinal tract, lower gastrointestinal tract, hepatobiliary- pancreatic, 
abdominal wall, or other), the duration of surgery in minutes and the presence of 
adhesions. The severity of adhesions underneath the previous incision and at the 
operative area were assessed using the Zühlke classification, comprising grade 0, 1 
and 2 as no or mild adhesions and grade 3 and 4 as severe adhesions. Adhesiolysis 
time was measured in minutes from the start of adhesiolysis until the operative area 
was cleared of adhesions. 
The incidence of any intra-abdominal complications within 30 days of the index 
operation, comprising intra-abdominal sepsis, abscess, anastomotic leakage, fistula, 
delayed diagnosed perforation and postoperative hemorrhage were collected after 
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A median incision was used in 343 (66%) patients and 159 (31%) patients had severe 
adhesions underneath the incision. Pre-operatively, 165 (33%) patients had abdominal 
pain of whom 129 (26%) patients reported a NRS score of 4 or higher. 412 (80%) patients 
did not use analgesia, whereas 48 (9%) used opioid analgesia pre-operatively. 144 (28%) 
patients had abdominal pain more than 3 months before surgery. The median score 
of the GSRS before the operation was 6 (IQR 3 – 10). Postoperatively, the median 
minimal value of the NRS was 2 (0 – 4) and the median maximal value was 4 (2 – 5). 
49 (10%) patients developed an intra-abdominal complication.
Results
755 operations included in the LAPAD study were assessed for eligibility in this study. 
93 operations were not included due to incomplete questionnaires (53) or because 
the same patient was operated multiple times during the LAPAD study(40). 662 
patients were included in the study, 29 patients deceased within 6 months and 115 
patients did not return the questionnaires 6 months postoperatively. Thus, 518 (78%) 
patients were available for analysis (figure 1). Six (1%), ten (2%) and twelve (2%) patients 
had missing data regarding the severity of adhesions underneath the incision, operative 
area and other areas respectively. 188 (35%) patients had missing data on the post- 
operative NRS score at day 2. 
Baseline characteristics
The baseline characteristics are shown in table 1. The indication for surgery was a 
malignancy in 47%, a ventral hernia in 19% or other indications in 27%. The anatomical 
location of surgery was the lower gastrointestinal tract in 221 (43%), the hepato -
biliary-pancreatic tract in 94 (18%) and the abdominal wall in 90 (17%) patients. 
Figure 1  Flow-chart.
Table 1  Baseline characteristics; † mean and standard deviation, all other values are 
percentiles or median with interquartile range.
Patient factors Included patients (N = 518)
Sex
Male 296 (57%)
Female 222 (43%)
Age† 58 (± 13)
BMI† 25.86 (± 4.40)
P-Possum score 2.25 (0.90 – 5.80)
Preoperative Mental Health subscale SF-36 0.72 (0.60 – 0.88)
Preoperative Role Emotional subscale SF-36 1.00 (0.33 – 1.00)
Preoperative Social Functioning SF-36 0.75 (0.50 – 1.00)
Preoperative Vitality subscale SF-36 0.60 (0.40 – 0.80)
Number of previous abdominal operations
0 181 (35%)
1 or 2 212 (41%)
≥3 125 (24%)
Indication for surgery
Malignancy 242 (47%)
Ventral Hernia 96 (19%)
Ulcerative colitis 10 (2%)
Crohn’s disease 14 (3%)
Chronic pancreatitis 10 (2%)
Diverticulitis 12 (2%)
Other 141 (27%)
Pre-operative abdominal pain and gastrointestinal complaints
Severity of preoperative pain
No pain 339 (67%)
NRS ≥1 and <4 36 (7%)
NRS ≥4 129 (26%)
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The characteristics of the non-responders are shown in table 2. Compared to responders, 
non-responders had more often a preoperative NRS >4 (p = 0.01), abdominal pain 
for longer than 3 months (p = 0.01) and preoperative opioid analgesia use (p = 0.04). 
They had a lower preoperative vitality score on the subscale (p = <0.01) and tended 
to have a lower preoperative mental health score on the subscale (p = 0.09) of the 
SF-36 questionnaire.
Table 1  Continued.
Patient factors Included patients (N = 518)
Presence of pain in time
No pain 339 (65%)
Pain ≤ 3 months 35 (7%)
> 3 months 144 (28%)
Usage of analgesia
No analgesia 412 (80%)
Only NSAID or Acetominophen 58 (11%)
Opioid analgesia 48 (9%)
Preoperative GSRS score 6 (3 – 10)
Surgical factors
Anatomical location of surgery
Upper gastrointestinal tract 53 (10%)
Lower gastrointestinal tract 221 (43%)
Hepato-billiary-pancreatic 94 (18%)
Abdominal wall 90 (17%)
Other 60 (12%)
Surgical approach
Median incision 343 (66%)
Subcostal incision 76 (15%)
Other 55 (10%)
Laparoscopy 44 (9%)
Severity of adhesions underneath incision
No, or mild adhesions 353 (69%)
Severe adhesions 159 (31%)
Severity of adhesions at operation area
No, or mild adhesions 354 (70%)
Severe adhesions 144 (30%)
Severity of adhesions at other abdominal areas
No, or mild adhesions 407 (80%)
Severe adhesions 99 (20%)
Duration of adhesiolysis (minutes) 5 (0 – 26)
Duration of surgery (minutes) 205 (146 – 271)
Creation of an ostomy
Colostomy 36 (7%)
Ileostomy 63 (12%)
Acute postoperative pain 
Epidural analgesia 284 (55%)
NRS day 2
Minimal value 2 (0 – 4)
Maximal value 4 (2 – 5)
Postoperative complications
Intra-abdominal complication 49 (10%)
Relaparotomy 53 (10%)
Table 2  Characteristics of patients who did not return the questionnaire six months 
after discharge; † mean and standard deviation, all other values are percentiles or median 
with interquartile range.
Patients who 
returned the GSRS 
(n= 518)
Patients who did  
not return the GSRS 
(n= 115)
p-value
Sex 0.42
Male 296 (57%) 61 (53%)
Female 222 (43%) 54 (47%)
Age† 58 (± 13) 55 (± 17) 0.04
BMI† 25.86 (± 4.40) 25.29 (± 4.36) 0.21
Preoperative Mental Health subscale SF-36 0.72 (0.60 – 0.88) 0.68 (0.60 – 0.80) 0.09
Preoperative Role Emotional subscale SF-36 1.00 (0.33 – 1.00) 1.00 (0 – 1.00) 0.84
Preoperative Social Functioning SF-36 0.75 (0.50 – 1.00) 0.75 (0.50 – 1.00) 0.39
Preoperative Vitality subscale SF-36 0.60 (0.40 – 0.80) 0.50 (0.30 – 0.70) <0.01
Number of previous abdominal operations 0.73
0 181 (35%) 37 (32%)
1 or 2 212 (41%) 53 (46%)
≥3 125 (24%) 25 (22%)
Preoperative GIC score 6 (3 – 10) 8 (4 – 12) 0.04
Indication for surgery
Malignancy 242 (47%) 48 (42%) 0.33
Surgical approach 0.18
Median incision 343 (66%) 72 (63%)
Subcostal incision 76 (15%) 13 (11%)
Other 55 (11%) 13 (11%)
Laparoscopy 44 (8%) 17 (15%)
Preoperative abdominal pain 0.01
No pain 339 (67%) 58 (52%)
NRS <4 36 (7%) 13 (11%)
NRS >4 129 (26%) 41 (37%)
Presence of pain in time 0.01
No pain 339 (67%) 58 (52%)
Pain ≤ 3 months 35 (7%) 15 (13%)
> 3 months 144 (28%) 42 (37%)
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Risk factors for abdominal pain six months after surgery
The univariable analysis showed that female gender, number of previous abdominal 
operations, chronic pancreatitis and other indications for surgery, a preoperative 
NRS ≥4, pain existing longer than 3 months before surgery, usage of opioids as 
analgesic before surgery, other incisions, duration of adhesiolysis and of operation, 
severe adhesions underneath the incision and a higher NRS score at postoperative 
day 2 all significantly increased the risk for the presence of abdominal pain six month 
after surgery. A higher age, higher BMI, preoperative mental health, role emotional, 
social functioning and vitality SF-36 subscores, malignancy as indication for surgery, 
no pain before surgery and no usage of analgesia significantly decreased the risk for 
having abdominal pain six months after surgery (supplement 1). 
In the multivariable analysis, co-linearity was detected between the number of previous 
laparotomies and the presence of adhesions. After repeating the multivariable analysis, 
both variables were removed due to an increase in their respective p-values. The presence 
of pain either shorter (OR 2.69; p 0.016) or longer than three months (OR 3.99; 
p 0.000), usage of opioid analgesia preoperatively (OR 3.54; p 0.001), severe adhesions 
underneath the incision (OR 1.63; p 0.040) and a higher minimal NRS value on 
postoperative day 2 (OR 1.23; p 0.004) showed to independently increase the risk for 
chronic abdominal pain. Factors independently decreasing the risk for having 
abdominal pain six months after surgery were higher age (OR 0.97; p 0.001), BMI (OR 
0.93; p 0.006), preoperative mental health (OR 0.32; p 0.045), and usage of a median 
incision (OR 0.52; p 0.006) (table 4).
Risk factors for gastrointestinal complaints
In the univariable analysis, the number of previous operations, chronic pancreatitis as 
indication for surgery, a preoperative NRS ≥4, presence of pain longer than 3 months 
before surgery, usage of opioid analgesia preoperatively, severe adhesions not in the 
operative area and a higher preoperative GSRS score significantly increased the 
postoperative GSRS score. Malignancy and ulcerative colitis as indication for surgery, 
no preoperative pain, no preoperative usage of analgesia and creation of a colostomy 
decreased the postoperative GSRS score (supplement 2). 
Chronic pancreatitis as indication for surgery (B 4.20; p 0.03), 3 or more previous 
abdominal operations (B 1.03; p 0.03), presence of pain more than 3 months before 
surgery (B 1.61; p <0.01), upper gastrointestinal tract as the anatomical location of 
surgery (B 1.43; p 0.03) and a higher preoperative GSRS score (B 0.36; p <0.01) 
independently increased the GSRS score six months after surgery. Higher 
preoperative mental health score (B – 2.10; p 0.04), ulcerative colitis as indication for 
surgery (B – 5.58; p <0.01) and creation of a colostomy at the end of surgery (B – 
2.11; p 0.01) independently decreased the postoperative GSRS score six months 
after surgery (table 5).
Abdominal pain and complaints 6 months after surgery
Six months after surgery, 184 (36%) patients had abdominal pain impairing social 
functioning. The median GSRS score was 5 (IQR 3 – 10) (table 3). The most commonly 
reported symptoms were borborygmus by 310 (60%) patients, abdominal distension 
by 242 (57%), eructation by 260 (50%) patients and increased flatulence by 339 (65%) 
patients. 123 (24%) patients reported to have fecal incontinence impacting social 
functioning. Only 33 patients (6%) had no gastrointestinal complaints six months after 
surgery.
Table 2  Continued.
Patients who 
returned the GSRS 
(n= 518)
Patients who did  
not return the GSRS 
(n= 115)
p-value
Usage of analgesia 0.04
No analgesiaNSAID 412 (80%) 82 (71%)
Only NSAID or Acetominophen 58 (11%) 13 (11%)
Opioid analgesia 48 (9%) 20 (17%)
NRS day 2
Minimal value 2 (0 – 4) 2 (0 – 4) 0.97
Maximal value 4 (2 – 5) 3 (2 – 5) 0.82
Table 3  Abdominal pain and gastrointestinal complaints six months after surgery;  
all values are percentiles, except the postoperative GSRS score which is represented 
with a median value with interquartile range.
Included patients (N=518)
Intra-abdominal pain interfering with social functioning  
6 months after surgery
184 (36%)
Postoperative GSRS score 5 (3 – 10)
Heartburn 138 (27%)
Acid regurgitation 129 (25%)
Sucking sensations in the epigastrium 129 (25%)
Nausea and vomiting 155 (30%)
Borborygmus 310 (60%)
Abdominal distension 242 (57%)
Eructation 260 (50%)
Increased flatus 339 (65%)
Obstipation 60 (12%)
Diarrhea 88 (17%)
Fecal incontinence 123 (24%)
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Discussion
Over one third of the patients reported having chronic postoperative pain impacting 
social functioning and almost every patient had gastro-intestinal symptoms at six 
months after elective abdominal surgery. Preoperative pain, preoperative usage of opioid 
analgesia and more severe pain in the acute postoperative phase were the most 
relevant risk factors for chronic postoperative pain. Only severe adhesions underneath 
a midline incision were associated with chronic postoperative pain, further adhesion 
and adhesiolysis related parameters did not show importance for chronic pain. 
Chronic pancreatitis as indication for surgery , upper GI surgery and preoperative 
pain were the most relevant risk factors for postoperative gastro-intestinal symptoms. 
The few studies on abdominal surgical procedures show comparable incidences for 
CPAP, ranging between 18 to 32 percent.(1, 14) Gastrointestinal, hernia, breast and 
thoracic operations share similar risk factors for developing chronic postoperative 
pain such as female gender, younger age, and most importantly preexisting pain and 
low mental health status.(15) A minimal invasive approach does not seem to decrease 
the occurrence of postoperative chronic pain.(16) Long term preexisting pain, pre- 
operative opioid usage and more severe acute postoperative pain were the most 
relevant risk factors for CPAP. In contrast to some reports our data collection regarding 
preoperative factors was prospective and comprehensive and our analysis was rigorous, 
taking into account potential bias of missing and non-responders data. In addition to 
a large sample size and an almost 80 percent complete follow up, results are robust 
and generalizable to patients who undergo elective abdominal surgery.(17) A lower 
preoperative score on the mental health subscale increased the risk for CPAP and 
gastrointestinal complaints. The mental health subscale measures nervousness and 
depressive symptoms in patients.(13) Both psychological variables increase the risk 
for severe acute and chronic postoperative pain and more healthcare utilization.(3, 18) 
Altogether this suggests that patient and pain-related factors rather than surgical 
factors determine chronic postoperative pain. Outcomes are probably an under -
estimate because risk factors were more frequent in non-responders.
The association between adhesion (re)formation and chronic postoperative pain and 
gastrointestinal symptoms is subject of debate. Adhesion reformation after adhesiolysis is 
a more aggressive process with dense fibrous tissue formation which theoretically 
might result in chronic pain.(19, 20) At baseline, patients with adhesions had more often 
preoperative pain (results not shown). We found that more severe adhesions under- 
neath the incision significantly increased the risk for postoperative abdominal pain. 
More severe adhesions underneath the incision are a reflection of the number of 
previous laparotomies performed due to new or recurrent illness and conceivably 
preoperative pain.(21, 22) Adhesiolysis might also indirectly be responsible for CPAP 
through an increase in adhesiolysis related complications such as inadvertent 
enterotomy and intraabdominal abscess. Surgical complications, however, were not 
Table 4  Multivariable logistic regression analysis for having chronic postoperative 
abdominal pain.
Patient factor OR 95% CI OR p
Age† 0.97 0.96 0.99 0.001
BMI† 0.93 0.89 0.98 0.004
Preoperative Mental Health subscale SF-36 0.32 0.11 0.98 0.045
Presence of pain in time
No pain Ref.
Pain ≤ 3 months 2.69 1.21 6.00 0.016
> 3 months 3.99 2.48 6.42 0.000
Usage of analgesia
Opioid analgesia 3.54 1.66 7.57 0.001
Surgical approach
Median incision 0.52 0.33 0.83 0.006
Anatomical location of surgery
Upper gastrointestinal tract 1.85 0.91 3.77 0.091
Creation of a colostomy 0.40 0.15 1.05 0.064
Severe adhesions underneath incision 1.63 1.02 2.59 0.011
NRS day 2
Minimal value 1.23 1.07 1.41 0.004
Table 5  Multivariable logistic regression analysis for having gastrointestinal complaints 
six months after surgery.
Patient factor B 95% CI B p
Age† - 0.02 - 0.06 0.00 0.07
Preoperative Mental Health subscale SF-36 - 2.10 - 4.07 - 0.13 0.04
Indication for surgery
Ulcerative colitis - 5.58 - 8.39 - 2.77 <0.01
Chronic pancreatitis 4.20 1.41 6.99 <0.01
Number of previous abdominal operations
≥3 1.03 0.10 1.96 0.03
Presence of pain in time
> 3 months 1.61 0.58 2.65 <0.01
Anatomical location of surgery
Upper gastrointestinal tract 1.43 0.15 2.72 0.03
Creation of a colostomy - 2.11 - 3.62 - 0.61 0.01
Preoperative GSRS score 0.36 0.28 0.44 <0.01
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identified as risk factor for chronic abdominal pain, possibly due to the low complication 
rate. A median incision showed to decrease the risk for having abdominal pain after 
surgery. In patients undergoing a hysterectomy usage of a pfannenstiel incision 
increased the risk for having pain after surgery.(23) A possible explanation might be 
that when the skin and muscle is transected transversely e.g. transverse and 
subcostal incision, more nerve tissue is injured. 
Ninety percent of patients had any kind of gastrointestinal complaint six months after 
surgery and patients noted to have almost two times more often borborygmus, 
abdominal distension, eructation and increased flatulence impacting social functioning 
in comparison to abdominal pain. Our results indicate that the presence of pain, the 
number of operations and the location of the operation showed to be important risk 
factors for increasing the number of gastrointestinal complaints six months after 
surgery. Anatomical and physiological changes of the gastrointestinal tract after 
bowel resection and type of reconstruction may explain the higher prevalence of 
gastrointestinal complaints, for example, fecal incontinence in one quarter of patients 
and the lower GSRS score when reconstruction was not performed and an entero- 
stomy was created. 
Proper counseling and shared-decision making is important in treating patients and 
they should be aware that abdominal pain and gastrointestinal complaints may not 
decline after surgery. Surgeons should be aware of the high incidence of chronic 
postoperative pain and pay appropriate attention to the presence of pre-operative 
pain and psychological risk factors in the preoperative work up. Early involvement 
and postoperative follow-up of an anesthesiologist or pain specialist can improve 
direct postoperative pain management and limited evidence suggests that peri- 
operative analgesia may result in a reduced incidence of chronic postoperative pain.(24, 25) 
Conclusion
One in three patients will have chronic postoperative abdominal pain six months after 
elective abdominal surgery and 9 out of 10 patients gastrointestinal complaints. The 
duration and severity of preoperative pain, more severe acute postoperative pain and 
the presence of anxious and depressive symptoms were the most relevant risk 
factors whereas adhesions and adhesiolysis related problems were not evident as 
risk factor for CPAP. The number of operations and the anatomical location of the 
operation showed to be important risk factors for increasing the number of gastroin-
testinal complaints. 
Supplement 1  Univariable logistic regression analysis for having chronic 
postoperative abdominal pain.
Patient factor OR 95% CI OR p
Pre-operative clinical factors
Sex
Male Ref.
Female 1.86 1.30 2.68 <0.01
Age 0.97 0.95 0.98 <0.01
BMI 0.95 0.91 0.99 0.01
Preoperative Mental Health subscale SF-36 0.16 0.06 0.41 <0.01
Preoperative Role Emotional subscale SF-36 0.62 0.41 0.93 0.02
Preoperative Social Functioning SF-36 0.29 0.16 0.53 <0.01
Preoperative Vitality subscale SF-36 0.17 0.08 0.35 <0.01
Number of previous abdominal operations
0 Ref
1 or 2 1.51 0.99 2.32 0.06
≥3 194 1.20 3.13 0.01
Indication for surgery
Malignancy 0.47 0.32 0.68 <0.01
Ventral Hernia 1.05 0.66 1.67 0.83
Ulcerative colitis 0.20 0.03 1.57 0.13
Crohn’s disease 2.49 0.85 7.28 0.10
Chronic pancreatitis 17.13 2.15 136.27 0.01
Diverticulitis 1.84 0.59 5.80 0.30
Other 1.71 1.15 2.54 0.01
Pre-operative abdominal pain assessment
Severity of preoperative pain
No pain 0.21 0.15 0.32 <0.01
NRS >0 and <4 1.66 0.90 3.08 0.11
NRS ≥4 4.89 3.21 7.43 <0.01
Presence of pain in time
No pain 0.21 0.15 0.32 <0.01
Pain ≤ 3 months 1.58 0.79 3.15 0.20
> 3 months 4.75 3.16 7.15 <0.01
Usage of analgesia
No analgesia 0.30 0.19 0.46 <0.01
Only NSAID or Acetominophen 1.68 0.97 2.92 0.07
Opioid analgesia 5.80 2.98 11.29 <0.01
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Supplement 1  Continued.
Patient factor OR 95% CI OR p
Surgical factors
Anatomical location of surgery
Upper gastrointestinal tract 0.93 0.51 1.69 0.80
Lower gastrointestinal tract 1.09 0.76 1.57 0.64
Hepato-billiary-pancreatic 0.92 0.58 1.48 0.74
Abdominal wall 1.19 0.75 1.90 0.46
Other 0.75 0.42 1.35 0.34
Surgical approach
Median incision 0.69 0.48 1.01 0.06
Subcostal incision 1.00 0.60 1.66 0.99
Other 2.04 1.16 3.58 0.01
Laparoscopy 1.16 0.61 2.19 0.65
Presence of adhesions 1.07 0.74 1.54 0.73
Severe adhesions underneath incision 1.57 1.07 2.30 0.02
Severe adhesions at operation area 1.37 0.93 2.02 0.12
Severe adhesions at other abdominal areas 1.28 0.82 2.01 0.28
Duration of adhesiolysis (minutes) 1.01 1.00 1.01 0.07
Duration of surgery (minutes) 1.00 1.00 1.00 0.07
Creation of an ostomy
Colostomy 0.42 0.18 0.97 0.04
Ileostomy 1.23 0.71 2.10 0.46
Postoperative factors 
Epidural analgesia 0.79 0.55 1.14 0.21
NRS day 2
Minimal value 1.30 1.16 1.46 <0.01
Maximal value 1.19 1.09 1.31 <0.01
Any intra-abdominal complication 0.87 0.46 1.63 0.66
Relaparotomy 0.69 0.37 1.29 0.25
Supplement 2  Univariable logistic regression analysis for having gastrointestinal 
complaints six months after surgery.
Pre-operative clinical factors B 95% CI B p
Sex
Male Ref.
Female 0.21 - 0.61 1.03 0.61
Age† - 0.03 - 0.06 0.00 0.06
BMI† - 0.05 - 0.14 0.04 0.31
Preoperative Mental Health subscale SF-36 - 1.79 - 3.85 0.28 0.09
Preoperative Role Emotional subscale SF-36 - 0.56 - 1.21 0.70 0.60
Preoperative Social Functioning SF-36 - 0.25 - 1.67 1.18 0.74
Preoperative Vitality subscale SF-36 - 1.58 - 3.27 0.12 0.07
Number of previous abdominal operations
0 Ref
1 or 2 0.69 - 0.22 1.61 0.14
≥3 1.51 0.45 2.57 0.01
Indication for surgery
Malignancy - 0.84 - 1.66 - 0.03 0.04
Ventral Hernia 0.44 - 0.58 1.47 0.40
Ulcerative colitis - 5.28 - 8.18 - 2.38 <0.01
Crohn’s disease 0.17 - 2.32 2.66 0.89
Chronic pancreatitis 4.81 1.92 7.70 <0.01
Diverticulitis 1.89 - 0.76 4.55 0.16
Other 0.48 - 0.42 1.38 0.30
Pre-operative abdominal pain assessment
Severity of preoperative pain
No pain - 1.54 - 2.52 - 0.57 <0.01
NRS >0 and <4 1.01 - 0.43 2.44 0.17
NRS ≥4 1.16 0.15 2.18 0.03
Presence of pain in time
No pain - 1.54 - 2.52 - 0.57 <0.01
Pain ≤ 3 months - 0.44 - 2.03 1.15 0.59
> 3 months 1.95 0.91 2.99 <0.01
Usage of analgesia
No analgesia - 1.02 - 2.04 - 0.01 0.05
Only NSAID or Acetominophen 0.28 - 0.99 1.55 0.67
Opioid analgesia 1.61 0.21 3.01 0.03
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Supplement 2  Continued.
Pre-operative clinical factors B 95% CI B p
Surgical factors
Type of surgery
Upper gastrointestinal tract 1.04 - 0.28 2.35 0.12
Lower gastrointestinal tract - 0.74 - 1.56 0.08 0.08
Hepato-billiary-pancreatic 0.26 - 0.78 1.30 0.63
Abdominal wall 0.38 - 0.67 1.43 0.48
Other - 0.12 - 1.37 1.14 0.86
Surgical approach
Median incision 0.32 - 0.53 1.16 0.46
Subcostal incision - 0.12 - 1.26 1.01 0.83
Other 0.31 - 0.99 1.60 0.64
Laparoscopy - 1.09 - 2.53 0.34 0.14
Presence of adhesions 0.52 - 0.31 1.35 0.22
Severe adhesions underneath incision 0.51 - 0.37 1.38 0.26
Severe adhesions at operation area 0.19 - 0.70 1.08 0.67
Severe adhesions at other abdominal areas 1.17 0.15 2.20 0.03
Duration of adhesiolysis (minutes) 0.01 - 0.00 0.03 0.08
Duration of surgery (minutes) - 0.00 - 0.01 0.00 0.26
Creation of an ostomy
Colostomy - 2.32 - 3.88 - 0.76 <0.01
Ileostomy - 1.04 - 2.27 0.18 0.10
Postoperative factors 
Epidural analgesia - 0.36 - 1.17 0.45 0.38
NRS day 2
Minimal value 0.21 - 0.02 0.44 0.08
Maximal value 0.17 - 0.02 0.36 0.08
Any intra-abdominal complication - 0.71 - 2.07 0.65 0.31
Relaparotomy - 0.92 - 2.23 0.40 0.17
Preoperative GSRS 0.44 0.37 0.51 <0.01
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CHAPTER 6 ADHESIOLYSIS DURING REPEAT MEDIAN LAPAROTOMY
Introduction
Peritoneal adhesions develop in more than 90% of patients who have undergone 
abdominopelvic surgery.(1, 2) Complications due to peritoneal adhesions include a 
2-3% incidence of small bowel obstruction, a decreased pregnancy rate and chronic 
abdominal pain. Moreover, during reoperations, the need for adhesiolysis results in a 
6% incidence of iatrogenic bowel injury, increased operative time, and a longer and 
more complicated convalescence.(3) A longer duration of adhesiolysis and severe 
adhesions are associated with a higher incidence of postoperative complications.(4) 
Little is known about risk factors for the formation of peritoneal adhesions. Reported 
studies are small or of limited current relevance.(5, 6) Repeat surgery within the first 3 
months has been related to severe adhesions than surgery beyond this time.(7-9) 
However, the influence of the time interval between surgeries on the extent and 
severity of postsurgical adhesions is a topic of debate. Other risk factors that seem to 
impact the severity of adhesions are a history of peritonitis and presence of intra- 
peritoneal mesh.(10)
A recent systematic review has shown that anti-adhesive barriers are effective in 
reducing complications of adhesions.(11) It is important for clinical decision making and 
the optimal implementation of anti-adhesive strategies to understand which patients 
and which types of operations are at risk for developing more severe adhesions. 
Additionally, this could improve preoperative counseling and operative room strategy.
A comprehensive assessment of risk factors for prolonged and difficult adhesiolysis 
is challenging due to the wide variety of abdominal incisions and procedures used in 
clinical practice. A median laparotomy is a common route in both acute and elective 
open general abdominal surgery and is considered to be adhesiogenic.(12) In this 
study, we used a large prospective patient cohort to assess the impact of different 
clinical variables on adhesiolysis time needed to gain access to the peritoneum, and 
on the severity of adhesions in patients undergoing a repeat median laparotomy.
Methods 
We utilized data from consecutive patients who underwent a repeat median laparotomy 
and participated in the prospective LAPAD study (‘LAParotomy or LAParoscopy and 
Adhesions study’, clinicaltrials.gov registration number: NCT01236625). This study 
was approved by the local medical ethics committee, and was conducted according 
to the revised version of the Declaration of Helsinki (October 2008, Seoul). Detailed 
methods of the LAPAD study have been recently reported.(4) The LAPAD study included 
all patients admitted to the surgical ward of the Radboud University Medical Center 
for elective laparotomy or laparoscopy, thereby entering the peritoneal cavity, between 
June 2008 and June 2010. Demographic data, pre-operative surgical factors, and medical 
factors were prospectively collected. Demographic data collected were sex, age, body 
mass index, smoking status, and the number of pack-years. Preoperative medical 
Abstract
Background: Adhesiolysis during repeat surgery is associated with a high incidence 
of iatrogenic enterotomies and an increase in postoperative complications. Identification 
of risk factors would improve preoperative counseling and operating room strategy. 
Objective: The aim of this study was to identify pre-operative risk factors for prolonged 
and difficult adhesiolysis in a repeat median laparotomy.
Design: Prospective cohort study. Univariate and multivariate analyses were used to 
assess risk factors for prolonged and difficult adhesiolysis.
Settings: Radboud University Medical Center
Patients: Patients participating in the LAPAD study (clinicaltrials.gov NCT01236625) 
undergoing an elective repeat median laparotomy.
Main outcome measures: Detailed data regarding adhesiolysis to gain entry to the 
abdomen and adhesions underneath the previous incision were gathered by direct 
observation. 
Results: A total of 259 patients underwent a repeat median laparotomy. Adhesiolysis 
was required for 230 patients (89%); the remaining 29 patients (11%) did not have 
adhesions underneath the incision. Median adhesiolysis time underneath the midline 
incision was 10 minutes (IQR: 5 – 25). 76 patients (29%) had grade 1 or grade 2 
adhesions; 108 (42%) grade 3; and 46 (18%) grade 4. The number of previous 
laparotomies was the only independent risk factor for prolonged (p= ≤0.01; CI: 2.5 
– 14.10) and difficult adhesiolysis (p= ≤0.01, OR 4.21 CI 1.74 – 10.17). History of 
peritonitis, anatomical location of previous surgery, and the time interval between 
consecutive median laparotomies did not prolong adhesiolysis.
Limitations: Retrospective data collection of patients’ medical histories, no data on 
severity of previous peritonitis.
Conclusions: This study demonstrates that four or more previous laparotomies and 
the presence or history of an intra-peritoneal synthetic mesh are independently associated 
with a longer duration of adhesiolysis needed to gain access to the abdomen. A short 
time interval between median laparotomies or a history of peritonitis did not prolong 
the duration of adhesiolysis. 
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A univariable ANOVA analysis was performed to assess the correlation between the 
duration of adhesiolysis and demographic, pre-operative surgical and medical variables. 
All variables, with a p-value of ≤0.05 were then analyzed using a multivariable independent 
ANOVA analysis, with the exception of the Zühlke grade of adhesions. The coefficient 
(b), the p-value, and the 95% confidence interval are shown for all variables. A p-value 
of ≤ 0.05 was considered to be statistically significant.
We used a univariable logistic regression analysis to identify risk factors for the development 
of severe adhesions. All variables with a p-value of ≤0.05 were then analyzed using 
a multivariable logistic regression analysis with forced entry. The odds ratio with 95% 
confidence interval and the p-value are presented. A p-value of ≤ 0.05 was considered 
statistically significant.
We excluded cases with missing data from the analysis. Statistical analyses were 
conducted using SPSS for Windows version 20.0 (SPSS, Chicago, IL). 
Results
The LAPAD database consists of 755 operations carried out in 715 patients. 260 of these 
patients underwent a repeat median laparotomy. One patient was excluded due to a 
missing Zühlke score; thus, the analysis was performed using data from 259 patients.
Demographic, pre-operative surgical and medical data are presented in table 2. The 94 
(36%) patients with other benign indications for surgery are a heterogeneous group, 
comprising colostomy reversal in 11 (4%) patients and one patient due to a diaphragmatic 
hernia amongst other indications. 15 (6%) patients underwent their repeat median 
laparotomy within 0 to 3 months, of which only 1 (0.4%) patient within the first month. 
26 (10%) patients underwent a repeat median laparotomy within 4 to 6 months, 
61 (24%) patients within 7 to 12 months and 157 (61%) after 12 months. 
factors collected were long-term usage of corticosteroids, other immunosuppressive 
drugs and statins. Indications for the current operation were categorized as malignancy, 
ventral hernia, inflammatory bowel disease, or other indications. Pre-operative surgical 
factors included were the number of previous laparotomies and laparoscopies and 
the time interval between the preceding and the current median laparotomy. Additionally, 
the anatomical location of previous surgery, a history of peritonitis (defined as any 
generalized infection of the peritoneum), history of intra-peritoneal chemotherapy, 
and history or presence of an intra-peritoneal mesh were collected and analyzed as 
binary variables accounting for the cumulative operative history. The time interval 
between laparotomies was collected as a continuous outcome; however, we used 
a categorical variable (0-3 months, 4-6 months, 7-12 months, ≥12 months) in the 
analysis. Shorter time periods, for example a reoperation within 1 month, would result 
in numbers per category that are too low for meaningful comparison. For incision 
length of the current operation we used a categorical variable (e.g. upper, lower, and 
complete midline incision). 
During surgery, detailed information regarding adhesions and adhesiolysis was 
collected through direct observation by a trained researcher who did not take part in 
the operation. Adhesions were graded according to the Zühlke classification, shown 
in table 1.(13) The Zühlke grade of adhesions was not included in the multi-variable 
analysis for risk factors for a longer duration of adhesiolysis because it cannot be 
determined pre-operatively. According to the definition of the Zühlke classification, 
adhesiolysis-related complications mostly occur in the presence of grade 3 and 4 
adhesions.(4) Therefore we transformed the classification into a binary variable by 
merging grade 0, 1 and 2 (no or mild adhesions) and grade 3 and 4 (severe adhesions). 
The time needed for adhesiolysis was measured in minutes. Since the need for 
adhesiolysis in other parts of the abdomen varies depending on clinical circumstances, 
we only used adhesiolysis time needed to gain entry to the peritoneal cavity in our 
analysis. The incidences of iatrogenic enterotomy and seromuscular bowel injury 
during the duration of surgery were also collected for all patients. Iatrogenic enterotomy 
was defined as any unintended full-thickness bowel defect during the operation. 
A seromuscular injury was defined as an injury to the serosal and muscular layers 
of the bowel without visualization of the bowel lumen or spillage of bowel contents. 
The incidences of enterotmy and seromuscular injury presented, are the incidences 
during the complete operation. These findings were immediately recorded into a 
database by the researcher present in the operating room. 
Statistical methods
Continuous variables are presented as means with standard deviaton, or as medians 
with interquartile range in case of a non-normal distribution. Dichotomous or categorical 
variables are presented as absolute numbers and percentages.
Table 1  Zühlke classification.
Zühlke grade Adhesion description Severity of adhesions
0 No adhesions No, or only mild adhesions
1 Filmy adhesions, easy to separate by blunt 
dissection
2 Adhesions with beginning vascularization, 
blunt and partly sharp dissection necessary
3 Adhesiolysis possible by sharp dissection 
only, clear vascularization
Severe adhesions
4 Adhesiolysis possible by sharp dissection 
only, damage of organs hardly preventable
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In 98% patients the complete previous incision was used for gaining access. 
Adhesions underneath the incision were absent in 29 patients (11%); 76 patients 
(29%) had grade 1 and 2 adhesions, 108 patients (42%) had grade 3 adhesions, and 
46 patients (18%) had grade 4 adhesions. Median adhesiolysis time to gain entry in 
the abdomen was 10 minutes (5 – 25). During the total duration of surgery, an 
iatrogenic enterotomy occurred in 37 (14%) patients, whereas a seromuscular injury 
was noted in 95 patients (37%) (table 3). 
Table 4 shows median adhesiolysis time to gain entry in the abdomen, the severity of 
adhesions and the number of previous laparotomies stratified for patients with no 
organ injury, seromuscular injury and enterotomy.
Table 2  Baseline patient characteristics *mean ± SD, † median, IQR 25 -75, ‡ 
range, ¥ all abdominal wall operations were laparotomies where the peritoneal cavity 
was opened, Δ only one (0.4%) patient required a laparotomy within one month.
Patient factors Included patients (N = 259)
Sex
Male 146 (56%)
Female 113 (44%)
Age* 57.4 ± 13.8
Body mass index* 25.6 ± 4.6
Smoking status
Nonsmoker 87 (34%)
Ex-smoker 110 (43%)
Smoker 62 (24%)
Number of pack years† 10.6 (0 – 28.6)
Medication
Corticosteroids 14 (5%)
Other immunosuppressive agents 15 (6%)
Statins 53 (21%)
Number of previous laparotomies
1 82 (32%)
2 or 3 114 (26%)
≥4 (4 – 56)‡ 63 (42%)
Previous laparoscopy (1 – 2)‡ 36 (14%)
History of peritonitis 73 (28%)
Presence or history of an intra-peritoneal mesh 31 (12%)
Mesh without anti-adhesive coating 21 (8%)
Mesh with anti-adhesive coating 3 (1%)
Type of mesh unknown 7 (3%)
Anatomical location of previous surgery
Upper gastrointestinal tract 23 (9%)
lower gastrointestinal tract 204 (79%)
Hepato-biliary-pancreatic 33 (13%)
Abdominal wall¥ 76 (29%)
Female reproductive tract 47 (18%)
Urological tract 36 (14%)
History of emergency laparotomy 58 (22%)
Time to Relaparotomy
0-3 monthsΔ 15 (6%)
4-6 months 26 (10%)
7-12 months 61 (24%)
>12 months (13 – 624)‡ 157 (61%)
Table 2  Continued.
Patient factors Included patients (N = 259)
Indication for surgery
Malignancy 61 (24%)
Ventral hernia 91 (35%)
Inflammatory bowel disease 18 (7%)
Other 94 (36%)
Incision used
Lower median incision 95 (37%)
Upper median incision 60 (23%)
Complete median incision 104 (40%)
Table 3  Adhesion-related outcome measures, † median, IQR 25 -75.
Total adhesiolysis time underneath incision in minutes† 10 (5 – 25)
Zühlke score of adhesions underneath incision
0 (no adhesions) 29 (11%)
1 and 2 76 (29%)
3 108 (42%)
4 46 (18%)
Number of patients with an iatrogenic enterotomy 37 (14%)
Number of patients with an iatrogenic seromuscular injury 95 (37%)
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Risk factors for more severe adhesions underneath the incision
The number of previous laparotomies, ventral hernia as the indication for surgery, a 
history or presence of an intra-peritoneal mesh, previous emergency laparotomy and 
previous surgery on the abdominal wall were significant risk factors for severe 
adhesions in the univariable logistic regression analysis (supplement 2). 
In the multivariable logistic regression analysis, the only remaining significant risk 
factor for severe adhesions was a history of four or more previous laparotomies (p 
≤0.01; OR 4.18). There was a trend toward severe adhesions in patients with a previous 
emergency laparotomy (p= 0.07; OR 1.96) (table 6).
Risk factors for adhesiolysis time required to gain access to the peritoneum
In the univariable analysis, the number of previous laparotomies, ventral hernia as the 
indication for surgery, a history of peritonitis, history of intraperitoneal mesh or mesh 
still in situ, previous surgery on the lower gastro-intestinal tract or abdominal wall, a 
previous emergency laparotomy, and use of a complete midline incision significantly 
increased adhesiolysis time. In contrast, corticosteroid use and malignancy as the 
indication for surgery significantly correlated with a shorter adhesiolysis time 
(supplement 1).
Figure 1 shows a scatterplot of the time interval between surgeries plotted against 
adhesiolysis time needed to gain entry to the abdomen. The coefficient of the linear 
regression line is -0.02 (CI= -0.045 - -0.002) showing a significant but weak inverse 
correlation (p= 0.03).
In the multi-variable analysis, four or more previous laparotomies (p ≤0.01; CI 2.72 – 
13.81), a complete midline incision (p ≤0.01; CI 5.48 – 13.49) and a history or presence 
of intraperitoneal mesh (p 0.01; CI 2.31 – 15.05) remained as significant independent 
risk factors for a longer duration of adhesiolysis underneath the incision (table 5). 
History of peritonitis, previous surgery on the lower gastrointestinal tract or abdominal 
wall were not independent risk factors for increased adhesiolysis time in the 
multi-variable analysis. 
Table 4  Patient characteristics stratified for the severity of iatrogenic organ injury  
† median (IQR 25 – 75), ‡ the presented incidences, are the incidences during the 
complete operation.
No organ 
injury  
(n = 151)
Seromuscular 
injury‡  
(n = 71)
Enterotomy‡ 
(n = 37)
p
Total adhesiolysis time underneath 
incision in minutes †
7 (3 – 15) 18 (10 – 30) 23 (13 – 38) <0.01
Severity of adhesions <0.01
No, or mild adhesions 84 (56%) 17 (24%) 4 (11%)
Severe adhesions 67 (44%) 54 (76%) 33 (89%)
Number of previous laparotomies <0.01
1 59 (39%) 19 (26%) 4 (11%)
2 or 3 70 (46%) 26 (37%) 18 (49%)
≥4 22 (15%) 26 (37%) 15 (40%)
Figure 1  Correlation of time between laparotomies (in months) and adhesiolysis 
time (in minutes). The left side of the figure includes patient who underwent a repeated 
laparotomy within 12 months, the right side shows patients who underwent a 
repeated laparotomy.
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Discussion
Four or more previous laparotomies, a history or presence of an intra-peritoneal mesh, 
and the requirement of a complete midline incision were found to be independent risk 
factors for a longer duration of adhesiolysis. If all of these factors were present in a 
single patient in this study, an average of 41 minutes of adhesiolysis time would be 
required to gain access to the abdomen. The only independent risk factor for more 
severe adhesions was the number of previous laparotomies. Surprisingly, a shorter 
time interval between median laparotomies, a history of peritonitis, and the anatomical 
location of previous surgery did not prolong adhesiolysis. These factors were also not 
associated with more severe adhesions.
This is a large and unique prospective cohort study with an accurate and comprehensive 
assessment of pre-operative surgical and medical factors in a group of patients who 
have undergone one or more median laparotomies. While transverse incisions have 
gained popularity in colorectal fast-track surgery, a median laparotomy is still the incision 
of choice in many settings, including emergency laparotomy, open stoma formation, 
small bowel surgery, and open aortic reconstruction procedures. We assessed risk 
factors for both the duration of adhesiolysis and the severity of adhesions underneath 
the incision because the duration itself depends on the extent of the adhesions present. 
Duration of adhesiolysis may therefore be a more complete marker for operative difficulty 
while clearing the midline incision site from adhesions in order to gain entry to the abdomen. 
We decided not to include severity of adhesions in the multivariable analysis for the duration 
of adhesiolysis because adhesion severity cannot be determined pre-operatively. 
Progress has been made to locate adhesions by non-invasive means before surgery, 
however these techniques have not been fully developed for its standard use.(14)
We assessed 16 potentially relevant pre-operative factors for adhesion formation 
underneath the incision. However, we were unable to collect detailed data from the 
patients’ medical history that might impact adhesion formation, such as previous use 
of anti-adhesive barrier and data on abdominopelvic radiation. The latter would most 
likely regard pelvic radiation of gynecological malignancies which impacts pelvic 
adhesion formation more than adhesions underneath the incision. Missing data on 
previous use of anti-adhesive barriers is unlikely to affect the results because routine 
usage of barriers is very uncommon in the Netherlands.(15) The indication and type of 
previous operations could be reliably assessed from medical records and are 
considered relevant based on the relation between the type of surgical procedure 
and incidence of adhesive small bowel obstruction.(3) In our study, however, the type 
of previous surgery was not found to be an independent risk factor for duration of 
adhesiolysis or for severe adhesions underneath the incision, illustrating that risk 
factors may differ between these two sequelae of adhesion formation.
Our results support earlier findings that repeated laparotomies increase adhesiolysis 
time by approximately 10 to 15 minutes.(5, 16) These studies, consisting of smaller 
Table 5  Multivariable analysis showing the effect of patient factors on adhesiolysis 
time required to gain access to the peritoneum, † reference category, ‡ p= <0.05.
Patient factors B adjusted 95% Confidence 
interval P adjusted
Lower Upper
Medication
Corticosteroids -4.78 -12.22 2.67 0.21
Indication for surgery
Ventral hernia -0.40 -4.55 3.74 0.85
Malignancy -2.09 -6.45 2.27 0.35
Number of laparotomies in history
1†
2 or 3 0.52 -3.74 4.78 0.81
≥4 8.27 2.72 13.81 ≤0.01‡
Previous laparoscopy -0.88 -5.92 4.16 0.73
Peritonitis in history 1.89 -2.25 6.03 0.37
Intra-peritoneal mesh 8.68 2.31 15.05 0.01‡
Type of previous surgery
Lower gastrointestinal tract 1.93 -2.66 6.52 0.41
Abdominal wall -1.83 -6.69 3.03 0.46
History of emergency laparotomy 0.13 -4.31 4.57 0.95
Type of incision used current laparotomy 
Lower median incision†
Upper median incision -0.47 -5.11 4.17 0.84
Complete median incision 9.48 5.48 13.49 ≤0.01‡
Table 6  Multivariable analysis of the effect of surgical and medical factors on the 
severity of adhesions, † reference category, ‡ p= <0.05.
Patient factors OR 95% CI OR p
Lower Upper
Number of previous laparotomies
1†
2 or 3 1.02 0.56 1.85 0.96
4 or more 4.18 1.73 10.11 ≤ 0.01‡
Intra-peritoneal mesh 1.1 0.35 3.41 0.87
Anatomical location of previous surgery
Abdominal wall 1.87 0.83 4.23 0.13
History of emergency laparotomy 1.96 0.95 4.03 0.07
Indication for surgery
Ventral hernia 1.15 0.60 2.18 0.68
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The results of this study can be used to improve patient counseling and operating 
room strategy. Patients with a history of multiple laparotomies should be counseled 
regarding the risks of a prolonged and more difficult operation, and a subsequent 
increased risk of organ injury. The scheduled operative time for these patients can be 
increased if deemed necessary. Furthermore, if a laparoscopic procedure is considered, 
an open introduction should preferably be performed outside the prior incision. 
Using anti-adhesive barriers during repeat operations and after adhesiolysis seems 
to be less effective than primary prevention.(18, 19) Given the adhesiogenic nature of a 
median laparotomy, and given that repeat surgeries in the abdomen are likely to 
occur during a patients’ lifetime, using an anti-adhesive barrier at initial laparotomy 
might be most beneficial for the patient. 
Conclusion
This study demonstrates that four or more previous laparotomies, the presence or 
history of synthetic intra-peritoneal mesh, and the requirement of a complete midline 
incision independently prolonged the duration of adhesiolysis needed to gain access 
to the abdomen. Additionally, four or more previous laparotomies increased adhesion 
severity underneath the incision. 
populations undergoing colorectal surgery, did not differentiate between the number 
of previous laparotomies, and did not analyze potentially relevant surgical or medical 
factors for a longer duration of adhesiolysis or severe adhesions. A cross-sectional 
study of 448 patients with previous surgery showed an association between a greater 
number of adhesions throughout the abdomen and multiple previous abdominal 
operations.(10) We consider adhesiolysis time a more clinically relevant endpoint than 
the number of adhesions throughout the abdomen because the number alone may 
not complicate subsequent surgery.(10) The same study showed a comparable 
incidence to our study of the most severe adhesions, underscoring the finding that 
around 10% of patients with previous surgery are at risk for organ injury during 
adhesiolysis. Patients in the same study, who have had intestinal leakage or an 
abdominal abscess, had significantly more adhesions.(10) Congruently, we found a 
significant correlation between a history of peritonitis and a longer duration of 
adhesiolysis in the univariable analysis. However, after correcting for other medical 
and surgical factors, this effect did not remain significant. More severe peritonitis 
might evoke more extensive and severe adhesions, potentially lengthening 
adhesiolysis time. Unfortunately, data on the severity or extent of previous peritonitis 
were not available for our patients. Specific emergency laparotomies, such as 
damage control surgery, could lead to more severe adhesion formation due to 
increased peritoneal injury. However, we were unable to specify the various indications 
for an emergency laparotomy due to their low incidence.
Our findings suggest that more extensive and repeated injuries to the peritoneum 
with subsequent adhesiolysis leads to a more aggressive reformation of adhesions. 
Limited evidence suggests that the local expression of growth factors associated 
with adhesion formation, and of proteins regulating fibrinolysis, is increased in the 
peritoneum of patients with adhesions, potentially leading to aggravated adhesion 
reformation.(17, 18)
This study unexpectedly showed that a shorter time interval between laparotomies 
does not correlate with a longer duration of adhesiolysis or with more severe adhesions. 
The adhesiolysis time needed to gain entry to the abdomen remained constant in the 
first year, and declined only marginally after ten years. Although the regression line 
was significant, the coefficient was low, reducing the clinical relevance of this finding. 
This result differs from a small retrospective study on the timing of the reversal of 
Hartmann’s procedure, in which a difference in the severity of adhesions was found 
between patients undergoing a relaparotomy before 15 weeks versus after 15 weeks.
(7) Given the small sample of patients who underwent a repeat median laparotomy 
within three months in this study and our study, caution must be taken when 
interpreting these findings. Due to the same reason, only 1 (0.4%) patient underwent 
a repeat median laparotomy within one month, this study cannot answer the question 
if a reoperation within 1 month is associated with a longer duration of adhesiolysis.
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Supplement 1  Showing the effect of patient factors on adhesiolysis time *continuous 
variable with pearson’s correlation coefficient, † reference category, ‡ p= <0.05.
Patient factors B Standard 
error
P 95% Confidence 
interval
Lower Upper
Sex 3.45 1.86 0.07 -0.25 7.2
Age* 0.01* 0.06 0.938 -0.10 0.12
Body Mass Index* 0.10* 0.08 0.10 -0.04 0.25
Smoking status
Non-smoker†
Ex-smoker 2.12 2.22 0.35 -2.57 6.24
Smoker 0.14 2.48 0.96 -4.37 5.46
Packyears* 0.05* 0.06 0.45 -0.08 0.18
Medication
Corticosteroids -7.85 1.96 ≤0.01‡ -11.56 -3.80
Other immunosuppressive agents -2.10 5.90 0.75 -10.41 10.73
Statins -1.54 2.30 0.50 -5.91 3.35
Indication for surgery
Ventral hernia 5.12 1.91 0.01‡ 1.27 8.72
Malignancy -6.25 1.83 ≤0.01‡ -9.97 -2.61
Inflammatory bowel disease 2.04 5.49 0.72 -7.85 13.46
Other -0.89 1.97 0.66 -4.52 3.30
Number of previous laparotomies
1†
2 or 3 3.72 2.08 0.08 -.37 7.81
≥4 14.31 2.40 <0.01‡ 9.57 19.04
Previous laparoscopy 4.46 2.26 0.05 -0.17 8.83
History of peritonitis 6.39 2.33 0.01‡ 1.71 11.01
Intra-peritoneal mesh 12.01 3.97 ≤0.01‡ 4.62 20.26
Anatomical location of previous surgery
Upper gastrointestinal tract 1.70 2.78 0.56 -3.96 7.04
Lower gastrointestinal tract 4.49 2.06 0.04‡ 0.16 8.63
Hepato-biliary-pancreatic 4.50 2.86 0.11 -0.10 10.52
Abdominal wall 6.62 2.27 ≤0.01‡ 2.44 11.21
Female reproductive tract -0.04 2.25 0.98 -4.24 4.71
Urological tract -3.54 2.15 0.1 -7.26 1.28
History of emergency laparotomy 5.86 2.49 0.02‡ 1.03 10.62
Time to Relaparotomy
0-3 months†
4-6 months -8.41 6.41 0.18 -21.4 4.17
7-12 months -5.22 5.97 0.38 -17.28 5.55
>12 months -2.99 5.94 0.60 -15.16 8.10
Supplement 1  Continued.
Patient factors B Standard 
error
P 95% Confidence 
interval
Lower Upper
Type of incision used during current 
laparotomy 
Lower median incision†
Upper median incision -1.03 1.70 0.55 -4.60 2.21
Complete median incision 12.26 2.11 ≤0.01‡ 8.12 16.78
Zühlke classification
No adhesions
Zühlke classification 1 and 2 8.08 1.16 ≤0.01‡ 5.67 10.3
Zühlke classification 3 16.61 1.19 ≤0.01‡ 14.07 18.94
Zühlke classification 4 33.22 2.94 ≤0.01‡ 27.91 39.53
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Supplement 2  The effect of surgical and medical factors on the severity of adhesions 
*continuous variable, † reference category, ‡ p= <0.05.
Patient factors B Standard 
error
P OR 95% CI OR
Lower Upper
Sex -0.12 0.255 0.96 0.99 0.599 1.629
Age* 0.01 0.009 0.19 1.01 0.99 1.03
BMI* -0.02 0.03 0.57 0.99 0.93 1.04
Smoking status
Non-smoker†
Ex-smoker 0.23 0.29 0.44 1.26 0.71 2.23
Smoker 0.14 0.34 0.68 1.15 0.59 2.22
Packyears* 0.002 0.01 0.74 1.002 0.99 1.01
Medication
Corticosteroids -0.71 0.56 0.20 0.49 0.17 1.46
Other immunosuppressives 0.33 0.56 0.56 1.39 0.46 4.12
Statins -0.25 0.31 0.43 0.78 0.43 1.44
Indication for surgery
Ventral hernia 0.57 0.27 0.04‡ 1.77 1.03 3.02
Malignancy -0.46 0.30 0.12 0.63 0.35 1.12
Inflammatory bowel disease 0.93 0.58 0.11 2.53 0.81 7.90
Other -0.41 0.26 0.12 0.67 0.40 1.11
Number of previous laparotomies
1†
2 or 3 0.24 0.29 0.41 1.27 0.72 2.24
4 or more 1.89 0.42 ≤ 0.01‡ 6.62 2.89 15.14
Previous laparoscopy 0.66 0.40 0.1 1.93 0.89 4.19
History of peritonitis 0.37 0.29 0.20 1.45 0.83 2.55
Intra-peritoneal mesh 0.95 0.45 0.04 2.59 1.01 6.24
Anatomical location of previous surgery
Upper gastrointestinal tract 0.07 0.45 0.89 1.07 0.44 2.56
Lower gastrointestinal tract 0.54 0.31 0.79 1.71 0.94 3.12
Hepato-biliary-pancreatic 0.20 0.39 0.60 1.22 0.57 2.61
Abdominal wall 0.98 0.30 ≤ 0.01‡ 2.66 1.47 4.82
Emergency laparotomy 0.96 0.34 0.01‡ 2.60 1.34 5.04
Female reproductive tract 0.23 0.33 0.50 1.25 0.65 2.41
Urological tract 0.08 0.37 0.83 1.08 0.53 2.23
Time to relaparotomy
0-3 months -1.01 0.70 0.15 0.36 0.09 1.44
4-6 months -0.65 0.64 0.31 0.52 0.15 1.83
7-12 months -0.61 0.61 0.31 0.54 0.17 1.78
>12 months † 0.55
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CHAPTER 7 PREDICTORS FOR BOWEL INJURY
Introduction
Adhesion formation is the most important long-term complication of abdominal surgery, 
with a lifelong risk of developing a variety of clinical conditions including small bowel 
obstruction, infertility and chronic pain.(1;2) A possibly more important consequence of 
adhesion formation is the difficulty encountered during repeat surgery.(3;4) Adhesiolysis 
increases operating time and has an adverse effect on the patient’s convalescence, 
especially if a bowel injury occurs.(5-7) The incidence of accidental bowel injury is as high 
as 10–20 per cent in patients undergoing adhesiolysis.(4;6) The sequelae of bowel 
injury include unplanned bowel resections, an increase in the incidence of surgical 
complications, admission to an intensive care unit and even an increase in mortality. 
The mortality rate from bowel injury is estimated at between 8 and 50 per cent, 
depending on whether or not the defect was recognized during the operation.(4-6;8;9)
The authors have demonstrated previously that bowel injuries occur more often in 
patients who require extensive adhesiolysis, those with high adhesion scores or a history 
of multiple laparotomies, and patients who have had lower abdominal procedures.
(4;6;7) Most of these factors are not known before operation, but become apparent 
during the procedure. Estimating the risk of adhesiolysis-related complications, 
based on preoperative variables, would enable the risks and benefits of surgery for 
the individual patient to be taken into consideration; this information could be used 
during counselling, and to identify those who might benefit from the use of adhesion 
barriers.(10;11)
The aim of this study was to define preoperative predictors of bowel injury from data 
collected in a large prospective cohort of patients undergoing elective abdominal 
surgery. The authors also investigated whether a meaningful clinical scoring system 
could be developed to predict the risk of bowel injury.
Methods
This prospective observational study was carried out as part of the LAParotomy or 
LAParoscopy and Adhesiolysis (LAPAD) study (registration number NCT01236625; 
http://www.clinicaltrials.gov). The manuscript was written in accordance with the 
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) 
statement.(12) Detailed information on the LAPAD methods has been published 
previously.(4;7) The executive board of the institutional review board confirmed that the 
study was exempt from its approval. The LAPAD study was designed to assess the 
incidence and impact of adhesiolysis on perioperative and postoperative complications. 
Patient inclusion and data collection
All adult patients scheduled for elective abdominal surgery between 1 June 2008 and 
2 June 2010 at the Department of Surgery, Radboud University Nijmegen Medical 
Centre, were screened for inclusion. The inclusion criterion was an elective laparotomy 
Abstract
Background: Inadvertent bowel injury during adhesiolysis is a major cause of 
increased morbidity and mortality following abdominal surgery. Identification of risk 
factors predicting this complication would guide preoperative counselling and 
surgical decision-making. The aim of this study was to identify predictive preoperative 
factors for inadvertent bowel injury occurring during adhesiolysis.
Methods: All patients undergoing elective abdominal surgery between June 2008 
and June 2010 were evaluated prospectively as part of the LAPAD study. Data on 
adhesiolysis and inadvertent organ injury were gathered by direct observation during 
operation. Univariable logistic regression was used to investigate factors that increased 
the risk of inadvertent bowel injury. Independent predictors of bowel injury were identified 
using multivariable logistic regression and used to create a clinical nomogram. 
Registration number: NCT01236625 (http://www.clinicaltrials.gov).
Results: Of 715 patients eligible for analysis, 48 (6.7 per cent) had inadvertent bowel 
injuries. In 42 patients the defect was detected during operation and in nine at a later 
time (3 patients had both). Bowel resection was required for almost two-thirds of the 
enterotomies. The number of previous laparotomies, anatomical site of the operation, 
presence of bowel fistula and laparotomy via a pre-existing median scar were 
independent predictors of bowel injury. A clinical scoring system was constructed 
using a nomogram incorporating these risk factors; this had a predictive discrimination, 
measured as the area under the receiver operating characteristic curve, of 0.85. 
Conclusion: A nomogram based on four independent factors predicted the risk of 
inadvertent bowel injury. 
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Statistical analysis
For patients who had undergone several operations during the study interval, the 
most recent procedure was analysed and the others regarded as previous operations 
to avoid duplication of risk factors. 
Univariable logistic regression was used to study the differences in demographics, 
patient history, medication, operative risk scores and the planned procedure between 
patients with and without bowel defects. The incidence of bowel injuries and crude odds 
ratios (ORs) with 95 per cent confidence intervals (c.i.) were calculated. All predictors 
found to be significant in univariable analysis were included in a multivariable analysis. 
A stepwise, backwards selection procedure was used with a P entry ≤ 0.100 and 
P stay ≤ 0.100. The adjusted OR was calculated with 95 per cent c.i. The R2 value 
was computed to assess the information gained by addition of the co-variable(s) 
in the logistic regression model in comparison to a model without any co-variables. 
R2 ranges between 0 and 100 per cent, with 0 per cent indicating that the prediction 
model explains none of the variability in the outcome data and 100 per cent indicating 
a perfect fit on the data.
The area under the receiver operating characteristic (ROC) curve (AUC) was used to 
quantify predictive discrimination. In general, these measures can be expected to be 
too high because the model was developed solely using the study sample, and this 
model would be expected to perform less adequately on a different random sample. 
Therefore, to evaluate the reliability of the created prediction model, an internal 
cross-validation was performed using bootstrap methods. The corrected R2 and 
corrected AUC were calculated. 
A nomogram was constructed using the multivariable prognostic model using the 
standard methods of the Regression Modelling Strategies package version 4.1-1 for 
R 2.12.0.(14) Such a nomogram can be used to predict bowel injury in an individual 
patient by filling in the values for each independent risk factor. The corresponding 
number of points can then be read from the scale presented. These are then summed 
to give a total point score, which is translated into a risk of enterotomy by using the 
two scales at the bottom of the nomogram. The 95 per cent c.i. of the predicted risk 
can be read from a 95 per cent c.i. plot of the estimated risks. The 95 per cent c.i. 
values were obtained by simulating 1000 draws for each combination of risk factors 
from the model’s posterior distribution. 
R version 2.12.0 (R Project for Statistical Computing, Vienna, Austria) was used for 
statistical analysis. P < 0.050 was considered statistically significant in all analyses. 
or laparoscopy. Exclusion criteria were age under 18 years and mental disorder. 
Patients were included after giving oral and written informed consent. 
Patient, surgical and medical data were assessed prospectively before, during and 
after hospital stay, and from the outpatient clinic for 6 months after discharge. During 
surgery, detailed information on adhesions, adhesiolysis and inadvertent organ 
damage were collected through direct observation by a trained researcher who did 
not take part in the operation. 
Variables analysed
Preoperative data on demographics, patient history, medication, operative risk scores and 
the planned procedure were extracted from the database for analysis. Demographics 
analysed comprised: sex, age, body mass index, smoking habits, and alcohol abuse 
based on the Alcohol Use Disorders Identification Test score.(13) Variables extracted 
from the patient’s history included: laparotomies, laparoscopies, interval since last 
laparotomy, history of other surgery (and, if yes, what type of surgery), exploratory 
laparotomy, peritonitis, diabetes mellitus, inflammatory bowel disease and active 
malignancy. Medications included: corticosteroids, immunosuppressants, non-steroidal 
anti-inflammatory drugs, opioids and statins. The following operative risk scores were 
assessed: American Society of Anesthesiologists fitness classification, Portsmouth 
modification of the Physiological and Operative Severity Score for the enUmeration 
of Mortality and morbidity (P-POSSUM) and Revised Cardiac Risk Index. Aspects of 
the planned operation included: anatomical site of operation, median incision through 
a pre-existing scar, previous surgery at the anatomical site of the operation, resection 
of bowel fistula, surgical experience, operative severity, mesh for ventral hernia repair 
in situ and surgical approach.
To facilitate calculations, the variable anatomical operation site was categorized as 
lower gastrointestinal, abdominal wall or miscellaneous, the latter comprising upper 
gastrointestinal, hepatopancreatobiliary and other abdominal surgery associated 
with a low incidence of bowel injury.
Assessment of outcome
Bowel injury was classified as inadvertent enterotomy or a delayed diagnosis of 
perforation. Inadvertent enterotomy was defined as any iatrogenic unintended 
full-thickness bowel defect detected during operation. Pre-existing fistulas or defects 
created while dissecting the bowel loop that harboured the fistula were not scored as 
an inadvertent enterotomy. 
Delayed diagnosis of perforation was defined as a bowel defect with spill of gastro-
intestinal content that was diagnosed after surgery by imaging, at reoperation or at 
autopsy, and which was not explained by anastomotic leakage, bowel ischaemia or 
any other obvious causes of leakage unrelated to adhesiolysis.
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the previous 6 months. Patients with active malignancy had a lower risk of bowel 
injuries, but also had undergone fewer laparotomies previously. 
A previous laparoscopy had no significant effect on the risk of bowel injury. The risk 
of enterotomy was highest in patients scheduled for surgery of the abdominal wall 
and lower gastrointestinal tract. The risk also increased when surgery was planned 
using a median incision through a pre-existing scar, was at the same anatomical 
location as previous operations, required fistula resection, or a mesh was in situ from 
a previous ventral hernia repair. None of the demographic variables, medications or 
operative risk scores had a significant effect on the risk of bowel injury. 
Multivariable analysis of risk factors for bowel injury
In the multivariable analysis, four predictors were included in the final model (Table 2). 
A history of laparotomies was the strongest predictor of bowel injury, the risk increasing 
with each additional laparotomy. The anatomical site of planned surgery also had an 
independent impact on the risk of bowel injury. Other variables included in the multi- 
variable model were fistula resection and a median incision through a pre-existing scar.
The AUC as a measurement of the predictive discrimination of the model was 0.85 
and the R2 value was 25.8 per cent. After internal validation using bootstrapping, the 
AUC was 0.82 and R2 was 20.7 per cent.
Results
Of 844 consecutive elective operations that were eligible for inclusion, 89 were 
excluded for various reasons. Some 755 operations performed in 715 patients were 
available for analysis (Fig. 1). Most patients (62.9 per cent) were operated by one of 
13 senior consultants participating in the study, 6.9 per cent by one of three junior 
consultants and 30.2 per cent by one of 31 residents. Bowel injuries occurred in 48 
patients (6.7 per cent). In 42 patients a median of 1 (range 1–9) enterotomies was 
detected during the operation. A delayed perforation was diagnosed in nine patients. 
Three patients had both enterotomies detected during surgery and a delayed 
diagnosis of perforation.
A total of 73 enterotomies were detected in 42 patients. In 23 of these patients at least 
one of the enterotomies was made either under the incision, or during adhesiolysis 
between bowel and the abdominal wall. Eleven patients had an enterotomy in the left 
lower quadrant. The left upper quadrant and true pelvis was the location of an 
enterotomy in six and four patients respectively. Two patients had an enterotomy in 
the right half of the abdomen. Among the 42 patients with an enterotomy, the small 
bowel was lacerated in 28, the large bowel in nine, both small and large bowel in four, 
and one patient had a gastric enterotomy.
Impact of bowel injury
The mortality rate was higher in the bowel injury group than among those without 
bowel injury: 8 per cent (4 of 48) compared with 1.9 per cent (13 of 667) respectively 
(P = 0.022). All four patients who died in the bowel injury group had been diagnosed 
with a delayed perforation, and two also had an enterotomy detected during operation. 
One patient died after 4 days from ongoing abdominal sepsis after delayed perforation; 
the other three died from haemorrhage following relaparotomy, pneumosepsis or acute 
heart failure.
Enterotomy was followed by bowel resection in 26 of 42 patients, whereas enterotomies 
in the remaining patients were closed primarily. Thirteen of 48 patients with bowel 
injury required admission to an intensive care unit. Twenty-one patients (44 per cent) 
had one or more serious adverse events, which included abdominal sepsis (13 per 
cent), wound infection (17 per cent) and pneumonia (25 per cent).
Univariable analysis of risk factors for bowel injury
In univariable analysis, the number of previous laparotomies, and a history of surgery 
of the lower gastrointestinal tract, abdominal wall and urogenital tract were significant 
risk factors for bowel injury (Table 1; Table S1, supporting information). Patients who 
had undergone a single laparotomy previously had only a moderately increased risk 
of bowel injury; this increased dramatically with additional laparotomies. The risk of 
bowel injury was also higher when a previous laparotomy had been carried out within 
Figure 1  Flow chart of patients included in the study.
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A nomogram was constructed to calculate the risk of bowel injury (Fig. 2) and 95  per 
cent c.i. of the predicted risk calculated (Fig. 3). Several clinical examples of how the 
model can be applied are provided in Table S3 (supporting information).
Table 1  Risk factors for bowel injury identified by univariable logistic regression analysis.
No. of patients* Odds ratio† P
Patient history
 Laparotomies
 0
 1
 2 or 3
 ≥ 4 
2 of 263 (0.8)
5 of 186 (2.7)
24 of 191 (12.6)
17 of 75 (23)
1.00 (reference)
3.61 (0.69, 18.79)
18.75 (4.38, 80.39)
38.25 (8.60, 170.15)
< 0.001
0.128
< 0.001
< 0.001
 Lower GI surgery
 No
 Yes
9 of 378 (2.4)
39 of 337 (11.6)
1.00 (reference)
5.37 (2.56, 11.25) < 0.001
 Abdominal wall surgery
 No
 Yes
31 of 582 (5.3)
17 of 133 (12.8)
1.00 (reference)
2.61 (1.40, 4.86) 0.003
 Urological surgery
 No
 Yes 
36 of 635 (5.7)
12 of 80 (15)
1.00 (reference)
2.94 (1.46, 5.91) 0.003
 Active malignancy
 No
 Yes
40 of 375 (10.7)
8 of 340 (2.4)
1.00 (reference)
0.20 (0.09, 0.44) < 0.001
 Peritonitis
 No
 Yes
39 of 653 (6.0)
9 of 62 (15)
1.00 (reference)
2.67 (1.22, 5.82) 0.013
Aspects of planned operation
 Anatomical site of operation
 Miscellaneous
 Lower GI
 Abdominal wall
4 of 270 (1.5)
28 of 327 (8.6)
16 of 118 (13.6)
1.00 (reference)
6.23 (2.16, 17.99)
10.43 (3.40, 31.94)
< 0.001
0.001
< 0.001
 Repeated median laparotomy
 No
 Yes
11 of 462 (2.4)
37 of 253 (14.6)
1.00 (reference)
7.02 (3.51, 14.04) < 0.001
 Previous surgery at anatomical site
 No
 Yes
12 of 448 (2.7)
36 of 267 (13.5)
1.00 (reference)
5.66 (2.89, 11.09) < 0.001
 Resection of fistula
 No
 Yes
39 of 683 (5.7)
9 of 32 (28)
1.00 (reference)
6.46 (2.80, 14.90) < 0.001
 Mesh in situ
 No
 Yes
40 of 672 (6.0)
8 of 43 (19)
1.00 (reference)
3.61 (1.57, 8.30) 0.002
Table 2  Adjusted risk of bowel injury in multivariable logistic regression analysis. 
Values in parentheses are 95 per cent confidence intervals. GI, gastrointestinal.
Adjusted odds ratio P
History of laparotomies 
 0
 1
 2 or 3
 ≥ 4
1.00 (reference)
2.27 (0.40, 12.97)
10.03 (2.04, 49.24)
15.79 (2.97, 83.91)
< 0.001
0.355
0.005
0.001
Anatomical site of operation
 Miscellaneous
 Lower GI
 Abdominal wall
1.00 (reference)
3.81 (1.26, 11.55)
2.57 (0.78, 8.44)
0.050
0.018
0.120
Fistula surgery
 No
 Yes
1.00 (reference)
2.34 (0.95, 5.74) 0.064
Repeat median laparotomy
 No
 Yes
1.00 (reference)
1.99 (0.89, 4.44) 0.094
Figure 2  Nomogram to calculate the risk of enterotomy. Draw a vertical line for 
each variable to the ‘points’ axis at the top. Sum the points for the four variables and 
locate this total score on the ‘total points’ axis. Draw a vertical line from this through 
the bottom two scales to determine the linear predictor and the predicted risk of 
enterotomy. GI, gastrointestinal.
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operative aspects that can result in bowel injury, the absence from the present data 
of other potentially relevant risk factors, and unknown risk factors such as the variation 
among humans in the extent and severity of adhesion formation after a similar insult. 
It is questionable whether prediction of complications after surgery could ever reach 
100 per cent considering the interaction of multiple patient, surgeon and local 
environmental factors. Recently a prediction model for development of surgical-site 
infection found an incidence ranging from 15.6 to 36.1 per cent; a model predicting 
the need for blood transfusion in head and neck surgery yielded rates ranging from 
0.5 to 62 per cent.(18;19) The present model identified predictive factors that are easily 
assessed from the history of all elective surgical patients. This enables the prediction 
model to be validated in external populations.
In this study, previous laparoscopic surgery was not identified as a risk factor for 
bowel injury. This finding should be interpreted with caution because of the low 
incidence of major previous laparoscopic procedures in this series. There are limited 
data showing less adhesion formation and better adhesion-related clinical outcome 
with gynaecological laparoscopy and other minor general surgical procedures.(20) 
Evidence regarding laparoscopic colorectal surgery is not convincing, particularly 
because adhesion formation was assessed post hoc or as a secondary outcome in 
colorectal studies.(21;22) 
Other potential preoperative factors for prediction of adhesion-related complications 
are the use of adhesion barriers, and mapping of adhesions to the abdominal wall 
and between viscera.(11) Adhesion barriers were barely used in any of the previous 
operations in the present cohort, consistent with the low use of barriers reported in 
surveys.(10;23) Adhesion mapping was not included as a variable here because such 
diagnostic tools are still experimental.(24-26) No routine diagnostic tool exists that can 
reliably assess adhesions before surgery, especially those between viscera.
Two previous retrospective studies provided evidence that the number of previous 
laparotomies increases the risk of bowel injury at adhesiolysis.(6;17) In these studies 
age was also a risk factor, which could not be confirmed in the present cohort. Other 
risk factors identified in the present study had either not been analysed previously or 
did not show a significant effect.(6;16;27)
Some variables identified as potential risk factors in univariable analysis were not 
significant in the final multivariable risk model, including history of peritonitis, mesh in 
situ and time since last laparotomy, which have been associated with more dense 
and extensive adhesions in other studies.(7;28-31) Numbers in these subgroups might 
have been too small to demonstrate significance.
There was no difference in the risk of bowel injury between senior and junior 
consultants, and residents. However, high-risk patients were often scheduled for 
surgery by a consultant (or at least with a consultant available to assist), which might 
have obscured the impact of surgical experience in this observational study.
Discussion
This study identified four predictors of adhesiolysis-related bowel injury. Using the 
nomogram built on this prediction model, the risk of inadvertent bowel injury can be 
estimated for an individual patient. The risk estimate can be used to inform the patient 
about their risk of bowel injury during adhesiolysis when obtaining informed consent. 
In addition, the surgeon can use the information to weigh up the benefits and risks of 
surgery. The prediction model demonstrated good internal validation, with comparable 
AUC and R2 values after bootstrapping. The predicted risks of bowel injury ranged from 
0 to 50 per cent. 
This large prospective cohort study was designed specifically to assess complications of 
adhesiolysis by direct observation, thereby guaranteeing data accuracy, which enabled 
the search for risk factors related to adhesiolysis injury. Previous studies had to rely on 
medical records, which are often inaccurate when reporting adhesive complications.(15-17) 
The present results were obtained using robust statistical methods and were validated 
internally using bootstrapping.
Although this prediction model shows a good fit, it only identifies groups with low and 
moderate risk of bowel injury, with predicted risks ranging between 0 and 50 per cent. 
The inability to predict incidences above 50 per cent is most likely due to the many 
Figure 3  The predicted risk of enterotomy and 95 per cent confidence interval 
obtained by simulation.
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Although the statistical background of the risk model presented is complex, patients 
at risk of bowel injury are easily identified using the nomogram based on the four 
predictive factors from the multivariable model. Fewer than 10 per cent of surgeons 
inform their patients about the risks of adhesions.(10) Given the high risk of morbidity 
and increased perioperative mortality associated with bowel injuries, not informing 
patients about these risks could be deemed negligent.(32) The present results may be 
used to weigh up the risks and benefits of surgery for the individual patient. Most 
patients undergoing abdominal surgery have a vital (oncological) indication for 
surgery. However, many others with benign conditions undergo abdominal surgery to 
improve quality of life (ventral hernia with mainly cosmetic complaints). In these 
patients, the potential benefits of the operation and the risk of reducing quality of life 
owing to bowel injury can now be discussed more appropriately. Having identified a 
high-risk patient, precautions can be taken, such as scheduling extra operating 
theatre time, and recruiting a dedicated consultant and operating room team. 
Future studies are needed to evaluate whether reduction of adhesion formation by 
the use of adhesion barriers can decrease the risk of bowel injury during reoperations.
(11;33)
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Introduction
An increasing number of patients undergo abdominal surgery multiple times during 
their lifetime, due to a higher life expectancy and advances in surgical technology this 
is expected to increase even further.(1, 2) Today, as many as 40 to 66% of elective 
procedures in general surgery are reoperations.(3-5) It is estimated that 10 to 37% of 
patients undergoing elective abdominal surgery will require repeat abdominal surgery and 
might thus benefit from the use of anti-adhesive barriers.(6, 7) During reoperations, the 
need for adhesiolysis results in increased operative time, a six to ten percent incidence 
of inadvertent bowel injury and a longer and more complicated convalescence. The 
risk for bowel injuries is amplified by each consecutive laparotomy and can be as 
high as 50%.(8) Furthermore, increased postoperative mortality and higher healthcare 
costs are reported especially when adhesiolysis resulted in bowel injury.(5, 9) 
It is important to understand which patients will require repeat surgery for the optimal 
resource utilization and implementation of anti-adhesive strategies in order to reduce 
adhesiolysis-related complications. A recent systematic review and meta-analyses of 
four commercially available anti-adhesive barriers demonstrated that these barriers 
effectively reduce the incidence and severity of adhesions and operative time.(10) 
Currently, it is unknown which patients are at risk for undergoing repeat abdominal 
surgery. The risk of repeat abdominal surgery has only been investigated in a number 
of disease specific cohorts which assessed risk factors for undergoing repeat surgery 
for disease recurrence.(11, 12) Population-based studies only focused on the incidence 
and did not provide patient specific risk factors for undergoing repeat surgery.(6, 7) 
The aim of this study is to analyze patterns of repeat abdominal surgery during 
long-term follow-up and identify risk factors for requiring repeat abdominal surgery in 
a cohort of patients undergoing elective abdominal surgery.
Material and methods
Study design and patients
This is a follow-up study of the prospective LAPAD study (‘LAParotomy or LAParoscopy 
and Adhesions study’, clinicaltrials.gov registration number: NCT01236625). Detailed 
methods of the LAPAD study are reported recently.(5) The LAPAD study included all 
patients admitted to the surgical ward of the Radboud university medical center for 
elective laparotomy or laparoscopy between June 2008 and June 2010. Demographics, 
pre-operative surgical factors and medical patient factors were prospectively collected. 
Patients who deceased within 30 days after discharge of the index admission were 
excluded from this study. Data on endpoints were gathered from 30 days after 
discharge until November 2013. For patients with multiple operations included in the 
LAPAD study, data was gathered from the last included operation. Patients and their 
general practitioners were contacted separately and a questionnaire was sent 
regarding admissions to the departments of surgery for hospitalization for repeat 
Abstract
Purpose: Today, 40 to 66% of elective procedures in abdominal surgery are reoperations. 
Reoperations show increased operative time and risk for intra- and postoperative 
complications, mainly due to the need to perform adhesiolysis. It is important to 
understand which patients will require repeat surgery for optimal utilization and 
implementation of anti-adhesive strategies. Our aim is to assess the incidence and 
identify risk factors for repeat abdominal surgery.
Methods: This is the long-term follow-up of a prospective cohort study (LAPAD study; 
clinicaltrials.gov: NCT01236625). Patients undergoing elective abdominal surgery 
were included. Primary outcome was future repeat abdominal surgery and was defined as 
any operation where the peritoneal cavity is reopened. Multivariable logistic regression 
analysis was used to identify risk factors.
Results: 604 (88%) out of 715 patients were included, median duration of follow-up 
was 46 months. 160 (27%) patients required repeat abdominal surgery and underwent 
a total of 234 operations. The indication for repeat surgery was malignant disease 
recurrence in 49 (21%), incisional hernia in 41 (18%) and indications unrelated to the 
index surgery in 58 (25%) operations. Older age (OR 0.98; p 0.002) and esophageal 
malignancy (OR 0.21; p 0.034) significantly reduced the risk of undergoing repeat 
abdominal surgery. Female sex (OR 1.53; p 0.046) and hepatic malignancy as indication 
for surgery (OR 2.08; p 0.049) significantly increased the risk of requiring repeat 
abdominal surgery.
Conclusions: One in four patients will require repeat surgery within 4 years after elective 
abdominal surgery. Lower age, female sex and hepatic malignancy are significant risk 
factors for requiring repeat abdominal surgery.
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required multiple operations, the date, surgical approach and indication for surgery 
were registered separately.
Statistical methods
Continuous variables are presented as means with standard deviation, or medians with 
interquartile range if non-normal distribution. Dichotomous or categorical variables 
are presented as absolute numbers and percentages. 
Univariable and multivariable logistic regression analysis was performed to identify 
risk factors for unplanned repeat abdominal surgery. All variables, with a p-value of 
≤0.10 were analyzed using a multivariable logistic regression analysis with stepwise 
backwards selection, P entry ≤0.10 and P stay ≤0.10. The odds ratio, the 95% confidence 
interval of the odds ratio and the p-value of risk factors are presented. The area under 
the receiver operating characteristic (ROC) curve (AUC) was used to quantify the 
predictive value of the logistic regression analysis.
A Kaplan-Meier analysis was performed showing the cumulative hazard risk of patients 
requiring repeat abdominal surgery over time. 
A value of p ≤ 0.05 was considered significant. Statistical analysis was performed 
using SPSS for Windows version 20.0 software (SPSS, Chicago, IL). There was only 
minimal missing data, thus we excluded per analysis those cases with missing data.
Results
715 patients were eligible for inclusion in this study, 25 patients died within 30 days 
after discharge of the index admission terminating their follow-up. Out of 86 patients 
that were excluded, 27 patients declined to participate in follow-up and 59 patients 
were lost to follow-up, leaving 604 (88%) patients for inclusion (Figure 1). The median 
duration of follow-up was 46 (IQR 33 – 54) months. 
Baseline characteristics at index operation and incidence of repeat  
abdominal surgery
Table 1 shows the baseline characteristics. Mean (SD) age was 59 (± 14) and 343 
(57%) patients were male. A median incision was used in 392 patients, a subcostal in 
86 and other incisions were used in 70 patients, whereas a laparoscopic procedure 
was performed in 56 patients. Severe adhesions in the operative area were seen in 
187 (31%) of the patients. An ostomy was created in 107 (17%) patients. 53 (9%) 
patients developed a postoperative intra-abdominal complication. 
Patients that were excluded were significantly younger (mean 55 years of age versus 
59 years; p 0.04), had more often a diagnosis of inflammatory bowel disease (17 (20%) 
versus 65 (11%); p 0.01) and had less often an esophageal malignancy (4 (5%) versus 
85 (14%); p 0.02) in comparison to patients included in the follow-up study. Other 
baseline characteristics did not show significant differences (results not shown).
abdominal surgery and episodes of bowel obstruction. Data was collected from 
medical records of hospitals and nursing homes when applicable. A waiver was obtained 
from the medical ethical committee of the Radboud university medical center 
(registration number: 2013/097) for this study.
Variables
Baseline demographics included sex, age, body mass index, American Society of 
Anesthesiologists classification, P-Possum score, presence of malignancy, number 
of previous laparotomies (0, 1 or 2, ≥3) and laparoscopies (0 and 1 or more), 
anatomical location of previous surgery and index operation (lower gastro-intestinal, 
abdominal wall, other) and surgical approach (median, subcostal, other incision, and 
laparoscopy). Data on intra-operative factors collected were adhesiolysis time (0-30, 
≥31 minutes), complete adhesiolysis defined as all peritoneal adhesions lysed, 
severity of adhesions underneath the incision, operative area and other abdominal 
areas according to the Zühlke classification(13) comprising 0, 1 and 2 as no or mild 
adhesions and 3 and 4 as severe adhesions, the location of adhesions (upper and 
lower abdomen) any iatrogenic organ injury due to adhesiolysis, estimated blood 
loss and the creation of an ostomy at the end of surgery. Postoperative data collected 
was the incidence of any intra-abdominal complication within 30 days of the index 
operation, comprising intra-abdominal sepsis, abscess, anastomotic leakage, fistula, 
delayed diagnosed perforation, hemorrhage and a relaparotomy or relaparoscopy.
Endpoints
Repeat abdominal surgery was defined as any operation were the peritoneal cavity is 
opened. In this study we analyzed reoperations during the long-term follow-up (after 
30 days from discahrge). Immediate reoperations for serious adverse events of the 
index operation have previously been described.(5) Repeat abdominal surgeries were 
categorized in a planned or an unplanned operation. Planned repeat operations were 
defined as all repeat operations that are part of a staged treatment strategy (e.g. 
closure of a protective loop ileostomy, or staged resection of synchronous hepatic 
metastasis from a colorectal carcinoma in situ). An operation was defined as 
unplanned if it was not part of the initial treatment strategy. The number of laparotomies 
and laparoscopies, the time interval between last included surgery and repeat 
abdominal surgery, surgical approach (open or laparoscopic), anatomical location 
and indication for repeat surgery were registered. Indications for repeat abdominal 
surgery were categorized as malignant disease recurrence comprising both loco- 
regional recurrence and distant metastasis, incisional or parastomal hernia, emergency 
laparotomy, adhesive small bowel obstruction or adhesiolysis for abdominal pain, 
ostomy closure including loop ileostomy closure, relocation of ostomy, new ostomy 
creation for any reason, new malignancy and other indications. For patients who 
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The incidence and characteristics of repeat abdominal surgery are shown in Table 2. 
160 (27%) patients underwent a total of 234 repeat abdominal operations, 108 (18%) 
Patients had 1 laparotomy, 29 (5%) had 2 laparotomies, 16 (3%) patients underwent 
3 or more laparotomies and 14 (2%) patients required a laparoscopy. 196 (84%) 
Operations were unplanned and 38 operations were staged procedures of which 
32 (84%) were loop ileostomy closures. 134 (22%) Patients underwent at least one 
unplanned repeat abdominal operation. The anatomical location of repeat surgery 
was most often the lower gastrointestinal tract in 98 (45%) and abdominal wall in 
49 (23%). The indication for repeat surgery was malignant disease recurrence in 49 
(21%), incisional or parastomal hernia in 41 (18%) and other indications in 58 (25%) 
operations. Other indications comprised predominately of open or laparoscopic chole- 
cystectomy (28% of other indications), results not shown. 3 patients required a protective 
loop ileostomy during an unplanned repeat operation, which needed subsequent 
closure. The cumulative incidence of repeat abdominal surgery after 2 years is 20% 
(figure 2).
Figure 1  Flow-chart. Table 1  Baseline characteristics.
Patient factors Number of patients (N = 604)
Sex
Male 343 (57%)
Female 261 (43%)
Age* 59 ± 14
BMI* 25.7 ± 4.4
Smoking status
Non-smoker 77 (34%)
Ex-smoker 111 (50%)
Smoker 36 (16%)
Physiologic-Possum score† 16 (14 – 20)
ASA-score
1 104 (17%)
2 370 (61%) 
3 130 (22%)
Diagnosis of IBD 65 (11%)
Number of previous laparotomies
0 220 (36%)
1 or 2 255 (42%)
≥3 129 (21%)
Previous laparoscopy
Yes 531 (88%)
No 73 (12%)
Anatomical location previous surgery
Upper GI 31 (5%)
Lower GI 291 (48%)
Abdominal Wall 115 (19%)
HPB 66 (11%)
Other 200 (33%)
Malignancy as indication for surgery
Colorectal 108 (18%)
Hepatic 68 (11%)
Esophageal 42 (7%)
Other 85 (14%)
Benign indication for surgery
Ventral hernia 104 (17%)
Fistula 35 (6%)
Other 194 (32%)
Anatomical location index operation
Lower GI 264 (44%)
Abdominal Wall 102 (17%)
Other 238 (39%)
Surgical approach
Median 392 (65%)
Subcostal 86 (14%)
Other 70 (12%)
Laparoscopy 56 (9%)
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Table 1  Continued.
Patient factors Number of patients (N = 604)
Presence of adhesions
Yes 379 (63%)
No 225 (37%)
Adhesiolysis time (minutes)
0-30 474 (79%)
>31 130 (21%)
Adhesion severity underneath incision
No or mild adhesions 419 (70%)
Severe adhesions 178 (30%)
missing data 7 (1%)
Adhesion severity operative area
No or mild adhesions 407 (69%)
Severe adhesions 187 (31%)
Missing data 10 (2%)
Adhesion severity other abdominal areas
No or mild adhesions 460 (78%)
Severe adhesions 127 (22%)
Missing data 17 (3%)
Iatrogenic organ injury due to adhesiolysis 148 (25%)
Ostomy created
Ileostomy 69 (11%)
Colostomy 38 (6%)
Wound classification
Clean 237 (39%)
Clean-contaminated 325 (54%)
Contaminated 39 (7%)
Dirty 3 (1%)
Length of surgery 202 (145 – 269)
Intra-abdominal complication 53 (9%)
Relaparotomy 51 (9%)
Table 2  The number of patients that underwent repeat abdominal surgery as well as the 
anatomical location and indication of repeat abdominal surgery. * three patients required 
the formation of a protective loop ileostomy during a reoperation and subsequent closure.
Repeat surgery
Patients undergoing repeat surgery
Yes 160 (27%)
No 444 (73%)
Patients undergoing unplanned repeat surgery
Yes 134 (22%)
No 470 (78%)
Number of laparotomies
1 108 (18%)
2 29 (5%)
≥3 (3-5) 16 (3%)
Laparoscopy
Yes 14 (2%)
No 590 (98%)
Number of planned operations 38 (16%)
Closure protective loop ileostomy 32
Staged resection synchronous colorectal metastasis 3
Ileo-anal pouch 2
Colostomy reversal 1
Number of unplanned operations 196 (84%)
Anatomical location
Upper GI 5 (2%)
Lower GI 98 (45%)
HPB 35 (16%)
Abdominal Wall 49 (23%)
Vascular 3 (1%)
Other 27 (13%)
Indication repeat surgery
Malignant disease recurrence 49
Incisional/parastomal hernia 41
Emergency laparotomy 19
Adhesion-related surgery 11
Ostomy closure
Protective loop ileostomy* 35
Colostomy 1
Ileo-anal pouch 3 
Relocation ostomy 14
Ostomy creation 2
New malignancy 5
Other 58
Department performing the operation
Surgery 225
Gynecology 5
Urology 4
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Univariable logistic regression for risk factors of requiring unplanned repeat 
abdominal surgery
Female gender (OR 1.60; p 0.02), severe adhesions underneath the incision (OR 
1.54; p 0.04), at the operative area (OR 1.53; p 0.04) and other abdominal areas (OR 
1.62; p 0.03) and an iatrogenic enterotomy (OR 2.19; p 0.03) were significantly 
associated with an increased risk for undergoing repeat abdominal surgery. Three or 
more previous laparotomies (OR 1.61; p 0.07), lower gastrointestinal tract as the 
anatomical location of previous abdominal surgery (OR 1.44; p 0.07), hepatic 
malignancy as indication for surgery (OR 1.67; p 0.07), more than 30 minutes of 
adhesiolysis (OR 1.47; p 0.09) and intra-abdominal complications (OR 1.65; p 0.07) 
showed a trend towards an increased risk for repeat abdominal surgery. Higher age 
(OR 0.98; p <0.01), higher Physiologic Possum score (OR 0.94; p 0.01), esophageal 
malignancy (OR 0.16; p 0.01) and laparoscopic surgery (OR 0.40; p 0.04) were 
significantly associated with a reduced risk for undergoing repeat abdominal surgery. 
A trend for reduced risk for repeat abdominal surgery was seen for patients with an 
ASA-score of 3 (OR 0.58; p 0.10), (supplement 1) . 
Multivariable logistic regression for risk factors for undergoing unplanned 
repeat abdominal surgery 
Female sex (OR 1.53; p 0.046) and hepatic malignancy as indication for surgery 
(OR 2.08; p 0.049) were significantly associated with an increased risk for undergoing 
unplanned repeat abdominal surgery. Older age (OR 0.98; p 0.002), esophageal 
malignancy (OR 0.21; p 0.034) and laparoscopic surgery (OR 0.26; p 0.007) were 
significantly associated with a reduced risk of undergoing repeat abdominal surgery. 
The area under the curve, representing the predictive value of the variables incorporated 
in the multivariable logistic regression analysis was 0.67 (95% CI 0.62 – 0.72). 
Table 3 shows the incidence of unplanned repeat abdominal surgery stratified for the 
anatomical location of the index operation, demonstrating that the abdominal wall (25%) 
and lower gastro-intestinal tract (24%) have the highest incidence, although this did not 
reach a statistical significant difference (p = 0.53). 
Figure 2  Cumulative risk over time for requiring repeat abdominal surgery, straight 
black line represents the mean cumulative incidence, the dashed line represents the 
95% confidence interval of the mean cumulative incidence.
Table 3  The incidence of unplanned repeat abdominal surgery stratified for anatomical 
location of index operation.
Unplanned 
repeat 
abdominal 
surgery
Anatomical location of index operation
Upper GI Lower GI HPB Abdominal 
Wall
Other
No 59 (84%) 200 (76%) 82 (79%) 77 (76%) 52 (81%)
Yes 11 (16%) 64 (24%) 22 (21%) 25 (25%) 12 (19%)
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differences that would affect our results. Databases of Dutch general practitioners 
keep nearly complete medical records of patients, including correspondences from 
hospital admissions, making the results of our study very reliable.
Most data on risk factors for repeat operations, albeit scarce, are from studies in 
patients with a ventral hernia or inflammatory bowel disease that only report on repeat 
surgery for disease recurrence.(11, 12, 14, 15) This only accounts for approximately half 
of all repeat operations according to our results, meaning that previous studies suffer 
from underreporting of risk factors for repeat surgery in general. For patients with a 
ventral hernia, size of the defect, previous repair, and an open approach increased 
the risk of repeat surgery, whereas older age decreased the risk for recurrent hernia 
repair.(11, 15) Disease specific patient factors could improve the predictive value of our 
analysis, due to the heterogeneity of our population we did not incorporate all disease 
specific factors which is a limitation of our approach to include all types abdominal 
surgery in the study. Our study also showed that older age was correlated with a 
lower incidence of repeat abdominal surgery. Young patients have a higher life-time 
risk for developing new disease that may require abdominal surgery and are also 
more often fit for subsequent surgery, explaining that patients of older age have a 
reduced risk for requiring repeat surgery. Patients who have had a hepatic resection 
for a malignancy have about a twofold increased risk for a repeat operation. Most 
likely this will be a subsequent liver procedure because more than half of patients 
develop a recurrence within 2 years of whom 40% is eligible for a reoperation.(16, 17) 
Patients who underwent a laparoscopic procedure had a significantly decreased risk 
for repeat surgery, however, only a small number of patients in this series underwent 
a laparoscopic procedure and these patients mostly had an uncomplicated medical 
history. This result should be interpreted with caution. Female gender was an 
independent risk factor for unplanned repeat abdominal surgery. This result is 
undoubtedly attributed to the risk of gynecological operations, and probably a higher 
incidence of gallstone disease and pelvic (floor) disorder in women.(18, 19) 
Around 15% of the total amount of repeat abdominal operations were loop-ileostomy 
closures. It is debatable to consider loop ileostomy closures as repeat abdominal 
surgery, as they are viewed as minor procedures. However, during a loop ileostomy 
closure the peritoneum is opened and adhesiolysis might be necessary. Furthermore, 
a systematic review showed that the overall morbidity of a loop ileostomy closure is 
17% and that 4% of patients undergoing a loop ileostomy closure require a laparotomy.
(20) Therefore, we accounted loop ileostomy closures in our study as repeat abdominal 
surgery. Most ileostomy closures were staged procedures (91%) and were not 
incorporated in the analysis assessing risk factors for unplanned repeat abdominal 
surgery. In our cohort, 9% of the patients underwent a laparoscopic procedure, this 
is somewhat low compared to today’s surgical practice. However, the most common 
indications for repeat abdominal surgery were malignant disease recurrence or other 
Discussion
Our results show that one in four patients will require repeat abdominal surgery within 
4 years after elective abdominal surgery. Female sex and hepatic malignancy had an 
increased risk for unplanned repeat abdominal surgery. Older patients, patients 
undergoing laparoscopic surgery and patients with esophageal malignancy as the 
indication for surgery had a significantly lower risk for unplanned repeat abdominal 
surgery. 
The incidence in our study, with a median of 4 years follow-up, was higher than that 
of a US population based study of predominantly colorectal procedures with a 
follow-up of two years (14%), but lower than a population based ten-year follow-up 
study of patients undergoing a first abdominal operation in Scotland in the year 1986 
(36,7%), nicely demonstrating the effect of time on incidence of repeat surgery.(6, 7) In 
contrast to these studies, we utilized detailed and accurate baseline data of a 
prospective cohort study with real time assessment of the index operation, providing 
us with the opportunity to reliably assess the incidences of and the majority of risk 
factors for repeat abdominal surgery. Although our cohort is drawn from a tertiary 
referral center and therefore contains more complex abdominal surgery, the results of 
the above mentioned studies suggest that patients undergoing surgery in a secondary 
care hospital have a similar incidence of repeat abdominal surgery. 
The attrition bias of this study is low with a 88% completed follow-up of patients 
included in the study. Although, there are significant differences at baseline, with 
regard to age, diagnosis of inflammatory bowel disease and esophageal malignancy, 
these differences are small which reflects the large sample size rather than meaningful 
Table 4  Multivariable logistic regression analysis with backward selection for unplanned 
repeat surgery; Nagelkerke R2 = 0.091.
Patient factor OR 95% CI OR p
Sex
Male Ref
Female 1.53 1.01 3.18 0.046
Age 0.98 0.96 0.99 <0.01
Hepatic malignancy 2.08 1.00 4.33 0.049
Esophageal malignancy 0.21 0.05 0.89 0.034
Surgical approach
Median ref
Subcostal 0.56 0.26 1.16 0.119
Other 0.92 0.50 1.70 0.785
Laparoscopy 0.26 0.10 0.69 0.007
Intra-abdominal complication 1.75 0.99 3.10 0.053
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Conclusion
In our cohort, one in four patients will require repeat surgery within 4 years after elective 
abdominal surgery mostly due to malignant disease recurrence, incisional or parastomal 
hernia or reasons unrelated to the index operation. The lower gastrointestinal tract, 
hepato-pancreatico-biliary tract and the abdominal wall are anatomical locations 
predominately involved at repeat abdominal surgery. Lower age, females and patients 
with a hepatic malignancy show the greatest risk for requiring repeat abdominal surgery. 
Results may guide cost effective use of anti-adhesion barriers.
indications, both are unaffected by the surgical approach of the index surgery. The 
incidence of a ventral hernia or a small bowel obstruction is lower after a laparoscopic 
procedure.(9, 21) However, the incidence of a ventral hernia is still 10.8% and the 
incidence of small bowel obstruction is 5.5% three years after laparoscopic surgery. 
In our study, these two indications comprise a minority of indications for requiring 
repeat abdominal surgery. 
An important key finding in our study is that 9 out of 10 repeat operations are 
unplanned and almost half is unrelated to the index operation. These results cause a 
paradigm shift, implicating that the potential benefit of adhesion barriers is not 
confined to two-stage procedures and disease with known high risk for reoperations 
for small bowel obstruction or ventral hernia. The high rate of unplanned reoperations 
suggest a potential for adhesion barriers to reduce morbidity and healthcare costs 
due to adhesiolysis-related complications. The effectiveness of anti-adhesive barriers 
has been demonstrated in a systematic review and meta-analysis showing reduced 
operative time and a decreased incidence of adhesions up to 50%.(10, 22) The in- 
hospital costs are around 4500 U.S. Dollars higher for patients requiring adhesiolysis 
during surgery compared to patients not requiring adhesiolysis.(5) A study assessing 
the cost-effectiveness of anti-adhesive barriers showed that barriers costing 50£ 
would pay back the cost of its investment if it reduced adhesion-related readmissions 
for small bowel obstruction by 16%.(23) Even greater benefits might be gained from 
reducing adhesiolysis-related complications during repeat abdominal surgery and 
could be as high as 927 US Dollars after open surgery and 380 US Dollars after 
laparoscopic surgery.(5, 9, 24) 
Our study showed most reoperations involve the lower gastrointestinal and hepatic- 
pancreatic-biliary tract and the abdominal wall. In general, younger patients and 
female patients might benefit most from anti-adhesive barriers, as they have the 
highest risk for unplanned reoperations. Patients undergoing a second hepatic 
resection suffer from increased operative time and a higher incidence of organ injury, 
mostly due to adhesiolysis.(25, 26) A clinical trial assessing the efficacy of an anti- 
adhesive barrier in two-stage hepatic resection found a reduction in the extent and 
severity of adhesions as well as a reduction in time needed to mobilize the liver. 
A trend was seen towards less postoperative complications after the second hepatic 
resection.(25) Patients who are operated upon because of a hepatic malignancy might 
benefit from placement of an anti-adhesive barrier around the liver because they 
have a two-fold increased risk for requiring repeat surgery, consisting mainly of 
repeat hepatic resections. 
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Supplement 1  Univariable logistic regression analysis for unplanned repeat surgery.
Patient factor OR 95% CI OR p
Sex
Male Ref.
Female 1.60 1.09 2.35 0.02
Age 0.98 0.97 0.99 <0.01
BMI 0.97 0.92 1.01 0.13
Smoking status
Non-smoker Ref
Ex-smoker 1.12 0.73 1.72 0.59
Smoker 0.87 0.49 1.54 0.64
Physiologic Possum score 0.94 0.90 0.98 0.01
ASA-score
1 Ref
2 0.92 0.56 1.53 0.75
3 0.58 0.30 1.10 0.10
Diagnosis of IBD 1.17 0.64 2.12 0.62
Number of previous laparotomies
0 Ref
1 or 2 1.39 0.88 2.17 0.16
≥3 1.61 0.96 2.71 0.07
Previous laparoscopy
Yes 1.17 0.66 2.07 0.59
No Ref
Anatomical location previous surgery
Upper gastrointestinal tract 0.83 0.34 2.08 0.70
Lower gastrointestinal tract 1.44 0.98 2.12 0.07
Abdominal Wall 1.23 0.77 1.98 0.39
HPB 0.76 0.39 1.46 0.41
Other 1.07 0.72 1.61 0.61
Malignancy as indication for surgery
Colorectal 0.71 0.41 1.21 0.21
Hepatic 1.67 0.96 2.91 0.07
Esophageal 0.16 0.04 0.68 0.01
Other 0.79 0.44 1.41 0.42
Benign indication for surgery
Ventral hernia 1.06 0.64 1.76 0.81
Fistula 1.66 0.79 3.49 0.18
Other 1.29 0.86 1.93 0.21
Anatomical location index operation
Other Ref
Lower GI 1.37 0.89 2.11 0.15
Abdominal Wall 1.39 0.80 2.43 0.24
Supplement 1  Continued.
Patient factor OR 95% CI OR p
Surgical approach
Median Ref
Subcostal 0.94 0.54 1.64 0.82
Other 1.15 0.64 2.06 0.82
Laparoscopy 0.40 0.17 0.96 0.04
Adhesiolysis time
0-30 Ref
≥31 1.47 0.94 2.29 0.09
Zühlke score underneath incision
No or mild adhesions Ref
Severe adhesions 1.54 1.02 2.31 0.04
Zühlke score operative area
No or mild adhesions Ref
Severe adhesions 1.53 1.02 2.30 0.04
Zühlke score other abdominal areas
No or mild adhesions Ref
Severe adhesions 1.62 1.04 2.53 0.03
Iatrogenic injury due to adhesiolysis
Enterotomy 2.19 1.07 4.47 0.03
Seromuscular injury 1.25 0.77 2.02 0.36
Other organ injury 1.18 0.56 2.49 0.66
Wound classification
Clean Ref
Clean-contaminated 1.01 0.68 1.52 0.95
Contaminated 1.07 0.48 2.39 0.87
Dirty 1.78 0.16 20.00 0.64
Ostomy 1.41 0.87 2.27 0.16
Duration of surgery 1.00 1.00 1.00 0.41
Intra-abdominal complication 1.65 0.96 2.84 0.07
Relaparotomy 1.52 0.81 2.87 0.20
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CHAPTER 9 BOWEL OBSTRUCTION
Introduction
Adhesion formation is the most common complication of abdominal and pelvic surgery 
and comprises a lifelong risk of bowel obstruction, difficulties during reoperations, 
female infertility and chronic abdominal pain.(1-3) The incidence of reoperation for 
adhesive bowel obstruction following general abdominal surgery is 2.5% and carries 
a considerable in-hospital mortality rate of 2.5%. The prevalence of medical and 
surgical complications is 8% and 6%, respectively.(1, 4, 5) Adhesions are the most 
common cause of bowel obstruction, accounting for 56% of all cases.(1) Surgery of 
the lower gastrointestinal tract seems the most important risk factor for the occurrence 
of adhesive bowel obstruction. Conflicting results have been found for many other 
demographic and particularly surgery related factors.(1, 6)
Most epidemiological knowledge regarding adhesive bowel obstruction is derived 
from data of regional and national registries and retrospective cohorts of acute surgery for 
bowel obstruction and elective abdominal surgery.(1) Due to the design of these studies 
it is unknown whether specific surgical factors, such as presence of adhesions, 
during elective abdominal surgery increase the risk of bowel obstruction.(7-11) 
A large comprehensive prospective cohort study, performed by our group, showed 
that the need for adhesiolysis during repeat surgery resulted in an increased 
incidence of iatrogenic organ injury, increased operative time and a longer and more 
complicated convalescence.(2) These prospective data provided the opportunity to 
perform a follow-up study and to accurately assess the impact of specific surgical 
factors on the incidence of adhesive bowel obstruction in patients undergoing all 
types of elective abdominal surgery. We focused on the severity of adhesions and 
adhesiolysis data at initial surgery as potential surgical risk factors.
Methods
Study design and patients
This is a long-term follow-up study of the prospective LAPAD study (‘LAParotomy or 
LAParoscopy and Adhesions study’, clinicaltrials.gov registration number: NCT01236625). 
Detailed methods of the LAPAD study are reported.(2) The LAPAD study included all 
patients admitted to the surgical ward (no day care or short stay) of the Radboud 
university medical centre for elective laparotomy or laparoscopy between June 2008 
and June 2010. Baseline data regarding demographics, pre-operative surgical factors, 
medical patient factors, intra-operative surgical factors and postoperative variables 
were prospectively collected at the time of the LAPAD study. 
Patients that died within 30 days after discharge of the initial admission were excluded 
from this study. Data on the primary outcome measure was gathered retrospectively 
from 30 days after discharge until November 2013. Data was gathered from the last 
included surgery for patients with multiple abdominal surgeries included in the 
LAPAD study. Patients and their general practitioners were contacted separately and 
Abstract
Background: The incidence of reoperation for adhesive bowel obstruction following 
general abdominal surgery is 2.5% and carries a considerable risk of mortality 
and morbidity. Adhesions account for 56% of all cases of bowel obstruction. Most 
epidemio logical knowledge regarding adhesive bowel obstruction is derived from 
data of national registries and retrospective cohorts of elective abdominal surgery. 
Due to the design of these studies it remains unknown whether specific surgical 
factors impact the occurrence of bowel obstruction. We aimed to comprehensively 
assess risk factors for the incidence of adhesive bowel obstruction with emphasis on 
intra- operative surgical factors.
Methods: Follow-up study of the prospective LAPAD study (clinicaltrials.gov registration 
number: NCT01236625) including patients undergoing all types of elective open or 
laparoscopic abdominal surgery. Primary endpoint of this study was (suspected) 
adhesive bowel obstruction. Univariable and multivariable logistic regression analysis 
were used to assess risk factors. 
Results: 604 (88%) of 715 patients could be included. A total of 38 (6%) patients 
experienced an episode of adhesive bowel obstruction. Surgery on the lower gastro-
intestinal tract (OR 4.57, p <0.01) and the severity of adhesions in the operative area 
(OR 2.37, p 0.04) independently increased the risk for adhesive small bowel 
obstruction. 
Conclusion: Patients undergoing surgery on the lower gastrointestinal tract and 
patients with more severe adhesions present at surgery have an increased risk for 
adhesive bowel obstruction.
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‘definitely adhesive’ if imaging (CT or MRI showing diagnostic signs suggestive of 
adhesive small bowel obstruction(16, 17)) or intra-operative findings showed adhesions 
as the cause. Bowel obstruction was defined as ‘probably adhesive’ when no other 
cause could be identified during the diagnostic work-up. Other causes included 
‘tumor’ if an intra-abdominal tumor was the cause, ‘incarcerated hernia’ if bowel was 
trapped in an hernia and reduction was not possible and ‘other cause’ if another 
cause than the above mentioned pathologies caused the bowel obstruction. For patients 
with multiple episodes of bowel obstruction, the etiology was assessed per episode.
Statistical methods
Continuous variables are presented as means with standard deviaton, or medians 
with interquartile range (25 – 75) in case of a non-normal distribution. Dichotomous 
or categorical variables are shown as absolute numbers and percentages. 
A univariable logistic regression analysis was performed to assess risk factors for 
patients with at least one adhesive bowel obstruction comprising ‘definitively adhesive’ 
and ‘probably adhesive’. All predictors found to be significant in univariable analysis 
were considered for multivariable analysis due to the low incidence of adhesive bowel 
obstruction. For the multivariable logistic regression analysis, a stepwise backwards 
selection procedure was used with a P entry ≤0.10 and P stay ≤0.10. The adjusted OR 
was calculated with 95 per cent confidence interval. The R2 value was computed to 
assess the amount of variation explained by addition of the variables in the model. 
A Kaplan-Meier analysis was performed calculating the cumulative hazard risk of 
adhesive bowel obstruction over time. For each independent risk factor derived from 
multivariable analysis a separate Kaplan-Meier analysis was done.
A p value of ≤ 0.05 was considered significant. Statistical analysis was performed 
using SPSS for Windows version 20.0 software (SPSS, Chicago, IL). There was only 
minimal missing data, thus we excluded per analysis the cases with missing data.
Results
715 patients were assessed for inclusion, 25 patients died during admission or within 
30 days after discharge, 27 declined to participate, 58 did not respond and 1 patient 
was lost to follow-up. 604 (88%) patients were included in this study (figure 1). The median 
follow-up duration was 46 (IQR 33 – 54) months. 
Baseline characteristics and incidence of bowel obstruction
Baseline characteristics, including missing data, are shown in table 1. 220 (36%) 
patients had no history of prior abdominal surgery, 255 (42%) had 1 or 2 and 129 
(21%) patients had 3 or more previous abdominal operations. The anatomical location 
of the index operation was the lower gastrointestinal tract in 264 (44%), abdominal 
wall in 102 (17%) and other in 238 (39%) patients. Surgeries performed on the lower 
a questionnaire was sent regarding admissions to departments of internal medicine 
or surgery for episodes of bowel obstruction and hospitalization for repeat abdominal 
surgery. Additionally, data was collected from medical records of hospitals and nursing 
homes when applicable. A waiver was received from the medical ethical committee of 
the Radboud university medical center (registration number: 2013/097) for this study.
Patients admitted with a bowel obstruction were treated in accordance with local 
protocols, closely resembling the international guideline presented by Catena et al.
(12) In general, patients were admitted to the hospital and managed conservatively 
with nasogastric tube decompression, intravenous fluids and an abdominal CT-scan 
within 48 hours. The conservative treatment was continued for a maximum of 72 hours. 
For patients showing signs of peritonitis, irreducible hernia or signs of strangulation, 
abdominal CT imaging and surgery was performed on the same day of admission.
Variables
The included baseline demographics comprise sex, age, Body Mass Index, American 
Society of Anesthesiologists classification(13), P-Possum score(14), presence of 
malignancy and a diagnosis of inflammatory bowel disease. Surgical factors included 
were the number of previous laparotomies (0, 1 or 2, ≥3) and laparoscopies (0 and 1 
or more), anatomical location of previous surgery (upper gastrointestinal tract, lower 
gastrointestinal tract, abdominal wall, hepato-pancreato-biliary and other), anatomical 
location of index operation (lower gastro-intestinal, abdominal wall, other) and 
surgical approach (median, subcostal, other incision, and laparoscopy). Intra-opera-
tive factors collected were adhesiolysis time (0-30, ≥31 minutes), complete 
adhesiolysis defined as all peritoneal adhesions lysed, severity of adhesions 
underneath the incision, operative area and other abdominal areas according to the 
Zühlke classification(15) comprising 0, 1 and 2 as no or mild adhesions and 3 and 4 
as severe adhesions, the location of adhesions (upper and lower abdomen) any 
iatrogenic organ injury due to adhesiolysis, estimated blood loss, the creation of an 
ostomy at the end of surgery and total operative time. Postoperative factors collected 
were the incidence of any intra-abdominal complication within 30 days of the index 
operation, comprising intra-abdominal sepsis, abscess, anastomotic leakage, fistula, 
delayed diagnosed perforation, hemorrhage and a relaparotomy or relaparoscopy.
Endpoints
The primary endpoint of this study was adhesive bowel obstruction, comprising both 
small bowel and colonic obstruction. Bowel obstruction was defined as no passage 
of feces with nausea, vomiting, cramping abdominal pain, absence of bowel 
movements and signs of abdominal distention at physical examination. The time 
interval between last surgery and bowel obstruction, duration of admission and 
treatment was registered. The causes of intestinal obstruction were categorized as 
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gastrointestinal tract consisted mainly of right colectomy and sigmoid or rectal 
resections. The abdominal wall as anatomical location of surgery included principally 
the component-separation-technique with or without a mesh. The type of operations 
in the other anatomical locations category comprised mainly out of resection of the 
upper gastrointestinal tract and hepatic-biliary-pancreatic surgery and other types of 
surgery. In 379 (63%) patients the presence of adhesions was confirmed during the 
index procedure, 187 (32%) patients had severe adhesions in the operative area. 
Complete adhesiolysis was performed in 156 (27%) patients, 193 (33%) patients did 
not have complete adhesiolysis, for 30 patients it was unknown if adhesiolysis was 
complete. An ostomy was created in 107 (18%) patients. 
A total of 58 (10%) patients experienced an bowel obstruction, 49 patients experienced 
1 episode and 9 patients 2 or more episodes, reaching a total of 71 episodes of bowel 
obstruction. 38 (66%) of 58 patients had at least 1 episode of adhesive bowel obstruction. 
Seven patients had a recurrent episode of bowel obstruction after their first bowel 
obstruction. Five patients had a total of two episodes, one patient had three episodes 
and one patient had a total of five episodes of bowel obstruction. The cause of bowel 
obstruction was definitely adhesive in 11 (16%) episodes, probably adhesive in 37 (52%), 
tumor in 14 (20%), incarcerated hernia in 2 (3%) and other causes in 7 (10%) patients 
(table 2). Of the patients presenting with bowel obstruction caused by adhesions, one 
patient (3%) had an obstruction of the large bowel. Of the 58 patients that had an 
episode of bowel obstruction, 19 patients did not have adhesions at their index surgery. 
Of the 38 patients with an adhesive bowel obstruction only 10 patients did not have 
adhesions at their original surgery. Three out of ten patients with an adhesive bowel 
obstruction requiring surgery did not have adhesions at their original surgery.
The episode of bowel obstruction could be managed conservatively in 54 (76%) 
patients. 17 (24%) episodes were managed by an operation, due to adhesions in 10 
Figure 1  Flow-chart. Table 1  Baseline characteristics, * Mean ± Standard deviation, † Median IQR (25 – 75).
Patiënt factors Baseline 
characteristics (n= 604)
Sex
Male 343 (57%)
Female 261 (43%)
Age* 59 ± 14
BMI* 25.7 ± 4.4
Smoking status
Non-smoker 212 (35%)
Ex-smoker 278 (46%)
Smoker 113 (19%)
P-Possum-score* 16 (14 – 20)
ASA-score
1 104 (17%) 
2 370 (61%)
3 130 (22%)
Number of previous laparotomies
0 220 (36%)
1 or 2 255 (42%)
≥3 129 (21%)
Previous laparoscopy
Yes 73 (12%)
No 531 (88%)
Anatomical location previous surgery
Upper GI 31 (5%)
Lower GI 291 (48%)
Abdominal Wall 115 (19%)
HPB 66 (11%)
Other 200 (33%)
Malignancy as indication for surgery
Yes 295 (49%)
No 309 (51%)
Diagnosis of inflammatory bowel disease
Yes 65 (11%)
No 539 (89%)
Anatomical location index operation
Lower GI 264 (44%)
Right colectomy 68 (26%)
Sigmoid or rectal resection 99 (38%)
Subtotal or proctocolectomy 32 (12%)
Other 65 (24%)
Abdominal Wall 102 (17%)
Other 238 (39%)
Upper GI 70 (29%)
HPB 104 (44%)
Other 64 (27%)
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episodes, due to an obstructing tumor in 4, incarcerating hernia in 2 and 1 was 
caused by a jejunostomy catheter. All patients with an adhesive bowel obstruction 
that required surgery were operated through an open incision. The median length of 
stay for patients admitted with a bowel obstruction was 6 days. 
Univariable logistic regression for risk of adhesive bowel obstruction
Three or more previous laparotomies (95% CI OR 1.31 – 6.37, p= 0.01), lower gastro-
intestinal tract as the anatomical location of previous surgery (95% CI OR 1.09 – 4.33, 
p= 0.03), a diagnosis of inflammatory bowel disease (95% CI OR 1.53 – 7.19), lower 
gastrointestinal tract as the anatomical location of the index operation ( 95% CI OR 
2.19 – 15.11, p 0.01), adhesiolysis time of >30 minutes during index operation (95% CI 
OR 1.47 – 5.67, p 0.01), severe (Zühlke grade 3 or 4) adhesions underneath the 
incision (95% CI OR 1.16 – 4.35, p <0.01), severe adhesions in the operative and 
other abdominal areas (95% CI OR 1.49 – 5.64, p <0.01 and 95% CI OR 1.46 – 5.65, 
p <0.01), iatrogenic organ injury due to adhesiolysis (95% CI OR 1.38 – 5.25, p <0.01) 
and creation of an ostomy during the index operation (95% CI OR 1.71 – 6.77, p 0.01) 
significantly increased the risk for (definitively and probably) adhesive bowel 
obstruction (Figure 2). A trend was seen towards an increased risk for adhesive 
bowel obstruction for adhesions located in the lower part of the abdomen (95% CI OR 
Table 1  Continued.
Patiënt factors Baseline 
characteristics (n= 604)
Surgical approach
Median 392 (65%)
Subcostal 86 (14%)
Other 70 (12%)
Laparoscopy 56 (9%)
Presence of adhesions
Yes 379 (63%)
No 225 (37%)
Adhesiolysis time (minutes)
0-30 474 (79%)
>31 130 (22%)
Complete adhesiolysis
No adhesiolysis 225 (37%)
Yes 156 (26%)
No 193 (32%)
Missing data 30 (5%)
Adhesion severity underneath incision
No or mild adhesions 419 (69%)
Severe adhesions 178 (30%)
Missing data 7 (1%)
Adhesion severity operative area
No or mild adhesions 407 (67%)
Severe adhesions 187 (31%)
Missing data 10 (2%)
Adhesion severity other abdominal areas
No or mild adhesions 460 (76%)
Severe adhesions 127 (21%)
Missing data 17 (3%)
Adhesions in the upper abdomen
Yes 233 (39%)
No 352 (58%)
Missing data 19 (3%)
Adhesions in the lower abdomen
Yes 275 (46%)
No 301 (50%)
Missing data 28 (4%)
Iatrogenic organ injury due to adhesiolysis 148 (24%)
Estimated blood loss† (ml) 450 (100 – 1013)
Ostomy created
Ileostomy 69 (11%)
Colostomy 38 (6%)
Total operative time (min) 201 (144 – 269)
Intra-abdominal complication 53 (9%)
Relaparotomy 51 (8%)
Table 2  Incidence of bowel obstruction, † Median IQR (25 – 75), ‡ range.
Bowel obstruction Outcome
Patients with bowel obstruction 58 (10%)
Patients with adhesion-related bowel obstruction 38 (6%)
Episodes of bowel obstruction
0 546 (90%)
1 49 (8%)
≥2 (2 – 5)‡ 9 (2%)
Cause of obstruction
Adhesions
Definitely adhesive 11 (16%)
Most likely adhesive 37 (52%)
Tumor 14 (20%)
Incarcerated hernia 2 (3%)
Other 7 (10%)
Treatment
Conservative 54 (76%)
Operative 17 (24%)
Length of hospital stay† 6 (4 – 11)
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Multivariable logistic regression for risk of adhesive bowel obstruction
In multivariable analysis, the lower gastrointestinal tract as the anatomical location of 
the index operation was the strongest independent risk factor for adhesive bowel 
obstruction (95% CI OR 1.71 – 12.22, p <0.01) (table 3). The severity of adhesions in 
the operative area was also an independent risk factor (95% CI OR 1.02 – 5.51, p 0.04). 
The number of previous laparotomies was not an independent risk factor.
Figure 3 and 4 show the cumulative risk over time for the occurrence of adhesive 
bowel obstruction stratified by the severity of adhesions and the anatomical location 
of the index operation (p <0.01 and p <0.01). 
0.94 – 3.71, p= 0.07). Complete adhesiolysis of the abdomen in comparison to non- 
complete adhesiolysis during the index operation did not reduce the risk for the 
occurrence of adhesive bowel obstruction (95% CI OR 0.42 – 2.01, p= 0.84). Post- 
operative intra-abdominal complications did not increase the risk for adhesive bowel 
obstruction (95% CI OR 0.42 – 3.64, p= 0.69).
Figure 2  Univariable logistic regression adhesion-related bowel obstruction;  
OR Odds ratio, 95% CI OR 95% confidence interval of the odds ratio, p p-value. Table 3  Multivariable logistic regression adhesion-related bowel obstruction; OR Odds 
ratio, 95% CI OR 95% confidence interval of the odds ratio, p p-value; Nagelkerke R2 0.15.
Patient factor OR 95% CI OR p
Number of previous laparotomies
0 Ref
1 or 2 0.60 0.23 1.55 0.29
≥3 1.89 0.68 5.29 0.23
Anatomical location index operation
Other Ref
Lower GI 4.57 1.71 12.22 <0.01
Abdominal Wall 0.90 0.22 3.72 0.89
Zühlke score operative area
No or mild adhesions Ref
Severe adhesions 2.37 1.02 5.51 0.04
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Discussion
About 6% of patients will develop an episode of adhesive bowel obstruction within 4 
years following elective general abdominal surgery. Surgery on the lower gastrointes-
tinal tract and severe adhesions at the index operation increase the risk for adhesive 
bowel obstruction by 5 and 3 times, respectively.
The incidence of adhesive bowel obstruction is higher than the 2.5% reported in the 
literature.(1) A likely explanation is the different data source. The reported incidence is 
mainly derived from registry based studies using (operative) coding systems, which 
are associated with reporting bias and might represent an underestimation of the 
total incidence.(7, 18) We might have slightly overestimated adhesions as the cause of 
small bowel obstruction by including patients who were managed conservatively and 
in whom adhesions as the cause for obstruction was strongly suspected in the 
absence of other causes. All cases of bowel obstruction were scrutinized to rule out 
other potential causes of bowel obstruction.(1) We chose to incorporate conservatively 
Figure 3  Cumulative risk over time for an episode of bowel obstruction stratified  
by the severity of adhesions during the index operation (p= <0.01). The dotted line 
represents severe adhesions, whereas the straight line represents no or mild 
adhesions.
Figure 4  Cumulative risk over time for an episode of bowel obstruction stratified  
by the anatomical location of the index operation (p= <0.01). The dotted line 
represents the lower gastrointestinal tract, the dotted and dashed line represents 
the abdominal wall and the straight line other anatomical locations.
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due to increased peritoneal inflammation seems to only weakly relate to the clinical 
expression of adhesive bowel obstruction.(20, 21) 
In a large clinical adhesion prevention trial the only factor significantly impacting the 
occurrence of adhesive small bowel obstruction was the usage of Seprafilm© at the 
index operation.(22) Due to its design, this trial was not suitable to assess risk factors 
for the main study endpoint. Additionally, the univariable risk analysis only assessed 
the episodes of adhesive small bowel obstruction that were treated surgically, which 
does not reflect the total incidence of adhesive small bowel obstruction as mentioned. 
Therefore the results of their analysis for factors impacting the occurrence of adhesive 
small bowel obstruction should be interpreted with caution. 
We demonstrated that complete adhesiolysis does not decrease the risk for adhesive 
bowel obstruction. Scarce evidence suggests that due to the upregulation of proteins 
involved in peritoneal adhesion formation, adhesion reformation might be aggravated 
after adhesiolysis.(23, 24) Therefore, we advocate not to perform routine complete 
adhesiolysis during abdominal surgery, also because prolonged adhesiolysis is 
associated with increased risk of an iatrogenic enterotomy.(2) Our study showed that 
a history of multiple previous abdominal operations and more severe adhesions 
impact the occurrence of adhesive bowel obstruction, thus it might be advantageous 
to prevent adhesions from the first abdominal operation. Patients undergoing surgery 
on the lower gastrointestinal tract and patients with more severe adhesions after 
multiple previous operations should be counseled regarding an increased risk for 
adhesive bowel obstruction. 
managed cases because this reflects the complete morbidity of adhesive bowel 
obstruction and may elucidate important risk factors. In the Netherlands, patients 
have their medical data registered at a general practitioner’s practice or a doctor at a 
nursing home when applicable. Furthermore, patients generally present their 
complaints at a general practitioner first, meaning that the medical history of the 
patient is complete and available. This type of healthcare organization improves the 
accuracy of data, even when obtained in a retrospective manner. A limitation of this 
study is the low absolute number of cases with adhesive bowel obstruction. Point 
estimates of the odds ratios of risk factors in regression analysis should therefore be 
interpreted with caution. Still, even with this low number of cases, the severity of 
adhesion at the index operation was found to be an independent risk factors for 
developing adhesive bowel obstruction.
This is the largest and most comprehensive cohort study, including intra-operative 
adhesion related factors. With an 88% completed follow-up of patients included in the 
LAPAD study and the low incidence of adhesive bowel obstruction, the attrition bias 
of this study is low, making it unlikely that missing outcome data would affect our 
results. The length of our follow-up period was sufficient for the majority of bowel 
obstructions to occur, although new cases of ASBO continue to develop for many 
years after surgery, previous studies have demonstrated that the majority of cases 
develop within the first 4 years.(9) 
This study showed that the presence of severe adhesions increased the risk for 
adhesive bowel obstruction by two-fold and it significantly decreased the time to first 
episode of adhesive bowel obstruction. These results refute the relatively popular 
opinion that single strand of adhesions cause a higher risk for bowel obstruction than 
multiple tenacious adhesions. Possible explanation might be that due to more severe 
adhesions the bowel will be increasingly adhered to itself and to the abdominal wall, 
thereby compromising normal intra-abdominal bowel movement and increasing the 
chance of the occurrence of an obstruction. Surgery on the lower gastrointestinal 
tract, predominantly causes adhesion formation between the colon, small bowel, 
abdominal wall and, retroperitoneum. This might explain our finding that surgery on 
the lower gastrointestinal tract increases the risk for adhesive bowel obstruction by 
four times in comparison to other anatomical locations in the abdomen.(1, 8, 9) The 
negative impact of large peritoneal dissection in colorectal surgery is illustrated by 
the finding that a panproctocolectomy and total colectomy carry the highest risk for 
adhesion-related readmissions.(19) We did not find an association between intra- 
abdominal complications and an increased risk for adhesive bowel obstruction. 
This might be partially explained by the low incidence of intra-abdominal complications 
in our cohort. A study showed an increased incidence of small bowel obstruction 
after perforated appendicitis versus uncomplicated appendicitis. Although intra- 
abdominal complications may aggravate adhesion formation, severity of adhesions 
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CHAPTER 10 PREVENTION OF ADHESION REFORMATION IN EXPERIMENTAL MODELS
Introduction
Postoperative adhesions form after abdominal surgery due to injured peritoneal 
surfaces and cause a life-long risk for small bowel obstruction, chronic pain, infertility 
and complications during reoperations.(1) Today, as many as 40- 66% of elective 
procedures in general surgery are reoperations.(2-4) During reoperations, adhesions 
are present from previous operations in about 90 percent and the need for adhesiolysis 
results in an increased operative time and a more complicated convalescence. The 
incidence of iatrogenic bowel injury during adhesiolysis is estimated at 6-10% and is 
associated with increased postoperative mortality and healthcare costs.(1, 4) Adhesion 
reformation is of particular clinical importance, the risk of iatrogenic bowel injury and 
more severe adhesions exponentially increases after multiple abdominal operations.(5, 6) 
Evidence suggests that the local expression of growth factors and proteins inhibiting 
fibrinolysis are increased in the peritoneum of patients with adhesions already present, 
potentially leading to aggravated adhesion reformation.(7, 8) As a result, adhesion barriers 
may be less efficacious in preventing adhesion reformation. This is supported by a 
clinical study in which icodextrin 4% had a non-significant reduction of the incidence 
of adhesion reformation from 95.7% at baseline to 68.7% at the second look operation 
whereas it did seem to prevent de novo adhesion formation.(9) A systematic review and 
meta-analysis demonstrated reduction of clinically relevant consequences of adhesions 
by hyaluronate carboxymethylcellulose and oxidised regenerated cellulose, however, 
included studies predominantly reported on prevention of ‘de novo’ adhesion formation 
or did not differentiate between patients with and without adhesions present at the 
index operation(10). Awareness of reduced efficacy in preventing adhesion reformation 
compared to ‘de novo’ adhesion formation is low among surgeons.(11) 
During pre-clinical evaluation adhesion barriers are tested for their efficacy in preventing 
‘de novo’ adhesion formation. It is unknown to which extent barriers are tested for 
prevention of adhesion reformation and which experimental models are most valid for 
translation into clinical efficacy. In this systematic review and meta-analysis we com-
prehensively assess the use of five commercial available adhesion barriers and 
laparoscopic adhesiolysis in preventing adhesion reformation in animal models. 
Additionally, the impact of different study characteristics on the incidence of adhesion 
reformation and quality of adhesions was investigated to provide guidance for the 
design and the execution of future studies. 
Methods
Search strategy, inclusion and exclusion criteria
In June 2017 electronic searches were performed in the Pubmed and Embase data- 
bases. The search strategies involved the following search components: “adhesion” 
and “peritoneum”, “peritoneal adhesion”, “animal”, “prevention”, “adhesiolysis”, “anti-
adhesive” and both the generic and trade names of known adhesion barriers. 
Abstract 
Background: As many as 40- 66% of elective procedures in general surgery are 
reoperations. During reoperations, adhesions are often already present from previous 
operations and the need for adhesiolysis results in an increased operative time and 
a more complicated convalescence. During pre-clinical evaluation adhesion barriers 
are tested for their efficacy in preventing ‘de novo’ adhesion formation. It is unknown 
to which extent barriers are tested for prevention of adhesion reformation and which 
experimental models are most valid for translation into clinical efficacy. In this 
systematic review and meta-analysis we comprehensively assess the use of five 
commercial available adhesion barriers and laparoscopic adhesiolysis in preventing 
adhesion reformation in animal models.
Methods: Pubmed and EMBASE were searched for relevant studies. Included studies 
assessed peritoneal adhesion reformation not in the presence of an intra-peritoneal 
mesh after a standardized peritoneal injury and reported incidence of adhesions or 
an adhesion score as outcome. A modified scoring system was used to assess the 
methodological quality.
Results: 93 studies could be included. 84 studies assessed the efficacy of an 
adhesion barrier and 9 assessed surgical technique. No study met the criteria for low 
risk of bias. The pooled incidence of adhesions in the control groups was 90.99%. 
None of the commercially available adhesion barriers significantly reduces the 
incidence of adhesion reformation. Three commercially available adhesion barriers 
reduced the adhesion score of reformed adhesions, Seprafilm (SMD 1.38; p <0.01), 
PEG (SMD 2.08; p <0.01) and Icodextrin (SMD 1.85; p <0.01). There is no difference 
between laparoscopic or open adhesiolysis with regard to the incidence of adhesion 
reformation or the adhesion score (RR 1.14; SMD 0.92; p = >0.05)
Conclusions: Current commercially available adhesion barriers and laparoscopic 
adhesiolysis without using an adhesion barrier do not reduce the incidence of 
adhesion reformation in animal models. The methodological quality of animal models 
is poor and there is great heterogeneity with regard to the animal models used for 
assessing the efficacy of adhesion barriers. 
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We devised an 8-point scoring system to assess the methodological quality of included 
articles based on the tool published by Hooijmans et al..(14) Our methodological scoring 
system contained presence of an ethical statement, adequate allocation sequence 
generation, similar groups at baseline, blinded from treatment allocation, method of 
serosal injury specified and standardized, random outcome assessment, blinded 
outcome assessment and incomplete outcome data adequately addressed. Studies 
meeting 7 or 8 methodological criteria of risk of bias assessment were considered to 
have a low risk of bias.
Two outcome measures were assessed: incidence of adhesions and adhesion score. 
Type of scoring system (tenacity, extent, morphology, mixed) and the minimal and 
maximal value of the scoring system used were collected.
Data synthesis and statistical analyses
Data were analyzed using STATA 11.2, using the ‘metan’ package. Meta-analysis was 
performed for two outcome measures, the incidence of adhesions and adhesion 
score. The incidence of adhesions in the control groups was pooled using inverse 
variance. Additionally, the incidence of adhesions was computed by means of a risk 
ratio summary statistic and the adhesion score by computing the standardized mean 
difference (SMD) using Hedges’ G. A random effects model was used to account for 
heterogeneity between the studies. Subgroup analyses were performed on both 
outcome measures and metaregression was used to assess significant differences 
between the subgroups. A minimum of 5 studies were required in each subgroup to 
perform an analysis. Subgroup analyses were performed for: animal species, gender, 
type of model, method of adhesiolysis, time interval between surgery, type of scoring 
system and repeated injury at 2nd laparotomy. The efficacy of commercial available 
barriers, oxidized regenerated cellulose, hyaluronate carboxymethylcellulose, icodextrin, 
polyethylene glycol and dextran, was assessed irrespective of the number of studies 
available for analysis. Additionally, the efficacy of saline for reducing the incidence of 
adhesions and the adhesion score was assessed.
When a study contained multiple control groups, the control group without an 
intervention was used. Additional positive control groups were analyzed as treatment 
groups. If a study contained multiple dosages or volumes of the same adhesion 
barrier, the most efficacious dosage or volume was chosen. If multiple treatment 
groups were compared with one control group the number of animals in the control 
group were divided by the number of treatment groups. When data were presented 
only graphically, we extracted numerical data from the graphs using ImageJ© digital 
image analysis software. In case the incidence in the control and treatment group 
was 100%, the incidence in both groups was reduced with 10% to facilitate meta- 
analysis. If standard error was reported this was converted to a standard deviation for 
meta-analysis. If the standard deviation was 0, the lowest standard deviation of 
We combined this with a search filter designed specifically to enhance the retrieval of 
animal studies.(12, 13) The complete search can be found in digital supplement 1.
The inclusion criteria and method of analysis were specified in advance in a protocol 
which is published on the website of SYRCLE. Studies were screened on the basis of 
title and abstract by two independent reviewers (CS and MS) in the webbased 
program EROS©. In case of doubt, the full paper was evaluated. Differences were 
discussed, and if necessary resolved with the help of a third person (RtB). Inclusion 
criteria were: the study assessed peritoneal adhesion reformation not in the presence 
of an intra-peritoneal mesh after a standardized peritoneal injury and addressed one 
of the following outcomes: incidence of adhesions or an adhesion score. Studies 
were excluded if it was not performed in animals or it was not an original full paper 
presenting original data. Chinese, Arabic and Cyrillic papers were excluded. If necessary, 
papers in languages other than English were translated. 
Studies were excluded from the systematic review if there was no numerical or 
graphical data on any of the outcome measures, it used an intra-peritoneal mesh, 
was not an adhesion reformation model, the adhesion barrier was not applied intra- 
peritoneally or if the group of animals was not treated according to the same protocol. 
All studies were evaluated by two researchers independently from each other and 
any disagreements were discussed. Studies were excluded from the meta-analysis 
if there was no control group or no treatment group, if the group size was unknown, 
if the mean score was unknown or if there was no variance reported in the article. 
The authors of articles with unreported data on relevant outcome measures or study 
details were contacted via e-mail. In case the authors did not respond, one follow-up 
e-mail was sent.
Study characteristics and data extraction
The following data were extracted from studies included in the systematic review: 
animal species (rat, rabbit, mouse, other), sex (male, female, mixed, unknown), number of 
animals in treatment and control groups, number of animals excluded or deceased, 
reason for exclusion, cause of death, type of model (cecal abrasion, uterine horn, 
other(for example ischemic button)), type of control group (internal or external), 
intervention used as control (no intervention, saline, placebo or a combination of 
these), perioperative treatment with analgesia, antibiotics or fluids for resuscitation, 
standardized peritoneal injury, timing of intervention (1st and 2nd or only at the 2nd 
operation), repeated injury at 2nd surgery, and the method of adhesiolysis (sharp and 
blunt, coagulation). Cecal abrasion as type of model comprised four variations: cecal 
abrasion alone, cecal abrasion plus sidewall damage, cecal abrasion plus ileal 
damage, and sidewall damage alone. We included the latter because cecum is 
regularly attached to the peritoneal sidewall area after damage. Bibliographic details 
such as author and year of publication were also registered. 
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Incidence of adhesions in control groups and impact of study characteristics 
on outcome
The pooled incidence of adhesions in the control groups was 90.99% (Figure 4). Only 
one model did not develop any adhesions at all, this study (Luciano 1989 B) used a 
laparoscopic peritoneal sidewall abrasion model. The range of incidences of adhesions 
in control groups, excluding the study performed by Luciano 1989 B, was (60% to 
100%).
another group within that study was used to facilitate meta-analysis. In case a study 
contained separate protocols for multiple groups, these were analyzed as being separate 
studies.
Publication bias was assessed for the overall efficacy of adhesion barriers for the 
incidence of adhesions and adhesion score using a funnel plot with an Egger regression 
analysis. 
Results
The search in PubMed and EMBASE yielded 6329 unique records of which 4555 
could be excluded after checking the title and abstract. Out of 1774 studies, 93 (5%) 
studies assessed adhesion reformation and met our inclusion criteria, the other 
studies assessed de novo adhesion formation whether or not in the presence of an 
intra-peritoneal mesh (figure 1). 
Characteristics of included studies
The characteristics of the 93 included studies are shown in figure 2. 84 studies 
assessed the efficacy of an adhesion barrier, whereas 9 studies assessed surgical 
technique. 53 (57%) studies used a cecal abrasion model, 34 (36%) an uterine horn 
model and 6 (7%) studies used other experimental models. From the 53 cecal 
abrasion models, 14 used a cecal abrasion only model, 8 a cecal abrasion plus ileal 
damage, 25 a cecal abrasion plus sidewall injury and 6 studies used a sidewall injury 
alone. Eleven (12%) studies applied an adhesion barrier at both surgeries. No study 
combined laparoscopic adhesiolysis with an adhesion barrier. 53 (57%) studies 
assessed the incidence of adhesions as outcome measure and 46 could be included 
in meta-analysis. 68 (73%) studies assessed an adhesion score as outcome measure 
and 51 (55%) could be included in meta-analysis. 
Risk of bias
The risk of bias is shown in figure 3. No study met the criteria for low risk of bias. 
Therefore we could not perform a subgroup analysis for low risk of bias studies. Eight 
(9%) studies reported and used an adequate randomization method, 52 (56%) 
studies mentioned randomization but did not specify the method of randomization 
and 33 (35%) studies did not use an adequate randomization method. 55 (59%) 
studies adequately blinded outcome assessment, whereas 1 (1%) study did not specify 
blinding outcome assessment and 37 (40%) studies did not adequately blinded 
outcome assessment. 15 (16%) studies adequately blinded treatment allocation, in 76 
(82%) studies it was not specified and in 2 (2%) studies it was not performed. 
Figure 1  Flow-chart.
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Subgroup analysis of the impact of experimental factors on the incidence of adhesion 
reformation showed significant heterogeneity between studies using rats (RR 0.88) 
and rabbits (RR 0.67; p =0.046). A trend was observed for significant heterogeneity 
between studies incorporating a repeated peritoneal injury (RR 0.62) or not (RR 0.84; 
p = 0.09). Type of model and gender showed no significant heterogeneity between 
studies (table 1). 
Figure 2  General characteristics of the studies included in the systematic review: 
Animal species: 1 rabbit, 2 rat, 3 other, 4 not applicable (NA), 5 NA; Sex: 1 male, 2 female, 
3 mixed, 4 unknown, 5 NA; Type of experimental model: 1 cecal abrasion, 2 uterine 
horn, 3 other, 4 NA, 5 NA; Type of control group: 1 external control, 2 internal control,  
3 NA, 4 NA, 5 NA; Intervention used in control group: 1 no intervention, 2 saline,  
3 placebo, 4 multiple control groups, 5 other adhesion barrier; Time interval between 
2nd operation and sacrifice: 1 7 days, 2 14 days, 3 21 days, 4 other, 5 unknown; 
Repeated peritoneal injury at second laparotomy; 1 Yes, 2 No, 3 Unknown,  
4 NA, 5 NA; Method of adhesiolysis: 1 blunt/sharp, 2 coagulation, 3 unknown,  
4 NA, 5 NA; Perioperative antibiotics, fluid resuscitation or analgesia: 1 Yes, 2 No,  
3 Unknown, 4 NA, 5 NA; Type of scoring system: 1 tenacity, 2 extent, 3 morphology, 
4 combined, 5 other.
Figure 4  Funnel plot showing the incidence of adhesion reformation as a percentage 
of the total number of animals in the control group.
Figure 3  Risk of bias for the studies included in the systematic review showing  
the proportion of studies scoring low risk of bias (yes), high risk of bias (No) or did 
not specify (NS) the key methodological variables.
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Subgroup analysis of the impact of experimental factors on the adhesion score of 
reformed adhesions showed significant heterogeneity between studies using male 
(SMD 1.15) and female animals (SMD 2.05; p =0.03). The type of adhesion scoring 
system used showed a trend towards significant heterogeneity (p = 0.09). Type of 
model, species, repeated peritoneal injury and the time-interval between laparotomies 
showed no significant heterogeneity between studies (table 2). 
A subgroup analysis of using an adhesion barriers at the first and second surgery 
could not be performed because only two studies with incidence and only four with 
adhesion score as outcome measurement were available. 
Table 1  Subgroup analysis using meta-regression for assessing the impact of 
experimental factors on the incidence of adhesions, NS not specified, ‡ reference 
category, *not performed due to the low number of studies with this study 
characteristic.
Subgroup Number  
of studies
Effect size 95% confidence 
interval
Heterogeneity
lower upper I2 residual p
Experimental model
Cecal abrasion‡ 31 0.80 0.73 0.87
Uterine horn 7 0.90 0.69 1.12
Other* 3
Between subgroup 0.00 0.41
Animal species
Rabbit 19 0.67 0.55 0.80
Rat 16 0.88 0.80 0.97
Other*‡ 6
Between subgroup 0.00 0.05
Gender
Female‡ 17 0.79 0.66 0.92
Male 8 0.85 0.75 0.94
Mixed* 3
NS 13
Between subgroup 0.00 0.21
Repeated peritoneal injury
No‡ 36 0.84 0.78 0.91
Yes 5 0.62 0.37 0.86
Between subgroups 0.00 0.09
Table 2  Subgroup analysis for the adhesion score, NS not specified, ‡ reference 
category, *not performed due to the low number of studies with this study characteristic 
or because subgroup is not specified.
Subgroup Number 
of studies
Effect size 95% confidence 
interval
Heterogeneity
lower upper I2 residual p
Experimental model
Cecal abrasion 25 1.66 1.24 2.08
Uterine horn‡ 19 2.01 1.51 2.51
Other* 2
Between subgroup 70.43 0.45
Animal species
Rabbit 25 1.87 1.44 2.31
Rat 15 1.99 1.42 2.56
Other*‡ 6
Between subgroup 68.09 0.56
Gender
Female‡ 29 2.05 1.68 2.42
Male 6 1.15 0.40 1.91
Mixed* 3
NS* 8
Between subgroup 63.46 0.03
Repeated peritoneal injury
No‡ 38 1.81 1.47 2.16
Yes 8 1.91 1.10 2.71
Between subgroups 70.48 0.84
Time between surgery
7 days 12 2.21 1.58 2.83
14 days 17 1.53 1.03 2.03
21 days 6 2.02 1.20 2.84
Other*‡ 11
Between subgroups 67.16 0.30
Method adhesiolysis
Blunt and sharp 20 1.77 1.28 2.27
Coagulation 7 1.87 1.02 2.72
NS* 19
Between subgroups 70.22 0.96
Type of adhesion scoring system
Tenacity‡ 10 1.40 0.76 2.05
Extent 16 2.15 1.63 2.67
Combination 18 1.63 1.16 2.10
Other* 2
Between subgroups 65.04 0.09
184 185
CHAPTER 10 PREVENTION OF ADHESION REFORMATION IN EXPERIMENTAL MODELS
the efficacy of Seprafilm (RR 0.90; p 0.24), 5 studies assessed Oxidized Regenerated 
Cellulose (ORC; RR 0.80; p 0.49), 2 studies assessed PEG (RR 0.85; p 0.09), 4 studies 
assessed Dextran (RR 0.99; p 0.30) and 1 study assessed the efficacy of Icodextrin 
(RR 0.56; p 0.06). Saline (RR 0.98; p 0.59) did not reduce the incidence of adhesion 
reformation.
In contrast to reduction of incidence, three commercially available adhesion barriers 
individually reduced the adhesion score of reformed adhesions (figure 6). Three studies 
Efficacy of adhesion barriers
Adhesion barriers, when pooling all studies (including commercially available and 
experimental barriers), reduce the incidence of adhesion reformation (Risk Ratio 1.35; 
95% CI 1.21 – 1.50; p <0.01) and the adhesion score of reformed adhesions (SMD 
1.94; 95% CI 1.61 – 2.27; p <0.01). The forest plots are shown in supplement 1 and 2. 
When analyzed separately, none of the commercially available adhesion barriers 
reduces the incidence of adhesion reformation (figure 5). Three studies assessed 
Figure 5  Forest plot showing the efficacy of commercially available adhesion 
barriers in reducing the incidence of adhesion reformation.
Figure 6  Forest plot showing the efficacy of commercially available adhesion 
barriers in reducing the adhesion score of reformed adhesions.
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There was no difference between laparoscopic or open adhesiolysis with regard to 
the incidence of adhesion reformation (RR 1.14; figure 7). 
A trend was seen toward a reduced adhesion score in favor of laparoscopic adhesiolysis 
(SMD 0.92; p 0.07; figure 8). Publication bias was not assessed due to the limited 
number of studies available for analysis. 
Discussion
Concise statement of principal findings
The results of this systematic review and meta-analysis show that none of the 
commercially available adhesion barriers reduces the incidence of adhesion 
reformation, however, reduce the severity of reformed adhesions in animal studies. 
There is no evidence regarding the efficacy of laparoscopic adhesiolysis in reducing 
the incidence of adhesion reformation. Only 5% of all animal studies on adhesion 
prevention assessed the efficacy of adhesion barriers or surgical technique for the 
prevention of adhesion reformation. Studies were highly heterogeneous with regard 
to the employed study characteristics, and overall methodological quality was poor.
assessed the efficacy of Seprafilm (SMD 1.38; p <0.01), 4 studies assessed the 
efficacy of PEG (SMD 2.08; p <0.01), 1 study assessed the efficacy of Icodextrin 
(SMD 1.85; p <0.01). Three studies assessed the efficacy of Dextran (SMD 0.51; 
p 0.11), and 6 studies assessed the efficacy of ORC (SMD 1.06; p 0.07), and did not 
significantly reduce the adhesion score of reformed adhesions. Saline (SMD 0.40; 
p 0.51) did not significantly reduce the adhesion score of reformed adhesions.
Publication bias of studies assessing the efficacy of adhesion barriers
Analysis of the funnel plot was performed for the overall efficacy of adhesion barriers 
in reducing the incidence of adhesions and in reducing the adhesion score. The 
egger’s regression analysis showed no significant evidence for publication bias in 
both outcome measures (incidence of adhesions p = 0.18; adhesion score: p = 0.50). 
Trim and fill analysis did not indicate any missed data points. 
Efficacy of surgical technique
Seven out of 9 studies that assessed surgical technique compared the efficacy of 
laparoscopic versus open adhesiolysis. Three studies used the incidence of adhesion 
reformation and 4 studies used an adhesion score as outcome measure. Two studies 
assessed the efficacy of CO2 or Nd:YAG laser versus electro microsurgery (data not 
pooled).
Figure 7  Forest plot showing the efficacy of laparoscopic versus open adhesiolysis 
in reducing the incidence of adhesion reformation.
Figure 8  Forest plot showing the efficacy of laparoscopic versus open adhesiolysis 
in reducing the adhesion score of reformed adhesions.
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sion-related complications. Seprafilm® and Adept® (Icodextrin) were the most used 
adhesion barriers.(11) The indications for using Seprafilm® as described by the 
manufacturer do not differentiate between preventing ‘de novo’ adhesions or 
reformed adhesions whereas the indication for using Adept® is limited to preventing 
adhesion reformation in gynecological laparoscopic adhesiolysis and is contra-indi-
cated in patients requiring a laparotomy incision, bowel resection, appendectomy or 
that have peritonitis.(18, 19) The efficacy of Adept in reducing the incidence of adhesion 
reformation after laparoscopic adhesiolysis in gynecologic surgery is questionable 
and there is no evidence for the effectiveness of Adept in general surgery, which 
findings compare with our animal data.(10, 20, 21) Prevention of adhesion reformation is 
key in reducing the clinical burden of adhesions and both experimental animal and 
clinical evidence is lacking in how to optimally prevent adhesion reformation by 
adhesion barriers.
Laparoscopic adhesiolysis did not significantly reduce the incidence of adhesion 
reformation in the included animal studies. In 3 studies assessing the incidence of 
adhesion reformation there was a minimal difference between open and laparoscopic 
adhesiolysis (RR 1.06). It has been reported that the incidence of de novo adhesion 
formation against the incision is reduced after laparoscopic surgery in comparison to 
open surgery and that laparoscopic surgery is associated with a reduced incidence 
of adhesive small bowel obstruction.(1, 22) A similar efficacy might not apply to 
adhesion reformation after adhesiolysis. Laparoscopic adhesiolysis as intended 
operative procedure is limited to improving fertility of women with peri-adnexal 
adhesions and treating chronic abdominal pain related to abdominal adhesions.(23, 24) 
Our animal data indicate that laparoscopic adhesiolysis alone is not effective in 
reducing the incidence of adhesion reformation, and could benefit from usage of an 
adhesion barrier as adjuvant to improve efficacy in reducing adhesion reformation.
We have found that the type of gender and animal used significantly impact adhesion 
reformation. We advocate that future studies should use mixed gender populations. 
When interpreting the results of animal studies assessing the efficacy of adhesion 
barriers, the large effect sizes in rabbits compared to rats should be taken into 
account. Possibly heterogeneity and predominant use of the uterine horn model in 
rabbits explain the difference. Unfortunately due to small subgroup size we were not 
able to further analyze the impact of covariates regarding animal species. Studies 
incorporating a repeated peritoneal injury showed a trend towards a lower effect size 
when assessing the incidence of adhesion reformation. We propose using a repeated 
peritoneal injury model because most reoperations in humans involves peritoneal 
dissection and subsequent damage.(25) The high heterogeneity of the included 
studies is reflected in the wide range of 60-100% in the incidence of adhesion 
reformation in control groups. It has been recognized that animal studies assessing 
the efficacy of adhesion barriers are highly heterogeneous and efforts have been 
Strengths and limitations of the present study
We were able to include a large number of studies per outcome measure, which 
enabled us to investigate the effect of several experimental factors. The studies 
included in our systematic review and meta-analysis were highly heterogeneous. We 
have accounted for this heterogeneity by using a random effects model and 
performing subgroup analysis, however, differences between subgroups should be 
interpreted with caution because some subgroups represent only few studies and a 
limited number of animals. The included studies may be subject to publication bias. 
Although the Egger’s regression and trim and fill analysis did not observe any 
significant publication bias, the included studies all reported that at least one of the 
adhesion barriers tested is effective in reducing the score of reformed adhesions. An 
explanation that at least one adhesion barrier was effective could be the differences 
in methodological quality, heterogeneity or only publication of positive results.(15) 
Importantly, this could lead to an overestimation of the effect sizes of the efficacy of 
adhesion barriers. Despite the potential overestimation none of the commercially 
available adhesion barriers reduced the incidence of adhesion reformation in 
individual analysis.
Comparison to other studies and clinical implications
The overall methodological quality was low as no studies met the criteria for low-risk 
of bias and reporting was poor. A recent systematic review demonstrated that this is 
the case for many animal studies in different medical fields.(16) The method of 
randomization and blinding of treatment allocation was not specified in 56% and 82% 
of the studies included in this systematic review. This underlines an important aspect, 
namely, the suboptimal reporting of key characteristics central to good scientific 
practice. One study demonstrated that the demands from nine different journals, 
selected on the basis that they publish a high number of animal studies, for the 
description of animal studies are limited in a way that studies cannot adequately 
repeated.(17) It is of great importance that the methodology and reporting of animal 
studies improve in order to increase the reproducibility and ultimately the translational 
value of animal studies to clinical practice. 
The commercially available adhesion barriers did not significantly reduce the 
incidence of adhesion reformation. 93 out of 1774 studies assessed the efficacy of 
adhesion barriers or surgical technique on adhesion reformation and only eleven 
studies assessed commercially available barriers with icodextrin being the most 
poorly studied with one study assessing its efficacy. Considering the rate of 40 to 
66% of reoperations in elective abdominal surgery and the large clinical burden of 
adhesiolysis, the number of animal studies assessing adhesion reformation is low.(2-4) 
In a national survey regarding the awareness of adhesions, almost 80% of the 
surgeons that have used adhesion barriers did so during reoperations for adhe-
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made to improve the standardization of animal models by comparing several models 
of adhesion formation.(26) However, this has not led to a experimental model employed 
by different study groups. Only 53 of 93 studies incorporated the incidence of 
adhesion reformation as an endpoint of the study. This is a relatively low number as 
only the absence of adhesions will preclude complications secondary to adhesiolysis, 
adhesive bowel obstruction and female infertility. To increase translational value, the 
primary endpoint of animal studies assessing the efficacy of adhesion barriers should 
be the overall incidence of adhesions. We have found a pooled incidence of 91% with 
a range of 60-100% in controls which can be used for power calculations of future 
studies. Almost all studies employed a different method to score adhesions and the 
method of scoring adhesions showed a trend towards a larger effect size when only 
extent was assessed in comparison to a score based on the tenacity or a combination of 
tenacity and extent. It has been tried to standardize the method of scoring adhesions, 
however this has not gained wide application.(27) Adhesion scores should only be 
incorporated as secondary endpoints and if scored, the tenacity of adhesions is 
particularly important as more tenacious adhesions correlates with iatrogenic organ 
injury during adhesiolysis.(4, 28) Systematic reviews and meta-analysis of animal studies 
have shown to be a useful tool in improving the design of future animal studies as well 
as an aid in the translation of animal studies to clinical trials.(29, 30) Our study provides 
several recommendations for improving experimental studies. Future animal studies 
testing new anti-adhesive agents should include both de novo adhesion prevention and 
adhesion reformation, use the most challenging model e.g. repeated peritoneal injury 
model, and use adhesion incidence as primary outcome. Furthermore, when designing 
a clinical study of adhesion prevention with barriers, patients with baseline adhesions 
should be analyzed separately in order to increase the clarity of results.
Conclusion
Current commercially available adhesion barriers and laparoscopic adhesiolysis 
without using an adhesion barrier do not reduce the incidence of adhesion reformation 
in animal models. Overall, the methodological quality of animal models is poor and 
there is heterogeneity with regard to the animal models used for assessing the efficacy 
of adhesion barriers. The results of this systematic review and meta-analysis can be 
used to aid in the improvement of the design of animal and clinical studies assessing 
adhesion-related outcomes.
Supplement 1  Pooled analysis of the efficacy of the different adhesion barriers in 
preventing adhesion reformation.
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Consequences of adhesiolysis during general abdominal surgery
Three studies in this thesis address the impact of adhesions and adhesiolysis on 
clinical morbidity and its associated costs, quality of life, functional status, chronic 
post-surgical pain and gastro-intestinal complaints. All three studies utilize data from 
the prospective LAPAD (LAParotomy or LAParoscopy and ADhesiolysis) study 
population.(1) The strength of these studies lies within the reliability and completeness 
of detailed information on pre-operative clinical data, postoperative complications 
and costs. During surgery, specific surgical data including adhesions and adhesiolysis 
was collected through direct observation by a trained researcher. Additionally, patients 
undergoing various types of abdominal surgery (upper gastrointestinal (GI), hepato- 
pancreatico-biliary (HPB), colorectal, hernia and vascular surgery) were included 
obtaining a broad picture of adhesiolysis related sequelae. A limitation of these 
studies is that the cohort is recruited from a single Dutch tertiary referral centre and 
therefore the results should be interpreted with caution regarding their generalizability to 
non-academic hospitals and other countries where the healthcare system significantly 
differs from the Dutch system. Another limitation is the small number of patients who 
underwent laparoscopic surgery. In the last decade the number of minimally invasive 
procedures increased almost exponentially and, for example, laparoscopic resection 
of colorectal cancer is standard of care in most western countries.(2, 3) However, a 
large proportion of patients in the LAPAD database that was operated via an open 
approach, would also not be routinely operated by laparoscopic approach nowadays 
(e.g. complex ventral hernia surgery).
The LAPAD study demonstrates that adhesiolysis requires a median of 20 minutes 
operative time and is associated with a 10% risk of an iatrogenic enterotomy. Patients 
requiring adhesiolysis have an increased incidence of sepsis, intra-abdominal 
complications, wound infections, longer hospital stay and higher mean hospital 
costs of about 4500 $ per admission. Patients with an iatrogenic enterotomy have a 
significantly increased risk for mortality. Clavien-Dindo grade 4 complications, 
readmissions and chronic abdominal pain showed to have the largest negative 
impact on functional status and quality of life. Additionally, one in three patients will 
have Chronic Postoperative Abdominal Pain (CPAP) and 9 out of 10 patients reported 
to have gastrointestinal complaints. The LAPAD study clearly demonstrates the 
significant clinical and socioeconomical burden of adhesiolysis, with impact on 
healthcare in and outside the hospital. In some hospitals already 40 to 66% of elective 
abdominal procedures in general surgery are reoperations and this percentage will 
increase due to a higher life expectancy and advances in surgical technology and 
anaesthesiology.(4-7) Our consistent results in the various domains of disease burden 
of adhesiolysis shifts the focus of adhesion research of bowel obstruction and 
female secondary infertility to adhesiolysis as the most relevant adhesion-related 
complication.
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The combined results of our four studies show that the number of previous laparo- 
tomies, a history or presence of an intra-peritoneal mesh, the requirement of a complete 
midline incision, surgery involving the lower gastro-intestinal tract, abdominal wall 
surgery and hepatic resections due to malignancy, young age and female sex are 
important risk factors for adhesion-related complications. Selecting a surgical population 
at risk before their first operation instead of using adhesion barriers after all laparo- 
tomies or laparoscopies may aid in more tailored adhesion prevention and improve 
cost-effectiveness. An additional argument to use an adhesion barrier at the first 
operation is the concern that adhesion barriers are less efficacious in preventing 
adhesion reformation. Adhesiolysis combined with icodextrin 4% had a non-significant 
reduction of the incidence of adhesion reformation from 95.7% at baseline to 68.7% 
at the second look operation whereas it did prevent de novo adhesion formation in 
laparoscopic gynaecological surgery.(18) Reduced efficacy in reoperations might explain 
some of the failures of anti-adhesive barriers in clinical trials that seemed successful in 
pre-clinical evaluation. Current commercially available adhesion barriers and laparo- 
scopic adhesiolysis without using an adhesion barrier do not reduce the incidence of 
adhesion reformation in the few animal studies performed on this subject. Animal 
models of adhesion reformation are an indispensable asset in the development of new 
barriers, which should be recognized by regulatory authorities and all manufacturers 
that develop anti-adhesive agents.
In the systematic review “Benefits and harms of adhesion barriers for abdominal 
surgery” clinical efficacy of adhesion barriers was demonstrated with level 1a 
evidence.(19) The studies, however, did not differentiate between patients with and 
without adhesions present at the index operation, and thus the efficacy of adhesion 
barriers was potentially underestimated. Unfortunately, this landmark study has not 
led to routine usage of adhesion barriers in abdominal surgery. Doubts about the 
need for adhesion prevention in the laparoscopic era and the perceived high costs of 
adhesion barriers are two important issues why adhesion barriers are seldom used.
(8, 9) A recent prospective multi-centre observational study comparing the incidence 
of adhesion formation after open or laparoscopic colorectal surgery showed that 
laparoscopic colorectal cancer resection is associated with a lower incidence of 
adhesions to parietal surfaces but not of visceral adhesions.(20) This finding combined 
with epidemiological data regarding adhesion-related complications after laparo- 
scopy plea for adhesion prevention in laparoscopic surgery. The use of adhesive 
barriers in open colorectal surgery was found to be cost-effective in preventing 
adhesion- related complications and associated with low costs (135 US dollars per 
patient) in laparoscopic colorectal surgery in a modelling study from our group 
(Stommel et al, submitted for publication). Notably, chronic pain was not incorporated 
in this analysis. The costs of chronic postoperative pain associated with adhesions is 
difficult to measure due to uncertain causality and the multi-disciplinary treatment 
Our studies provide key data for proper patient counselling and decision making 
before surgery. Less than 10% of surgeons and gynaecologists routinely inform their 
patients about the risks of adhesions and adhesiolysis during informed consent.(8-10) 
Awareness of the impact of adhesiolysis and CPAP should affect decision making for 
surgery, especially in elderly patients and in cases where alternatives for surgery are 
present. The importance of addressing quality of life and functional status is supported 
by studies in oncologic patients which show improved patient satisfaction, detection 
of unrecognized problems, better health outcomes and changes in therapeutic 
management in some cases.(11, 12)
Risk for adhesion-related complications
There is a lack of progress in implementing adhesion prevention by medical professionals 
and policy makers due to the lack of awareness regarding the negative impact 
adhesions have on patients and society. Studies show that the incidence of adhesion - 
related complications is frequently underestimated by surgeons and gynaecologists.
(8-10) Questions remain regarding the optimal strategy for using adhesion barriers to 
reduce clinically relevant outcomes. The second part of this thesis determined risk 
factors for adhesion-related complications in order to aid in improving patient 
selection that would benefit the most from adhesion barriers.
All four studies used the prospective data of the LAPAD study to assess risk factors for 
prolonged and difficult adhesiolysis, iatrogenic enterotomy, future repeat surgery and 
adhesive bowel obstruction respectively. A limitation is the relatively small study population 
for the number of risk factors that have been assessed and the number of patients who 
developed the outcome of interest. Thus, our results require validation in a large cohort 
including a greater proportion of patients undergoing laparoscopic surgery and patients 
from different types of hospitals. Two important developments in quantifying data on 
complications, the Classification of Intraoperative Complications (CLASSIC) for intra- 
operative and the Clavien-Dindo classification for post-operative complications, should 
aid in improved reporting.(13, 14) An important drawback of both classifications is that they 
lack data on the aetiology of complications, which makes it difficult to establish causality and 
to develop targeted interventions for prevention or improvement. “Big data”, a term used 
for datasets whose size, complexity and dynamic nature impose significant problems for 
traditional statistical methods, could be a next step in identifying patients at risk for adhe-
sion-related complications. Large observational datasets are well suited for developing 
predictive models and tools for analysing the data are becoming better useable and more 
sophisticated.(15) An example is the training of IBM’s Watson by oncologists from the 
Memorial Sloan- Kettering Cancer Center in aiding physicians in optimizing decision- 
making for patients with lung cancer.(16, 17) A dataset using observational data on a regional 
or national level that incorporates detailed patient- and disease-specific as well as peri- 
operative information could lead to improved patient selection for using adhesion barriers. 
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Concerted action is required from surgical specialists operating in the abdomen and 
pelvis, healthcare workers engaged in the peri-operative care of surgical procedures, 
hospital managers, insurance companies, policy makers and patients to improve 
clinical outcomes of adhesion-related complications. The focus should lie on value 
based healthcare taking into account patient reported outcomes and action should 
be undertaken to inform patients who will undergo abdominal surgery about their 
long term risk of adhesion-related complications. We started Delphi rounds to 
develop a clinical adhesion score which takes into account the four most relevant 
clinical problems of adhesions: adhesiolysis related complications, small bowel 
obstruction, female secondary infertility and chronic abdominal pain. The goal is to 
obtain uniformly defined clinically relevant outcomes for future research on peritoneal 
adhesions and adhesiolysis. Assessing outcomes critical for clinical decision making 
is challenging because complications from adhesions and adhesiolysis are diverse, 
and require long-term follow-up. 
Additionally, we are exploring a clinical diagnostic and therapeutic pathway by 
incorporating cineMRI, shared decision making and appropriate use of an adhesive 
barrier for chronic abdominal pain associated with adhesions. Improvement of 
imaging adhesions in the abdomen and pelvis away from the abdominal wall is 
studied with automatic computer analytic programs using images from cineMRI 
scans and first results are encouraging (Randall et al, accepted for publication in the 
British Journal of Radiology). Hopefully, this will make non-invasive detection of 
adhesions less operator and patient dependent and will improve patient selection for 
treatment decision in chronic abdominal pain. 
Improved efficacy in preventing adhesion reformation and usability during laparo- 
scopic surgery is key to the development of new barriers. However, preventing 
adhesion formation at the initial abdominal operation, either performed open or 
 laparoscopically, is the most important step to reduce the incidence of adhesion- 
related complications. 
This thesis adds substantial data to an evidence based guideline on peritoneal 
adhesions and adhesion prevention for general and gynaecological surgery. This 
guideline has recently been developed and is currently reviewed by members of the 
Dutch Adhesion Group. Broad acceptance and implementation of this guideline will 
reduce the disease burden of peritoneal adhesions for patients undergoing abdominal 
and pelvic surgery.
patients receive over a prolonged period of time.(21) Due to the low incidence of 
colorectal surgery in young fertile women, infertility was excluded from the analysis 
as well. However, secondary infertility inflicts a huge financial burden for patients; 
20% of an individual’s disposable income is required to pay for fertility treatment in 
most European countries.(22) Even when infertility and chronic postoperative pain are 
excluded, the incremental cost-effectiveness ratio for adhesion prevention is comparable 
to treating hypertension in order to reduce secondary complications, a disease for 
which treatment has gained worldwide acceptance for several decades.(23)
Future perspectives
The agenda of future research and developments in preventing the morbidity 
associated with peritoneal adhesions is depicted in Figure 1. The five most important 
goals for patients requiring abdominal surgery are:
1. Reducing the incidence of chronic postoperative abdominal pain associated 
with adhesions
2. Reducing iatrogenic organ injury during adhesiolysis
3. Reducing adhesive bowel obstruction
4. Reducing infertility caused by adhesions
5. Increasing the quality of life of patients potentially subjected to problems of 
peritoneal adhesions 
Figure 1  Adhesion 2.0 sustainable goals.
204 205
CHAPTER 11 GENERAL DISCUSSION
References
1. ten Broek, R.P., et al., Adhesiolysis-related morbidity in abdominal surgery. Ann Surg, 2013. 258(1): p. 98-106.
2. Kolfschoten, N.E., et al., Successful and safe introduction of laparoscopic colorectal cancer surgery in 
Dutch hospitals. Ann Surg, 2013. 257(5): p. 916-21.
3. Askari, A., et al., Selection for laparoscopic resection confers a survival benefit in colorectal cancer 
surgery in England. Surg Endosc, 2016. 30(9): p. 3839-47.
4. Christensen, K., et al., Ageing populations: the challenges ahead. Lancet, 2009. 374(9696): p. 1196-208.
5. Colon Cancer Laparoscopic or Open Resection Study, G., et al., Survival after laparoscopic surgery 
versus open surgery for colon cancer: long-term outcome of a randomised clinical trial. Lancet Oncol, 
2009. 10(1): p. 44-52.
6. Fazio, V.W., et al., Reduction in adhesive small-bowel obstruction by Seprafilm adhesion barrier after 
intestinal resection. Dis Colon Rectum, 2006. 49(1): p. 1-11.
7. Kwok, A.C., et al., The intensity and variation of surgical care at the end of life: a retrospective cohort 
study. Lancet, 2011. 378(9800): p. 1408-13.
8. Meuleman, T., et al., Adhesion awareness: a nationwide survey of gynaecologists. Eur J Obstet Gynecol 
Reprod Biol, 2013. 169(2): p. 353-9.
9. Schreinemacher, M.H., et al., Adhesion awareness: a national survey of surgeons. World J Surg, 2010. 
34(12): p. 2805-12.
10. Trew, G., et al., Post-operative abdominal adhesions—awareness of UK gynaecologists—a survey of 
members of the Royal College of Obstetricians and Gynaecologists. Gynecological Surgery, 2009. 6(1): 
p. 25-37.
11. Velikova, G., et al., Measuring quality of life in routine oncology practice improves communication and 
patient well-being: a randomized controlled trial. J Clin Oncol, 2004. 22(4): p. 714-24.
12. Chen, J., L. Ou, and S.J. Hollis, A systematic review of the impact of routine collection of patient reported 
outcome measures on patients, providers and health organisations in an oncologic setting. BMC Health 
Serv Res, 2013. 13: p. 211.
13. Dindo, D., N. Demartines, and P.A. Clavien, Classification of surgical complications: a new proposal with 
evaluation in a cohort of 6336 patients and results of a survey. Ann Surg, 2004. 240(2): p. 205-13.
14. Rosenthal, R., et al., Definition and Classification of Intraoperative Complications (CLASSIC): Delphi 
Study and Pilot Evaluation. World J Surg, 2015. 39(7): p. 1663-71.
15. Janke, A.T., et al., Exploring the Potential of Predictive Analytics and Big Data in Emergency Care. Ann 
Emerg Med, 2016. 67(2): p. 227-36.
16. Castaneda, C., et al., Clinical decision support systems for improving diagnostic accuracy and achieving 
precision medicine. J Clin Bioinforma, 2015. 5: p. 4.
17. Kohn, M.S., et al., IBM’s Health Analytics and Clinical Decision Support. Yearb Med Inform, 2014. 9: 
p. 154-62.
18. diZerega, G.S., et al., A randomized, controlled pilot study of the safety and efficacy of 4% icodextrin 
solution in the reduction of adhesions following laparoscopic gynaecological surgery. Hum Reprod, 
2002. 17(4): p. 1031-8.
19. ten Broek, R.P., et al., Benefits and harms of adhesion barriers for abdominal surgery: a systematic 
review and meta-analysis. Lancet, 2014. 383(9911): p. 48-59.
20. Stommel, M.W., et al., Multicenter Observational Study of Adhesion Formation after Open-and Laparo- 
scopic Surgery for Colorectal Cancer. Ann Surg, 2017.
21. Jansen, L.A., et al., Estimated hospital health costs of chronic abdominal pain in the Netherlands. Neth 
J Med, 2014. 72(2): p. 102-6.
22. Chambers, G.M., et al., The impact of consumer affordability on access to assisted reproductive technologies 
and embryo transfer practices: an international analysis. Fertil Steril, 2014. 101(1): p. 191-198 e4.
23. Nuckols, T.K., et al., Cost implications of improving blood pressure management among U.S. adults. 
Health Serv Res, 2011. 46(4): p. 1124-57.
Summary
Chapter 12
209
SUMMARY
Introduction
Since the ‘SCAR study group’ published its first landmark paper in 1999, demonstrating 
that adhesion formation is the most common cause of long-term complications after 
abdominal surgery, scientific interest in adhesion formation and adhesion prevention 
increased.(1-4) The recent publication of the systematic review and meta-analysis 
‘The burden of adhesions in abdominal and pelvic surgery’ from our group demonstrated, 
in a complete and concise manner, the large negative impact of adhesions and the 
four most important complications of peritoneal adhesions (small bowel obstruction, 
difficulties at repeat abdominal surgery, female infertility and chronic pain) on clinical 
and socio-economic outcomes.(5) Progress in improving adhesion prevention from 
medical professionals and policy makers has been stalled, probably due to the lack 
of awareness regarding the negative impact adhesions have on patients and society. 
Studies show that the incidence of adhesion-related complications is frequently 
underestimated by surgeons and gynaecologists and that less than 10% routinely 
inform their patients about the risks of adhesions during informed consent.(6-8) This 
thesis aims to improve the knowledge regarding the impact of peritoneal adhesions 
and adhesiolysis on postoperative outcomes and to investigate risk factors for 
adhesion- related complications.
Chapter 1 provides an introduction and outline of this thesis
Chapter 2 gives a comprehensive overview of the current knowledge regarding the 
inflammatory response of the peritoneum on various pathological triggers, such as 
surgical trauma, invasive pathogens and tumour. All mentioned triggers can be 
involved in abdominal surgery. Regardless of the type of injury to the peritoneal 
mesothelial cells, an inflammatory response is activated attempting to heal the 
peritoneal surfaces. The peritoneal response comprises four interacting pathways, 
an immunological, a humoral, a coagulation and a neurogenic pathway. Fibrous 
tissue connecting organs, surfaces and structures is commonly the ultimate result.
Our group demonstrated in 2000 in a retrospective series of 270 repeat intraperitoneal 
operations that an iatrogenic enterotomy occurred in 19% of patients and that these 
patients had significantly more postoperative complications and relaparotomies compared 
to those without an enterotomy.(9) With these results in mind, the LAParotomy or 
LAParoscopy and ADhesiolysis (LAPAD) study was performed, which results are 
described in Chapter 3. The LAPAD study is a prospective cohort study designed to 
assess data on adhesiolysis and inadvertent organ injury that were gathered by 
direct observation during the operation. A total of 755 surgeries in 715 patients were 
included. Adhesiolysis was required in 475 (62.9%) operations. Median adhesiolysis 
time was 20 minutes (range: 1177). Fifty patients (10.5%) who underwent adhesiolysis 
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opioid analgesia preoperatively (OR 3.54; p 0.001), severe adhesions underneath the 
incision (OR 1.63; p 0.040) and a higher numeric pain rating scale value on post- 
operative day 2 (OR 1.23; p 0.004) showed to independently increase the risk for 
CPAP. Chronic pancreatitis as indication for surgery (B 4.20; p 0.03), 3 or more 
previous abdominal operations (B 1.03; p 0.03), presence of pain more than 3 months 
before surgery (B 1.61; p <0.01), upper gastrointestinal tract as the anatomical location 
of surgery (B 1.43; p 0.03) and a higher preoperative GSRS score (B 0.36; 
p <0.01) independently increased the GSRS score six months after surgery. The number 
of operations and the anatomical location of the operation showed to be important 
risk factors for increasing the number of gastrointestinal complaints. The duration and 
severity of preoperative pain and the presence of anxious and depressive symptoms 
were the most relevant risk factors for CPAP whereas adhesions and adhesiolysis 
related problems were not. 
A median laparotomy is a common route in both acute and elective open general 
abdominal surgery. We used a large prospective patient cohort to investigate prolonged 
and difficult adhesiolysis in patients undergoing a repeat median laparotomy which 
is described in Chapter 6. Four or more previous laparotomies, a history or presence 
of an intra-peritoneal mesh, and the requirement of a complete midline incision were 
found to be independent risk factors for prolonged adhesiolysis through a median 
incision. The results of this study can be used to improve patient counselling, 
operating room strategy and choosing an entry method for the abdominal cavity at 
repeat surgery.
Given the increased morbidity when an iatrogenic enterotomy occurs in patients 
requiring adhesiolysis during surgery it is important to identify patients who are at risk 
for this complication. In Chapter 7 we developed a prediction model, scoring the risk 
for inadvertent enterotomy based on preoperative factors. The number of previous 
laparotomies, anatomical site of the operation, presence of bowel fistula and laparotomy 
via a pre-existing median scar were independent predictors of bowel injury. A nomogram 
was constructed incorporating these four risk factors. The area under the receiver 
operating characteristic curve was 0.85. The predicted risk in a patient who has all 
four risk factors is 50%. It was concluded that the nomogram accurately predicts the 
risk for bowel injury and can readily be used to identify high risk patients.
Previous laparotomies lead to prolonged and difficult adhesiolysis and impact the 
incidence of adhesiolysis-related complications. It would be of interest to assess the 
impact of specific surgical factors during elective abdominal surgery on the incidence 
of repeat abdominal surgery in order to improve patient selection for using adhesive 
barriers. The large amount of prospectively collected peri-operative data of the 
inadvertently incurred a bowel defect, compared to zero without adhesiolysis (P < 0.001). 
In univariate and multivariate analyses, adhesiolysis was associated with an increase 
of sepsis incidence [odds ratio (OR): 5.12; 95% confidence interval (CI): 1.06–24.71], 
intra-abdominal complications (OR: 3.46; 95% CI: 1.49–8.05) and wound infection 
(OR: 2.45; 95% CI: 1.01–5.94), longer hospital stay (2.06 ± 1.06 days), and higher 
hospital costs [$18,579 (15,204–21,954) vs $14,063 (12,471–15,655)]. Mortality after 
adhesiolysis complicated by a bowel defect was 4 out of 50 (8%), compared with 
7 out of 425 (1.6%) after uncomplicated adhesiolysis (OR: 5.19; 95% CI: 1.47–18.41). 
Adhesiolysis and inadvertent bowel injury have a harmful effect on the convalescence 
after abdominal surgery. 
The large negative impact of adhesiolysis during abdominal surgery on morbidity led 
to the hypothesis that adhesiolysis would impact quality of life as well. Therefore we 
prospectively collected data regarding quality of life and functional status in the 
LAPAD study by means of the Short-Form 36 (SF-36) and Duke’s Activity Status 
Index (DASI) questionnaires. The results of this study are described in Chapter 4. 518 
(78%) patients out of 662 were eligible for analysis and 319 patients required 
adhesiolysis during surgery. Postoperative quality of life did not significantly differ 
between both groups (p 0.12) and was not different from pre-operative values. 
Patients with adhesiolysis had a significantly lower pre- and postoperative functional 
status in comparison to these outcomes in patients not requiring adhesiolysis (p 
<0.01 and p <0.01). Higher age (p 0.05 and p <0.01), concomitant pulmonary 
disease (p 0.04 and p <0.01), postoperative Clavien-Dindo grade 4 complications (p 
<0.01 and p 0.05), readmissions within 30 days (p 0.01 and p <0.01), readmissions 
after 30 days (p <0.01 and p <0.01) and chronic abdominal pain 6 months after 
surgery (p <0.01 and p <0.01) were all associated with a significant and independent 
decline in quality of life and functional status six months after surgery. Patients 
requiring adhesiolysis have a lower pre- and postoperative functional status but 
adhesiolysis as such does not affect functional status and quality of life. Postoperative 
complications, readmissions and chronic abdominal pain are associated with a lower 
health status.
In the LAPAD study data regarding pain and pain-related factors was collected and 
because chronic postoperative abdominal pain (CPAP) showed to have a negative 
impact on quality of life we sought to assess risk factors for CPAP and gastrointestinal 
complaints and questioned if they relate to baseline adhesions in Chapter 5. Gastro-
intestinal Symptom Rating Scale (GSRS) was used to assess gastrointestinal 
complaints. 184 (36%) of 518 patients included in the analysis had CPAP. The median 
GSRS score was 5 (IQR 3 – 10). The presence of pain either shorter (OR 2.69; 
p 0.016) or longer than three months (OR 3.99; p 0.000) before surgery, usage of 
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Chapter 11 provides a general discussion of the research presented in this thesis 
and future perspectives on adhesions related problems based on the adhesion 2.0 
agenda. 
LAPAD study provided the opportunity to perform such a follow-up study. These results 
are presented in Chapter 8. Primary outcome was future repeat abdominal surgery 
and was defined as any operation where the peritoneal cavity is reopened. 604 (88%) 
out of 715 patients were included, median duration of follow-up was 46 months. 27% 
patients required repeat abdominal surgery within four years mostly due to malignant 
disease recurrence, incisional hernia and indications unrelated to the index surgery. 
The anatomical location of repeat surgery was most often the lower gastrointestinal tract 
and abdominal wall. Lower age, female sex and hepatic malignancy are significant 
risk factors for requiring repeat abdominal surgery. 
The overall incidence of adhesive bowel obstruction is 2.4% in a systematic review 
and meta-analysis. The incidence is significantly higher after paediatric and lower 
gastrointestinal tract surgery, and lower after laparoscopic surgery in comparison to 
open surgery.(5) This data is derived from regional and national registries and retro- 
spective cohorts of acute surgery for bowel obstruction and elective abdominal 
surgery. Due to the design of these studies it remains unknown whether specific 
surgical factors impact the occurrence of bowel obstruction. A follow-up study of the 
LAPAD enabled us to assess the impact of detailed surgical factors on the incidence 
of adhesive bowel obstruction in patients undergoing all types of elective abdominal 
surgery which is presented in Chapter 9. 604 patients were included and 6% of these 
patients developed an episode of adhesive bowel obstruction within 4 years. Surgery 
on the lower gastrointestinal tract and severe adhesions at the index operation 
increased the risk for adhesive bowel obstruction by 5 and 3 times, respectively. This 
study again demonstrated that adhesive bowel obstruction is a serious complication 
of colorectal surgery that needs to be routinely addressed by surgeons during 
informed consent. 
A systematic review and meta-analysis showed that hyaluronate carboxymethylcellulose 
and oxidized regenerated cellulose safely reduce clinically relevant consequences of 
adhesions. The studies incorporated in this systematic review did not differentiate 
between patients with and without adhesions present at the index operation, and 
potentially underestimate the efficacy of adhesion barriers.(10, 11) In Chapter 10 a 
systematic review on the prevention of adhesion reformation in animal models is 
presented providing translational data for the efficacy of adhesion barriers in reduction 
of adhesion reformation. Only 5% of all animal studies assessing adhesion prevention 
employed a model of adhesion reformation. Current commercially available adhesion 
barriers and laparoscopic adhesiolysis without using an adhesion barrier do not 
reduce the incidence of adhesion reformation in experimental animals. Overall, the 
methodological quality of animal studies was poor and there was great heterogeneity 
with regard to the animal models used for assessing the efficacy of adhesion barriers. 
214 215
CHAPTER 12 SUMMARY
References
1. Catena, F., et al., P.O.P.A. study: prevention of postoperative abdominal adhesions by icodextrin 4% 
solution after laparotomy for adhesive small bowel obstruction. A prospective randomized controlled 
trial. J Gastrointest Surg, 2012. 16(2): p. 382-8.
2. Ellis, H., et al., Adhesion-related hospital readmissions after abdominal and pelvic surgery: a retrospective 
cohort study. Lancet, 1999. 353(9163): p. 1476-80.
3. Fazio, V.W., et al., Reduction in adhesive small-bowel obstruction by Seprafilm adhesion barrier after 
intestinal resection. Dis Colon Rectum, 2006. 49(1): p. 1-11.
4. Mais, V., et al., Reduction of adhesion reformation after laparoscopic endometriosis surgery: a randomized 
trial with an oxidized regenerated cellulose absorbable barrier. Obstet Gynecol, 1995. 86(4 Pt 1): p. 512-5.
5. ten Broek, R.P., et al., Burden of adhesions in abdominal and pelvic surgery: systematic review and 
met-analysis. BMJ, 2013. 347: p. f5588.
6. Meuleman, T., et al., Adhesion awareness: a nationwide survey of gynaecologists. European Journal of 
Obstetrics & Gynecology and Reproductive Biology, 2013. 169(2): p. 353-359.
7. Schreinemacher, M.H.F., et al., Adhesion Awareness: A National Survey of Surgeons. World Journal of 
Surgery, 2010. 34(12): p. 2805-2812.
8. Trew, G., et al., Post-operative abdominal adhesions—awareness of UK gynaecologists—a survey of 
members of the Royal College of Obstetricians and Gynaecologists. Gynecological Surgery, 2009. 6(1): 
p. 25-37.
9. Van Der Krabben, A.A., et al., Morbidity and mortality of inadvertent enterotomy during adhesiotomy. 
Br J Surg, 2000. 87(4): p. 467-71.
10. diZerega, G.S., et al., A randomized, controlled pilot study of the safety and efficacy of 4% icodextrin 
solution in the reduction of adhesions following laparoscopic gynaecological surgery. Hum Reprod, 
2002. 17(4): p. 1031-8.
11. ten Broek, R.P., et al., Benefits and harms of adhesion barriers for abdominal surgery: a systematic 
review and meta-analysis. Lancet, 2014. 383(9911): p. 48-59.
Nederlandse samenvatting
Bibliografie
Dankwoord
Curriculum Vitae
RIHS PhD portfolio
Appendices
219
NEDERLANDSE SAMENVATTING
Introductie
De publicaties van de ‘SCAR studiegroep’ eind vorige eeuw hebben adhesies 
(verklevingen) als belangrijkste oorzaak van complicaties na buikchirurgie op de kaart 
gezet en de wetenschappelijke interesse in de preventie van adhesies vergroot.(1-4) 
Recent is door ons een systematische review getiteld ‘The burden of adhesions in 
abdominal and pelvic surgery’ gepubliceerd waaruit blijkt dat adhesies grote medische 
en sociale gevolgen hebben voor patiënten die een buikoperatie ondergaan en de 
bijbehorende financiële kosten hoog zijn.(5) De vier meest voorkomende complicaties 
van adhesies zijn darm obstructie, de complicaties van het moeten losmaken van 
adhesies bij herhaaldelijke operaties in de buik (adhesiolyse), onvruchtbaarheid bij 
vrouwen en chronische buikpijn. In de afgelopen jaren is weinig vooruitgang geboekt 
in het voorkomen van adhesies. Dit komt mede door het gebrek aan kennis van artsen 
en beleidsmakers in de zorg over de negatieve gevolgen van adhesies. Uit een korte 
kennistoets blijkt dat de incidentie van adhesie gerelateerde complicaties door 
chirurgen en gynaecologen sterk wordt onderschat. Ook informeert minder dan 10% 
van deze specialisten hun patiënten routinematig over de risico’s van adhesies voor- 
afgaand aan een operatie.(6-8) Dit proefschrift heeft tot doel de kennis over de 
negatieve gevolgen van adhesies en adhesiolyse op postoperatieve uitkomsten te 
vergroten, risicofactoren voor het ontstaan van complicaties door adhesies in kaart te 
brengen en om passende zorg te bieden voor de patiënt die een buikoperatie ondergaat.
Hoofdstuk 1 bevat een introductie van dit proefschrift waarin de problematiek van 
adhesies bij herhaalde buikoperaties en als oorzaak van een darmobstructie en 
chronische pijn wordt samengevat. Tevens worden de verschillende studies van dit 
proefschrift hierin beschreven.
Hoofdstuk 2 geeft een uitgebreid overzicht van de huidige kennis over de ontstekings-
reactie van het peritoneum (het buikvlies) wat het begin is van adhesievorming. Deze 
reactie kan in gang gezet worden door verschillende typen beschadiging van het 
peritoneum, waarvan chirurgisch trauma door een operatie de meest voorkomende is. 
Na een operatie, ongeacht het type, wordt een ontstekingsreactie op gang gebracht 
om het peritoneum te genezen. Deze ontstekingsreactie bestaat uit vier verschillende 
cascades, een immunologische, een humorale, een neurogene en een stollings-
cascade. Het uiteindelijke resultaat van deze cascades is meestal fibreus weefsel dat 
organen met elkaar en de buikwand verbind; dit zijn adhesies.
Uit een eerdere studie van onze groep is gebleken dat 19% van de patiënten, die 
opnieuw in de buik werden geopereerd, een enterotomie (onbedoelde perforatie van 
de darm) krijgen. Bij 54% van de patiënten met een enterotomie traden postoperatieve 
complicaties op. Postoperatieve complicaties traden op bij 35% van de patiënten 
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verband met de daling van de kwaliteit van leven en met het fysiek functioneren zes 
maanden na de operatie.
We concludeerden dat patiënten met adhesiolyse een lagere pre- en postoperatieve 
score hebben met betrekking tot het fysiek functioneren maar dat adhesiolyse geen 
onafhankelijke voorspeller is voor kwaliteit van leven en het fysiek functioneren na 
de operatie. Wel leiden ernstige postoperatieve complicaties, een heropname en 
chronische abdominale pijn, die alle drie vaker voorkomen na adhesiolyse, tot een 
lagere gezondheidsstatus zes maanden na buikchirurgie.
Uit hoofdstuk 4 blijkt dat chronische postoperatieve abdominale pijn (CPAP) veel 
optreedt en een verband heeft met een lagere kwaliteit van leven. Wij onderzochten 
in een vervolgstudie wat de risicofactoren zijn voor CPAP en andere gastro-intestinale 
klachten na een buikoperatie en of er een verband is tussen adhesies, adhesiolyse, 
chronische pijn en gastro-intestinale klachten. Deze studie is beschreven in 
hoofdstuk 5. De Gastro-intestinal Symptom Rating Scale (GSRS) werd gebruikt voor 
het in kaart brengen van de gastro-intestinale klachten. 184 (36%) van 518 patiënten 
hadden zes maanden na de operatie CPAP. De mediane GSRS score was 5 
(Interquartile Range 3 - 10). De aanwezigheid van pijn korter (OR 2.69, p 0.016) of 
langer dan drie maanden (OR 3.99; p 0.000) voor de operatie, preoperatief gebruik 
van morfinomimetica (OR 3.54; p 0.001), zeer fibreuze adhesies onder de incisie (OR 
1.63; P 0.040) en een hogere pijnscore op de tweede dag na de operatie (OR 1.23; 
p 0.004) gaven alle vijf een significant en onafhankelijk verhoogd risico op CPAP. 
Chronische pancreatitis als indicatie voor de operatie (B 4.20, p 0.03), drie of meer 
eerdere buikoperaties (B 1.03, p 0.03), aanwezigheid van pijn meer dan 3 maanden 
voor de operatie (B 1.61; p <0.01), het bovenste deel van het maagdarmkanaal als 
anatomische locatie van de operatie (B 1.43; p 0.03) en een hogere preoperatieve 
GSRS score (B 0.36; p <0.01) leidden tot een hogere GSRS score zes maanden na 
de operatie.
De duur en de ernst van pijn voor de operatie zijn de meest relevante risicofactoren 
voor het optreden van CPAP. Het aantal operaties en de anatomische locatie van de 
operatie zijn belangrijke risicofactoren voor gastro-intestinale klachten na een 
operatie. Adhesiolyse gerelateerde complicaties, zoals een enterotomie, hebben 
geen verband met het optreden van gastro-intestinale klachten of chronische buikpijn 
na de operatie.
Een mediane laparotomie is een veelgebruikte incisie voor zowel acute als electieve 
algemene buikchirurgie. We hebben een groot prospectief patiëntencohort gebruikt 
om langdurige en moeizame adhesiolyse te onderzoeken bij patiënten met een 
herhaalde mediane laparotomie. De resultaten hiervan zijn beschreven in hoofdstuk 6. 
Vier of meer voorgaande ‘open’ buikoperaties, het opnieuw (moeten) openen van de 
zonder enterotomie, dus aanzienlijk minder.(9) Gedetailleerde gegevens van patiënten en 
de uitgevoerde operaties waren niet voor handen in deze studie. De studie vormde 
de basis voor de LAParotomy or LAParoscopy and ADhesiolysis (LAPAD) studie, 
waarvan de resultaten zijn beschreven in hoofdstuk 3. De LAPAD studie is een groot 
prospectief cohortonderzoek met als doel de gevolgen van adhesiolyse en onopzettelijk 
orgaanletsel tijdens de operatie op postoperatieve uitkomsten nauwkeurig in kaart 
te brengen. In totaal waren 755 operaties bij 715 patiënten onderdeel van de studie, 
waarbij in 475 (62.9%) operaties adhesiolyse nodig was. De tijdsduur voor het los- 
maken van de adhesies verschilde van 1 tot 177 minuten en was mediaan 20 minuten. 
Bij vijftig patiënten (10.5%), waarbij tijdens de operatie adhesiolyse nodig was, 
ontstond een enterotomie. Dit aantal was 0 bij patiënten die geen adhesiolyse nodig 
hadden en dit verschil was significant, P < 0.001. In een multivariabele analyse was 
er een significante associatie tussen adhesiolyse en een toename van complicaties, 
waaronder sepsis (odds ratio (OR): 5.12; 95% betrouwbaarheid interval (CI): 1.06-24.71), 
intra-abdominale complicaties (OR: 3.46; 95% CI: 1.49-8.05), wondinfecties (OR: 2.45; 
95% CI: 1.01-5.94); het aantal opname dagen (2.06 ± 1.06 dagen), en tussen 
adhesiolyse en hogere ziekenhuiskosten ($ 18.579 (15.204-21.954) ten opzichte van 
$ 14.063 (12.471-15.655)). De sterfte na een operatie waarbij adhesiolyse nodig was 
en een enterotomie ontstond was 8 procent vergeleken met 1.6 procent zonder 
ontstaan van een enterotomie (OR: 5.19; 95% CI: 1.47-18.41). 
Wij concludeerden dat adhesiolyse met het optreden van een enterotomie negatieve 
gevolgen heeft op het herstel na buikchirurgie.
De gevonden negatieve gevolgen van adhesiolyse tijdens buikchirurgie op het post- 
operatieve herstel leidde tot de hypothese dat adhesiolyse ook de kwaliteit van het 
leven nadelig beïnvloedt. Daarom verzamelden we prospectief gegevens over kwaliteit 
van leven en het fysiek functioneren van patiënten in de LAPAD studie met behulp 
van de vragenlijsten Short Form 36 (SF-36) en Duke’s Activity Status Index (DASI). 
De resultaten van deze studie zijn beschreven in hoofdstuk 4. 518 van 662 (78%) 
patiënten konden worden geanalyseerd. Hiervan hadden 319 patiënten adhesiolyse 
nodig tijdens de operatie. De postoperatieve kwaliteit van leven verschilde niet 
significant tussen beide groepen (p 0.12) en verschilde ook niet van de preoperatieve 
kwaliteit van leven. Patiënten met adhesiolyse hadden een significant lagere pre- en 
postoperatieve score met betrekking tot het fysiek functioneren in vergelijking tot 
patiënten die geen adhesiolyse nodig hadden (p <0.01 en p <0.01). Een hogere 
leeftijd (p 0.05 en p <0.01), een chronische longaandoening in de voorgeschiedenis 
(p 0.04 en p <0.01), een ernstige postoperatieve complicatie (Clavien-Dindo graad 4) 
(p <0.01 en p 0.05), een heropname binnen 30 dagen (p 0.01 en p <0.01 ), een 
heropname na 30 dagen (p <0.01 en p <0.01) en chronische buikpijn zes maanden 
na de operatie (p <0.01 en p <0.01) hadden allemaal een significant en onafhankelijk 
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het vrouwelijk geslacht en een maligniteit van de lever waren de belangrijkste voorspellers 
voor het opnieuw moeten ondergaan van een buikoperatie binnen vier jaar.
Deze studie heeft resultaten opgeleverd die richting kunnen geven aan het efficiënt 
gebruik van maatregelen en middelen om adhesies en hieraan gerelateerde complicaties 
te voorkomen. 
De gemiddelde incidentie van een darmobstructie veroorzaakt door adhesies is 
2,4%. De incidentie is significant hoger na buikchirurgie op jonge leeftijd en operaties 
aan de dunne en dikke darm. De incidentie is lager na laparoscopische chirurgie in 
vergelijking met open buikoperaties.(5) Deze gegevens zijn afgeleid uit regionale en 
nationale registers en retrospectieve cohorten van electieve buikchirurgie en van 
acute operaties voor een darmobstructie. Door de aard van deze databases en het 
ontwerp van de studies kan niet worden onderzocht welke factoren tijdens de operatie 
het optreden van een darmobstructie in een latere fase beïnvloeden. In de LAPAD 
studie zijn deze gedetailleerde operatiegegevens wel verzameld en hebben we een 
follow-up studie verricht om te onderzoeken welke operatiefactoren het optreden van 
een darmobstructie door adhesies beïnvloeden. Dit is beschreven in hoofdstuk 9. 
Er werden 604 patiënten met een electieve buikoperatie geïncludeerd in deze studie. 
Hiervan had 6 procent binnen 4 jaar een of meerdere darmobstructies door adhesies 
doorgemaakt. Resecties van de dikke en/of de dunne darm en de aanwezigheid van 
ernstige verklevingen bij de voorgaande operatie verhoogden het risico op darm- 
obstructie met respectievelijk 500 en 300 procent. Deze studie heeft opnieuw 
aangetoond dat darmobstructie door adhesies een ernstige lange termijn complicatie 
van abdominale chirurgie is die routinematig door chirurgen moet worden besproken 
met patiënten. Daarnaast kunnen de resultaten gebruikt worden om richting te geven 
aan het gebruik van middelen ter preventie van adhesies.
In een systematic review hebben we recent aangetoond dat twee anti-adhesie 
middelen (hyaluronate carboxymethylcellulose en oxidized regenerated cellulose) 
complicaties van adhesies verminderen zonder ernstige bijwerkingen. De studies die 
in deze systematische review zijn opgenomen maken geen onderscheid tussen 
patiënten waarbij adhesies wel of niet aanwezig zijn bij de operatie en dus of deze 
middelen de novo adhesies of opnieuw vorming van adhesies na het losmaken 
voorkomen (adhesie reformatie). Op pathofysiologische gronden is er reden om aan 
te nemen dat het voorkomen van adhesie reformatie moeilijker is dan het voorkomen 
van de novo adhesies.(10, 11) 40-60% van de buikoperaties bij mensen, in sommige 
ziekenhuizen, zijn heroperaties waarbij verklevingen aanwezig zijn. In hoofdstuk 10 
worden de resultaten van een systematische review en meta-analyse over de 
preventie van adhesie reformatie in diermodellen beschreven en is bestudeerd of de 
dierexperimentele data translationele waarde hebben voor de werkzaamheid van 
hele mediane incisie en aanwezigheid of het aanwezig geweest zijn van een mesh in de 
buikholte bleken onafhankelijke risicofactoren te zijn voor een langdurige en moeizame 
adhesiolyse.
De resultaten van deze studie kunnen worden gebruikt om de preoperatieve 
informatie aan deze patiënten te verbeteren, bij het kiezen van de toegang tot de buik 
bij een volgende operatie en om de planning en logistiek van deze buikoperatie te 
optimaliseren.
Gezien de hoge morbiditeit bij patiënten met een iatrogene enterotomie door het 
losmaken of verwijderen van adhesies tijdens een operatie, is het belangrijk om het 
risico op een enterotomie vooraf in te kunnen schatten bij de individuele patiënt. Voor 
deze inschatting hebben we een voorspellingsmodel gecreëerd waarbij het risico op 
een iatrogene enterotomie is gebaseerd op preoperatief aanwezige gegevens, dit is 
beschreven in hoofdstuk 7. Het aantal eerdere buikoperaties, de anatomische plaats 
van de operatie, de aanwezigheid van een enterocutane fistel en een voorgaande 
operatie via een mediane incisie waren onafhankelijke voorspellers van een iatrogene 
enterotomie. Op basis van deze 4 risicofactoren is een nomogram gemaakt. De AUC 
(area under the operating characteristic curve) was 0,85 en het voorspelde risico bij 
een patiënt met alle vier de risicofactoren bedroeg 50%.
Het nomogram voorspelt nauwkeurig het risico op een iatrogene enterotomie en is 
een makkelijke tool om patiënten met een hoog risico op een enterotomie voorafgaand 
aan een buikoperatie te identificeren.
Eerdere buikoperaties kunnen leiden tot langdurige adhesiolyse bij een vervolgoperatie 
en houden verband met een verhoogde incidentie van adhesiolyse gerelateerde 
complicaties. Het is interessant om te kunnen voorspellen welke patiënten in de 
toekomst opnieuw een buikoperatie moeten ondergaan om bijvoorbeeld al bij de 
eerste buikoperatie middelen te gebruiken die adhesies voorkomen. De prospectief 
verzamelde en gedetailleerde data rondom de operatie in de LAPAD studie bood 
de gelegenheid om een follow-up studie uit te voeren waarbij werd gekeken of er 
voorspellers waren voor het opnieuw moeten ondergaan van een buikoperatie. 
De resultaten van deze follow-up studie zijn beschreven in hoofdstuk 8. De primaire 
studie uitkomst was de incidentie van buikchirurgie en werd gedefinieerd als iedere 
operatie waarbij de buikholte wordt heropend. 604 (88%) van de 715 patiënten uit 
de LAPAD studie konden worden geïncludeerd. De mediane duur van de follow-up 
was 46 maanden. 27% van de patiënten hadden opnieuw een buikoperatie nodig, 
hoofdzakelijk vanwege een recidief of metastase van de tumor waarvoor de originele 
buikoperatie was verricht, een littekenbreuk, maar ook voor indicaties die geen verband 
hielden met de voorgaande operatie. De anatomische locatie van de operaties in de 
follow-up betrof meestal de dunne of dikke darm en de buikwand. Een jongere leeftijd, 
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preventieve middelen voor adhesie reformatie bij patiënten. Slechts in vijf procent van 
alle dierstudies die adhesiepreventie onderzochten werd een model van adhesie 
reformatie gebruikt. Huidige commercieel verkrijgbare middelen ter preventie van 
adhesies en het toepassen van laparoscopie bij het losmaken van de adhesies 
verminderden de aanwezigheid van opnieuw gevormde adhesies niet in deze dier- 
modellen. De methodologische kwaliteit van de dierstudies was laag en er was veel 
heterogeniteit tussen de gebruikte diermodellen.
De conclusie is dat er vooralsnog geen dierexperimenteel bewijs is voor de werk- 
zaamheid van bestaande anti-adhesie middelen om adhesie reformatie te voorkomen. 
Gezien de hoge prevalentie van heroperaties in de buik bevelen wij aan om ieder 
nieuw middel tegen adhesies te testen op preventie van adhesie reformatie in een 
klinisch relevant adhesiolyse model. 
Hoofdstuk 11 betreft een algemene discussie over de klinische implicaties van de 
verschillende studies in dit proefschrift. Daarnaast worden de toekomstige doelen 
met betrekking tot onderzoek van adhesies en adhesie gerelateerde complicaties 
besproken op basis van onderstaande ‘Adhesion 2.0’ agenda.
Figure 1  De ‘Adhesion 2.0’ agenda.
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